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Abbreviations and Definitions 
 
Explanations of these terms and abbreviations also appear in the main text 
 
ICS   International Continence Society 
 
UI   Urinary Incontinence 
UUI/OAB  Urge urinary incontinence/overactive bladder 
SUI   Stress urinary incontinence 
MUI   Mixed urinary incontinence 
PFME   Pelvic floor muscle exercises 
NICE   National Institute for Health and Clinical Excellence 
HAD   Hospital Anxiety and Depression scale 
 
sEMG Surface electromyography.  The surface recordings of 
muscle activity through the monitoring of myoelectric signals 
(which can be used as a representation of muscle function 
for the purposes of biofeedback) 
 
CMRR Common Mode Rejection Ratio.  This is a measure of how 
successfully the common mode signal (electrical noise from 
the environment) is filtered out.  It is a term used to assess 
technical parameters of the sEMG equipment. 
 
iCSP Interactive CSP a web based discussion forum for Chartered 
Physiotherapists 
 
The Knack A conscious pre-emptive pelvic floor contraction used just 
prior to exertion activity, such as a cough, sneeze or lift 
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Biofeedback The technique by which a normally unconscious 
physiological process is presented to the patient 
and/or therapist as a visual auditory or tactile signal 
(Peschers et al., 2001). 
 
Self-efficacy The belief in one’s capabilities to organise and 
execute the sources of action required to manage 
prospective situations (Bandura, 1986). 
 
Adherence The extent to which the patient’s behaviour matches 
agreed recommendations from the prescriber (Horne 
et al, 2006). 
 
Health behaviour Behaviour performed by an individual, regardless of 
his/her perceived health status, with the purpose of 
protecting, promoting or maintaining his/her health 
(Harris & Guten, 1979). 
 
The (modified) Oxford (grading) Scale 
A subjective measure of pelvic floor muscle strength 
and lift using vaginal palpation.  Recorded on a six 
point scale from 0 to 5 (Messelink et al., 2005). 
 
BMI (Body Mass Index) A proxy calculation of body fat based on weight and 
height of an individual.  It is defined as an individual's 
body mass divided by the square of his or her height. 
Abstract 
 
Background Pelvic floor muscle exercises are a recommended first-line 
treatment for stress urinary incontinence (SUI) in women (NICE, 2006).  Poor 
adherence to pelvic floor muscle exercises (PFME) is a recognised problem 
which has the potential to compromise successful treatment (Bø, 1995; 
Alewijnse et al., 2001). Biofeedback is thought to help motivate PFME 
practice but so far this has not been evaluated in a randomised study. 
 
Aim This study tests the hypothesis that use of clinic-based sEMG 
biofeedback improves women’s motivation to exercise (PFME adherence) by 
increasing pelvic floor muscle exercise self-efficacy, an important construct in 
pelvic floor muscle exercise adherence behaviour.   
 
Method After ensuring that they are able to make an informed decision to 
participate, a sample of sixty women referred for physiotherapy treatment of 
SUI between December 2008 and February 2010, gave consent to participate 
in the study.  They were randomised into one of two groups.  Thirty one 
women received clinic-based sEMG biofeedback in addition to the usual care, 
twenty nine received the usual care. Each participant attended clinic twice in a 
three month treatment period.  Women were also asked to adhere to a daily 
home exercise programme (HEP).  The primary outcome was pelvic floor 
muscle exercise self-efficacy.  PFME self-efficacy and HEP adherence, were 
assessed by means of self-completed questionnaires.  
 
Results Ten women dropped out of the study before completion.  Both 
groups improved on all outcomes, but no significant difference was found 
between the groups in terms of self-efficacy levels or exercise adherence 
rates.  PFME recall was more accurate in the intervention group receiving 
clinic-based sEMG biofeedback.  A positive and significant relationship was 
confirmed between PFME self-efficacy and PFME adherence. These findings 
are discussed in respect to the concept of self-efficacy and behavioural 
change.  
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Conclusion In the short term, clinic-based sEMG biofeedback does not 
increase PFME self-efficacy or HEP practice beyond that achieved through 
instruction using vaginal palpation. These findings refute the belief that 
monitoring with sEMG biofeedback improves self-efficacy or women’s 
motivation to adhere to a HEP, but does suggest that biofeedback may be a 
useful adjunct to teaching PFME. 
  
Preface 
Working in the area of bladder and bowel dysfunction has, for the past 10 years, 
allowed me to meet, work and learn alongside a variety of health professionals 
and patients.  Through minor involvement in multi-centre trials, completing a 
post-graduate education course, visiting experienced clinicians and participation 
in conferences and study days, my interest in evidenced practice and research 
has developed.  The doctorate programme has enabled me to maintain a clinical 
caseload alongside conducting research, the design of which I think is important 
in keeping research relevant.  There is no better way of knowing what is current 
and relevant to patient care than to research while active in clinical practice.  
Having said this, maintaining these two strands of life has not been without 
difficulty and there have been frequent challenges in terms of balancing study, 
family and clinical obligations. Nevertheless it has been an enlightening journey 
which has helped to develop both my clinical and research skills, and working 
relationships.  The rigour of academic study requires dedicated time and 
focussed attention.  In addition, the relative newness of the course itself has 
necessitated repeated explanation as to the nature of the professional doctorate, 
a process which has helped to deepen my own understanding over time.  What 
the DProf offers in terms of multi-disciplinary study and the mutual support 
offered by cohort learning has enriched both my studies and my clinical 
perspective.  Similarly, joint clinical working and collaboration adds value to 
patient care, and, as in many other areas of health care, continence 
management functions best with an interdisciplinary approach.  
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Gynaecology, urology, nursing, physiotherapy and pharmacy all play a part in the 
overall management of the patient, with physiotherapy providing a particularly 
important role in the management of stress urinary incontinence (SUI).  This 
focuses on improvement of pelvic floor function by use of pelvic floor muscle 
exercises (PFME), with the aim of reducing urinary leakage episodes.  Teaching 
pelvic floor muscle exercises and working with my patients I became curious as 
to why some patients are keen to embrace pelvic floor muscle exercise treatment 
while others seem to struggle to remember to do it, or to commit to a regimen.  I 
could see that high levels of motivation and self-confidence were evident in 
patients who were successful in adhering to treatment and wondered if these 
dimensions could be enhanced in sessions with my patients.  
 
Self-efficacy is a psychological construct, levels of which are important in 
adopting and maintaining health behaviours, such as exercise adherence, 
motivation and self-management of treatment.  Self-efficacy also seems to have 
the potential to be influenced through intervention and clinical contact, an issue 
of increasing importance in the ongoing scrutiny of treatment cost-effectiveness. 
The existing research evidence for physiotherapy management of SUI is based 
on intensive rehabilitation programmes, which, while successfully demonstrating 
the efficacy of pelvic floor muscle exercises do not reflect the sometimes very 
limited level of support and supervision available to women who are accessing 
treatment.  Economic restrictions are increasingly  affecting all aspects of health 
delivery in both the private and public sectors, and continence services are under 
pressure to justify face-to-face clinical sessions in favour of encouraging self-
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management in patients.  More limited opportunity for clinician follow-up could 
have a negative impact on outcome with regards to PFME self-efficacy and 
PFME adherence, and the evidence would seem to support this.    
The clinical guideline for urinary incontinence (CG 40), published by the National 
Institute for Health and Clinical Excellence (NICE) in 2006, is used by health 
services as the standard for urinary continence assessment and treatment.  The 
NICE recommendations regarding treatment duration for exercise effectiveness 
and use of biofeedback in women with SUI initiated my interest in looking into 
conservative treatment effectiveness and whether some interventions may have 
benefit in improving self-efficacy and treatment adherence in a service where 
treatment supervision is more restricted.    
  
Treatment of incontinence is delivered as packages of care, making appraisal of 
the effectiveness of a single modality challenging.  Although PFME is advocated 
in treatment of SUI, the evidence relating to treatment effectiveness in the clinical 
reality of day-to-day practice is less abundant, highlighting the need for 
conducting pragmatic studies to explore this issue and interventions which may 
enhance exercise outcomes. Biofeedback is claimed to improve motivation and 
exercise adherence in women with incontinence, however this claim seems to be 
based on expert clinician opinion and speculation rather than specific studies. 
 
CHAPTER ONE  Background to the study 
1.1 Introduction 
This study investigates whether pelvic floor muscle exercise (PFME) self-efficacy 
and PFME adherence is enhanced by receiving clinic-based biofeedback 
treatment as part of a minimally supervised home PFME regimen for women with 
stress urinary incontinence (SUI).   
 
PFME performed by women for a minimum of three months are demonstrated to 
be effective in the first-line treatment of SUI (Hay-Smith & Dumoulin, 2006), and 
are advocated in Department of Health clinical guidelines enshrining best 
practice for the treatment of urinary incontinence (NICE, 2006).  Performing 
PFME consistently, several times a day over many weeks, gives a training effect 
to the muscles which is crucial for treatment success (Bø, 1995).  However 
achieving the required adherence level can be a challenge for both therapist and 
patients embarking on a conservative treatment programme, and may be a 
reason why some women appear to succeed with PFME where others do not.  
Adherence to PFME should therefore be optimised, as not realising the full 
benefits of exercise as a treatment for SUI may lead to premature or even 
unnecessary surgery.   
Confidence in the correct execution of PFME is important to levels of PFME self-
efficacy (Whitford & Jones, 2011) which is an important predictor of PFME 
adherence (Messer et al., 2007).  Behaviour-specific self-efficacy measures have 
allowed identification of important relationships, for example exercise self-efficacy 
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correlating positively with exercise adherence (Lyons, 1985) and assessment 
scales have been developed to assess PFME self-efficacy in the treatment of 
urinary incontinence (Broome, 1999; Chen, 2004).  Research indicates that high 
PFME self-efficacy is associated with greater PFME adherence and improved 
clinical outcomes in women with SUI (Broome, 1999; Alewijnse et al., 2001: 
Demain et al., 2006; Hay-Smith, Ryan & Dean, 2007; Chen & Tzeng, 2009).   
Self-efficacy as a psychological construct originated in Bandura’s Self-efficacy 
Theory (Bandura, 1977), and is found in many conceptual models of health 
behaviour. This theory assumes that human motivation and action are based on 
three beliefs, situation-outcome, action-outcome and perceived self-efficacy.  
These beliefs are illustrated by the example of pelvic floor exercises used in the 
treatment of incontinence in Table 1 below.   
  
Table 1 Self-efficacy theory translated to PFME in the treatment of SUI 
Situation-outcome If I do nothing my incontinence will worsen or I 
may require surgery. 
 
Action-outcome If I perform pelvic floor muscle exercises 
adequately my incontinence will improve. 
 
Perceived self-efficacy I am able to perform pelvic floor muscle 
exercises a) correctly and b) often enough, to 
be effective. 
 
 
The link between levels of self-efficacy and behavioural change have been made 
in other areas of health promotion, for example smoking cessation (Rosal et al., 
1998) and use of mammography services (Allen et al., 1998). However, although 
evidence establishes self-efficacy as an important determiner of such behaviour, 
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research to identify which treatment interventions can change self-efficacy is 
lacking (Ashford, Edmunds and French, 2010).  Pelvic floor physiotherapy would 
be expected to improve PFME self-efficacy as it usually involves individual 
assessment, instruction, advice and clinician support, all of which promote patient 
self-management and improvement of UI.  Some commentators propose that 
using machine-biofeedback, such as surface electromyography (sEMG), as part 
of pelvic floor physiotherapy treatment, may increase PFME motivation (Kegel, 
1948; Burgio, Robinson & Engel, 1986; Glavind, Nohr, Walter, 1996; Berghmans 
et al., 1998; Morkved, Bø & Fjortoft, 2002).  So far this claim has not been 
explicitly explored and recent review papers remain inconclusive as to the benefit 
of different methods of biofeedback (Herderschee et al., 2011).  
sEMG involves monitoring pelvic floor muscle exercise performance, usually via 
an intra-vaginal probe, displaying patient effort in graph-form on a computer 
screen. This graphical display can be used as a teaching tool during the clinic 
exercise session (Haslam, 2008b), allowing discussion between physiotherapist 
and patient regarding exercise performance and ways to improve.  Modification 
of effort is seen instantly on the screen.  sEMG can serve to inform an 
appropriate home exercise regimen and may also be used as a training aid.  The 
use of biofeedback would seem to fit well with the concept of enhancing 
perceived self-efficacy, as it imparts information to patients about the objective 
parameters involved in a muscle contraction, thought to be important in improving 
motivation and enhancing treatment adherence (Emmons & Rollnick, 2001).  The 
use of interventions to increase self-efficacy has been shown to improve self-
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management in diabetes management (Anderson et al., 1995), reduce risk 
factors relating to cardiovascular health (Edmundson et al., 1996) and increase 
adherence to PFME in pregnancy (Whitford & Jones, 2011).  However there 
appears to be very few intervention studies aimed at increasing PFME self-
efficacy in the treatment of urinary incontinence.  The aim of this study was 
therefore to investigate whether the addition of an intervention (sEMG 
biofeedback) to an existing clinical physiotherapy programme would increase 
PFME self-efficacy and PFME adherence thereby optimising success of PFME in 
the conservative treatment of women with SUI.  The diagram in figure 1 
represents the proposed relationship. 
PFME  
Self-efficacy 
PFME 
Adherence 
Pelvic floor 
muscle  
exercises 
sEMG 
Biofeedback 
Clinical 
Outcomes 
(Urinary 
leakage, 
QoL, PFME 
strength) 
 
Figure 1 Diagram proposing the theoretical relationships between PFME, biofeedback, 
PFME self-efficacy, PFME adherence and clinical outcomes. 
 
The diagram in figure 1 suggests that performing PFME with the assistance of 
sEMG biofeedback will affect PFME adherence and PFME self-efficacy.  
Changes in PFME adherence may also impact on PFME self-efficacy and vice 
versa.  Each may influence clinical outcomes, which in turn could impact on 
PFME adherence and PFME self-efficacy. 
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1.2 Background to Urinary Incontinence 
Urinary incontinence (UI) is defined as ‘the complaint of any involuntary leakage 
of urine’ (Abrams et al., 2002: p.1632).  It can occur as a result of a variety of 
disease processes and as such should be viewed as a symptom rather than a 
disease in itself.  Community prevalence of UI is thought to be high, however 
reports vary widely; from 50% of all people in residential care (Damian et al., 
2004) to between  6% and 72% of community-dwelling women aged 17 to 79 
(Hunskaar et al., 2002). True prevalence estimates are complicated by probable 
under-reporting of symptoms, either due to embarrassment or because effective 
management of mild symptoms means it is not perceived to be a problem (Shaw 
et al., 2006).  Nevertheless in general terms it can be said that UI is about twice 
as prevalent in women than men, increases with age and is estimated to affect 
about 30% of women over the age of 50 (Hannestad et al., 2000; Milsom et al., 
2009).  Urinary incontinence reduces quality of life, impinges on sexual life and 
causes social isolation (Temml et al., 2000). In addition, it leads to avoidance of 
physical exercise and activity, acknowledged as being important in maintaining 
general health and well-being and which increasingly forms a crucial part of many 
other disease-prevention strategies (Bouchard, Shephard & Stephens, 1994).   
Treatment of UI involves conservative measures (PFME, behavioural and 
lifestyle advice), investigations and tests (such as urodynamics studies), drug 
therapy, surgery and provision of containment products (such as absorbent 
pads).  These services carry a financial cost, requiring at least 2% of the annual 
health service budget (Ekelund, Grimby & Milsom, 1993).  Given the high 
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community prevalence of UI, and the increasing longevity and lifestyle 
expectations of women wishing to remain active into older age, delivering 
effective treatment can be seen as being extremely important; both in terms of 
addressing improvements in quality of life as well as helping prevent health 
decline, for a significant proportion of the population.   
 
1.3  Background to Stress Urinary Incontinence (SUI)  
Sub-divisions of UI, as classified by the International Continence Society (ICS), 
include stress urinary incontinence (SUI), urge urinary incontinence (UUI)/ 
overactive bladder (OAB) (see Table 2) and mixed urinary incontinence (MUI), 
which is a mixture of urge and stress symptoms.   
 
Table 2   Types of urinary incontinence (ICS definitions, Abrams et al., 2002) 
SUI Involuntary leaking of urine on effort or exertion 
such as coughing, sneezing or with exercise. 
 
UUI or OAB Urinary incontinence related to feelings of an 
overwhelming desire to empty the bladder 
(urgency of urination).  Leakage of urine is 
associated with, and immediately following, the 
feeling of needing to empty the bladder. 
 
 
 
SUI is characterised by involuntary loss of urine at times of raised intra-
abdominal pressure due, in part, to failure of the urethral sphincter closure 
mechanism and inadequately functioning pelvic floor muscles.  An Italian study 
(Siracusano et al., 2003) reported that 83% of women with incontinence were 
suffering with SUI.   SUI is thought to affect up to one in three women over 18 
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years of age in the UK (Hunskaar et al., 2004). These high figures are due to the 
main risk factor of pregnancy and vaginal delivery, with chronic coughing, 
smoking, constipation and obesity thought to be contributing factors (Bump et al., 
1992; Spence-Jones et al., 1994). Worsening symptoms are associated with the 
menopause (MacLennan et al., 2000) both as a function of age and of hormonal 
fluctuation.  
 
1.3.1 Treatments and use of PFME in SUI 
Continence is maintained by the interplay of many mechanisms, and relies on 
well-functioning neurological, cognitive, physiological and musculoskeletal 
systems.  Treatment of SUI includes surgery, such as colposuspension, which in 
recent years has been largely superseded by the Tension-free Vaginal Tape 
(TVT) and Trans-Obturator Tape (TOT).  Alpha-agonist medication increases 
bladder neck tone and is a more recent treatment addition.  The cure rates for 
Tape procedures are between 63% and 85% (Cody et al., 2003).  Apart from the 
usual risks involved with any surgery, there are five main complications of 
artificial sling (TVT/TOT) procedures.  These are failure to resolve symptoms of 
SUI (perhaps necessitating a repeat procedure), bladder injury, tape erosion, 
incomplete emptying of the bladder (requiring a period of intermittent 
catheterisation), and worsening or new symptoms of urinary urgency.  However, 
as a first line treatment, there is capacity to improve overall pelvic floor function 
and symptoms of urinary incontinence by exercising the pelvic floor muscles (Bø 
& Sherburn, 2005).  This approach has a long history of documented benefits 
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(Kegel, 1948) with high level research evidence supporting use of PFME in 
treatment of SUI.  Pelvic floor muscle training currently forms the mainstay of 
conservative treatment for SUI in women, and this is supported by Cochrane 
reviews (Dumoulin & Hay-Smith, 2010) and national guidance (NICE, 2006).  
Therefore the NICE guideline advocates confirming (by muscle palpation) that a 
correct PFM contraction is being achieved, and a 12-week period of supervised 
PFME prior to considering surgery.  For this to be successful, active patient 
participation is required. There are no contra-indications or precautions to PFME 
and they have no known side-effects.  However, pelvic floor muscle exercise 
studies produce variable cure rates indicating that PFME may not work for every 
woman.  Lack of success may be due to factors such as fascial weakness, nerve 
damage or anatomical anomalies, but another acknowledged issue is that of poor 
exercise adherence (Bø, 1995; Alewijnse et al., 2001; Chiarelli, Murphy & 
Cockburn, 2003).  
Adherence behaviour is affected by many factors, and self-efficacy plays an 
important role (Bandura, 1977).  Compliance with a PFME programme requires a 
high level of self-efficacy, with belief in the effectiveness of PFME and confidence 
in ability to perform the exercises thought to have the most influence on self-
efficacy (Hay-Smith, Ryan & Dean, 2007; Whitford & Jones, 2011). 
Physiotherapists are aware of the need to teach correct contraction of the pelvic 
floor muscles (Bump et al., 1991) and also to motivate, support and guide their 
patients in home exercise programmes.  Education regarding the benefits of 
PFME, individual exercise instruction and regular follow-up all seem to help with 
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this process (Lagro-Janssen et al., 1991; Kim, 2001; Konstantinidou et al., 2007).  
However, patient self-management of PFME seems to be associated with a 
decline in self-efficacy over time (Demain et al., 2006).  
Anecdotal and expert opinion suggests that women appear to benefit from the 
use of biofeedback, the visual feeding back of individual performance and 
progress providing a feeling of accomplishment (Burns et al., 1993; Laycock et 
al., 2001a; 2001b). In addition, the confirmation that women are performing 
PFME correctly is thought to play a role in encouraging and increasing motivation 
to perform PFME and improving adherence to an exercise regimen (Taylor & 
Henderson, 1986; Glavind, Nohr & Walter, 1996; Wong et al., 2001; Laycock et 
al., 2001a; Aukee et al., 2002; Mørkved, Bø & Fjortoft, 2002; Schmidt et al., 
2009).  However, these suppositions are untested, as it appears that no 
biofeedback studies have specifically evaluated PFME adherence or self-efficacy 
alongside clinical outcomes as primary outcomes.  Furthermore, studies 
assessing the clinical value of adding biofeedback seem to have produced 
contradictory evidence (de Kruif & van Wegen, 1996; Berghmans et al., 1998; 
Weatherall, 1999).  Clinical guidance currently concludes that biofeedback 
confers no added benefit to performing PFME.  Biofeedback is therefore not 
recommended for use routinely as part of pelvic floor muscle exercise training in 
women with SUI (NICE, 2006).   
 
Success in the conservative treatment of SUI in women relies in part on women’s 
ability to successfully follow a sufficiently intensive PFME training programme for 
a minimum period of 12 weeks (NICE, 2006).  Adherence to a correctly executed 
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exercise regimen is therefore of the utmost importance and crucial to successful 
treatment; lack of adherence being recognised as a major barrier to symptom 
improvement (Bø & Talseth, 1996; Chen et al., 1999).  Reasons for PFME non-
adherence may be varied but could be due to women having low PFME self-
efficacy.  Self-efficacy is the belief in one’s ability to make or pursue a specific 
action or change (Bandura, 1986) and is influenced by social, personal and 
situational factors. It is known to be an important construct in behaviour change 
and, in this context, is the belief that a woman can perform PFME correctly and 
often enough to be effective in improving her urinary incontinence.  Clinician- 
supported conservative treatment would be expected to increase self-efficacy, 
and less clinician supervision appears to compromise self-efficacy in women with 
SUI (Kim, 2001; Demain et al., 2006).  This is of concern, as continence service 
reviews increasingly scrutinise the cost-effectiveness of the contact time, and 
number of follow-up sessions, offered to patients.  As biofeedback is thought to 
improve motivation, it is proposed that the addition of sEMG biofeedback may 
function by increasing self-efficacy to perform PFME, enhancing the value of 
clinical contact time available to women.  
1.4 Conclusion  
Self-efficacy appears to be an important factor in motivation and a high level is 
associated with improved exercise adherence. Self-efficacy acts to enable an 
individual; increasing perceived ability to deal with unforeseen situations and 
giving a sense of control, and, in this way becomes a worthy outcome in itself.    
Inclusion of sEMG biofeedback sessions for women with SUI is already 
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recommended for women who are unable to perceive a PFME contraction (NICE, 
2006), and may improve PFME self-efficacy and PFME adherence in women with 
good PFME awareness, however this has not been studied before.  PFME 
success correlates highly with PFM training levels because there is a dose 
response (Bø, 2007).  Therefore poor exercise adherence compromises the 
PFME treatment effect. This is costly, not only economically due to wasted 
physiotherapy clinic time and continued use of containment products, but also in 
terms of human suffering through extending the misery for women suffering with 
urinary incontinence.  Interventions to support patient exercise adherence in 
order to maintain treatment intensity, where access to clinic session support may 
be limited, would have clear clinical and cost-effective advantages.  That said, 
machine-mediated biofeedback is an invasive intervention and has implications 
for resources.   Equipment and probes can be expensive and expertise in using 
the equipment and knowledge of muscle training is needed.  As sEMG is not 
available in all healthcare settings, it is also important to establish whether or not 
the current inequality of access to biofeedback services means that some 
patients are missing out on a potentially useful adjunct in their pelvic floor 
rehabilitation.    
 
Chapter Two describes the anatomy and function of the pelvic floor and outlines 
the rationale for exercising the pelvic floor muscles as a treatment approach for 
women with SUI.   Chapter Three explores adherence and the construct of self-
efficacy in behavioural change.  Chapter Four outlines the use of sEMG 
biofeedback in pelvic floor rehabilitation.  Chapter Five concludes with a review of 
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the literature relating to interventions to enhance self-efficacy in the treatment of 
UI, and an in-depth review of the randomised study evidence for the efficacy of 
machine-mediated biofeedback (with pelvic floor muscle exercise instruction as a 
comparator).  Against the backdrop of previous work conducted, justification is 
also presented for studying the role of clinic-based sEMG biofeedback in 
increasing PFME self-efficacy and adherence to PFME in women with SUI. 
Chapter Six outlines the methods of the study and Chapter Seven presents the 
results.  Chapter Eight discusses the results and the clinical and further research 
implications of the study conducted. 
 
 
 
 
 
CHAPTER TWO    Pelvic floor muscle exercises in the treatment of SUI 
 
The success of the physiotherapeutic treatment of SUI is based on improving the 
function of the pelvic floor muscles.  To understand this more fully, it is important 
first to explain how pelvic floor muscle anatomy and physiology contribute to 
maintaining continence. 
 
2.1 Muscle function 
Anatomically, the pelvic floor muscles consist of ‘superficial’ and ‘deep’ layers 
forming the floor of the pelvic basin. In conjunction with the endopelvic fascia and 
ligaments, the deep layers, otherwise known as the levator ani, form the levator 
plate providing support to the pelvic organs and helping to control the urethral 
and bowel sphincter openings (Figure 2). 
 
 
Figure 2 The female bladder viewed from above (taken from Gray’s Anatomy) 
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Ligaments and fascia of the pelvic floor are subjected to gravitational and 
abdominal pressure forces, with tonic activity in the pelvic floor muscles 
functioning to relieving this pressure, reducing strain and damage to connective 
tissues (Ashton-Miller & DeLancey, 2007).  Contraction of the pelvic floor 
muscles produces a forward (anterior) and upwards (cephaladic) movement, 
helping to close the pelvic openings (DeLancey, 1988), with a voluntary 
contraction of the pelvic floor muscles often described as a squeeze and inward 
lift.  
 
2.2   Mechanism of muscle action  
Pressure theory (Rud et al., 1980) posits that urethral closure pressure must be 
greater than bladder pressure to maintain continence.  Urethral closure pressure 
is achieved by the configuration of the striated urogenital sphincter muscle (made 
up of a large proportion of type 1 muscle fibres responsible for maintaining 
constant tone and allowing voluntary increases in tone), a loop of smooth 
detrusor muscle and the vascular plexus present within the urethral sub-mucosa.  
In addition, longitudinal and circular smooth muscle layers assist urethral closure.  
Hypertrophy of the pelvic floor muscles, achieved through exercising, is proposed 
to increase the resistance of the striated muscle layer in the urethral sphincter 
(Ashton-Miller & DeLancey, 2007). In addition contraction of the pelvic floor 
muscles produces elevation and clamping of the urethra raising urethral pressure 
and maintaining continence.  It is thought that this mechanism occurs 
automatically in continent women, milliseconds before a rise in bladder pressure 
(Constantinou & Govan, 1982).  In incontinent women use of a well-timed pre-
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emptive conscious PFM contraction (‘the knack’) is shown to be effective in 
preventing urinary leakage when coughing (Miller, Ashton-Miller & DeLancey 
1998) and ultrasound imaging of the pelvic floor and urethral position supports 
the contribution of muscle contraction timing to good pelvic floor function  
(Thompson & O’Sullivan, 2003; Jones, Peng & Constantinou, 2006).  The 
Hammock hypothesis (DeLancey, 1994) proposes that the anterior vaginal wall 
(plus connective tissue), the anterior portion of the levator ani, ligamentous 
attachments and the tendinous arch of the pelvic fascia act as a supporting 
‘hammock’ under the bladder neck and urethra maintaining anatomical position 
(see Figure 2) and also functioning as a ‘backstop’ against which the urethra is 
compressed during raised intra-abdominal pressure to maintain continence.  This 
rationale suggests that exercising the pelvic floor muscles increases the stiffness 
and rigidity in the levator ani, improving the function of the pelvic floor as a toned 
platform to squash the urethra against, keeping the urogenital hiatus closed and 
preventing descent during abdominal pressure and visceral inertial load (Bø, 
2004; 2007).  This theory is supported by studies demonstrating higher resting 
anatomical position of the pelvic floor in continent women (Peschers et al., 1997; 
Hoyte et al., 2001), smaller (MRI measured) surface area of the pelvic floor 
muscles (indicating increased tone) and greater resting urethral stability, both 
following a period of PFME training (Balmforth et al., 2004; Dumoulin et al., 
2007). 
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Figure 3 Diagram showing pelvic floor muscles in relation to bladder, vagina and bowel 
(courtesy of Julia Herbert). 
 
Pelvic floor muscle training has been shown to improve women’s overall 
continence status (Theofrastous et al., 2002), and positive correlation has been 
demonstrated between maximal pelvic floor strength and reduction in urinary 
leakage (Bø, 2003).  Pelvic floor muscles in women with urinary incontinence are 
also shown to measure less maximal strength, responsiveness, endurance and 
tone than asymptomatic women (Morin & Bourbonnaise, 2004).   
As a result of these findings, all mechanisms of PFM action are considered in the 
rationale for treatment.     
 
2.3   Exercise regimens  
PFME programmes aim to improve pelvic floor muscle strength and contraction 
timing in order to provide structural support, muscle tone or ‘stiffness’ and muscle 
responsiveness, thereby improving overall pelvic floor function (Bø, 2004).  In 
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women with no (or little) discernable pelvic floor muscle contraction (graded on 
the Modified Oxford Scale as 0 or 1) neuromuscular electrical stimulation (NMES) 
is advised in the first instance (Laycock et al., 2001 b).  If a muscle contraction is 
palpable, pelvic floor muscle exercises are encouraged using a regimen to 
facilitate muscle strengthening, responsiveness and endurance.  The pelvic floor 
muscles are composed of 33% ‘fast’ phasic fibres and 67% ‘slow’ tonic fibres.  
Slow motor units are initially recruited, followed by fast motor units as greater 
load is placed on the muscle and improved muscular effort is required (Mendell, 
2005). Therefore regimens to train both types of fibres are required to improve 
overall pelvic floor function.   
Sports science evidence advocates exercises should aim for low repetitions and 
high loading of muscles to achieve strengthening, high repetitions and low load 
for endurance, and rapid muscle contractions to improve responsiveness and co-
ordination (Bø, 1995).  Indirect training of the pelvic floor muscles via recruitment 
of the deep abdominal muscles, in particular Transversus Abdominus (Sapsford 
et al., 2001) is an approach developed in response to the observation that the 
pelvic floor muscles contract as part of the ‘abdominal capsule’ in core stability 
work. However the evidence for this approach with regards to treatment for SUI is 
sparse and remains a contentious issue (Bø et al., 2009; Sapsford, Hodges & 
Smith, 2010).  Low-level functional muscle work, that is low intensity contraction 
of PFM performed during everyday activity is also thought to improve continence 
(Carrierre, 2006), however evidence is lacking in support of this being used as 
the only method of treatment for SUI (Bø, 2007). 
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Regimens of exercises used in studies successfully demonstrating PFME 
effectiveness vary widely: Kegel (1951) suggested three exercise sessions a day 
aiming for 300 contractions, Bø et al. (1990) instruct 8-12 contractions performed 
three times a day, Choi, Palmer & Park (2007) advise at least 24 contractions per 
day, and others posit that pelvic floor strength can be maintained with as little as 
8-12 contractions performed three to four times a week (Dougherty et al., 1993; 
Bø, 1995).  As timing of contraction plays a role in reducing leakage, women are 
therefore encouraged to improve the responsiveness of pelvic floor muscle 
contractions as well as to perform the knack (Miller, Ashton-Miller & De Lancey, 
1998).  The knack is used just before moments of anticipated rise in intra-
abdominal pressure (such as coughing or when lifting), in order to counterbrace 
and stabilise the pelvic floor, assist urethral closure (reduce leaking) and prevent 
stretching and further weakening of the pelvic floor musculature.   
Current expert consensus from the evidence is that PFME should be performed 
daily and should address strengthening, co-ordination and endurance training 
principles, as depicted in Table 3, (Laycock et al., 2001b).  More recent guidance 
(NICE, 2006), recommends three PFME sessions a day for a minimum of 12 
weeks.  The aim of treatment is to improve timing of contraction, strengthening 
and stiffness of the pelvic floor (Dumoulin & Hay-Smith, 2010). 
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Table 3 Principles of muscle training (McArdle, 1994) 
 
Specificity 
 
 
The correct group of muscles needs to be worked. 
These muscles need to be identified and a correct 
contraction confirmed by palpation. 
 
 
Overload 
 
 
Muscles need to be worked harder than usual for 
them to improve.  This needs concentration and 
effort and is a continuous process.  This is achieved 
by changing ‘hold time’, repetitions or reducing the 
rest periods between contractions. 
 
 
Maintenance 
 
 
Exercise needs to continue on a regular basis to 
maintain improvement. This may be at a lower level 
than the initial training intensity. 
 
 
Reversibility 
 
 
If training stops, muscle function declines in 4-6 
weeks.  However this is itself reversible with 
resumption of training. 
 
 
 
2.4 Evidence for efficacy of PFME in SUI  
Randomised controlled trials (RCTs) evaluated in Cochrane reviews, the most 
recent of which was conducted by Dumoulin & Hay-Smith in 2010, strongly 
support the use of PFME in treating women with SUI.  This evidence not only 
shows PFME to be better than no treatment, but also reports a number of studies 
demonstrating cure rates of between 44% and 70% of participants (Henalla, 
Millar & Wallace, 1990; Wong et al., 1997; Bø, Talseth & Holme, 1999; Mørkved, 
Bø & Fjortoft, 2002; Dumoulin et al., 2004).  When evaluating this evidence, it 
must be remembered that clinic support available to research participants is often 
generous: three to four sessions a day with the physiotherapist for four weeks 
(Glavind, Nohr & Walter, 1996), twice a week for four weeks (Wong et al., 1997), 
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clinic training once a week (Henalla et al., 1989; Bø, Talseth & Holme, 1999; 
Mørkved, Bø & Fjortoft, 2002; Aksac et al., 2003; Dumoulin et al., 2004).  While 
delivering treatment intensively may ascertain efficacy of exercise treatment, 
frequent clinic sessions are becoming increasingly difficult to offer in day-to-day 
clinical practice, further emphasizing the importance of optimal patient adherence 
in ensuring that an effective level of muscle training is achieved.  Therefore 
interventions are needed to improve exercise adherence and ensure treatment 
success. 
 
2.5   Conclusion  
Although the literature highlights a number of studies using a variety of different 
PFME protocols, there remains strong evidence for recommending PFME in 
treating SUI. The rationale is that contracting the muscles correctly, maximally 
and repeatedly, over a minimum period of 12 weeks, improves pelvic floor 
muscle strength and contraction timing, thereby improving overall pelvic floor 
function and reducing urinary leakage.  However adherence is essential and poor 
adherence is a stumbling block to progress.   Regular and correct PFME are 
important for successful treatment, and adoption of a daily exercise routine and 
self-management of exercises in the long term is crucial in maintaining 
improvement and preventing reversibility (see Table 3).   
 
However, individuals who are prescribed an exercise routine will exhibit different 
health behaviour with varied levels of adherence. Therefore it is important to fully 
understand what influences a person’s health behaviour, and to be aware of 
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negative adherence so as to develop strategies to improve adherence to 
prescribed exercise routines for them to be effective.  This will be explored and 
expanded on in the next chapter.  
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CHAPTER THREE     Adherence and self-efficacy 
 
 
3.1 Introduction 
Maintaining good health and successful health treatment often depends on 
adopting advice and following treatment programmes.  Whether it is an exercise 
protocol, taking medication as prescribed, eating healthily or stopping smoking, 
healthy behaviour needs to carry on beyond the clinic and become a daily 
routine; a part of everyday life for the individual.  Behaviour is therefore linked to 
health and vice versa.  Health behaviour is defined by Harris & Guten (1979) as, 
 
‘behaviour performed by an individual, regardless of his/her perceived health 
status, with the purpose of protecting, promoting or maintaining his/her health’.  
 
The terms adherence and compliance are often used interchangeably in the 
literature.  Horne et al. (2006) usefully summarise the terminology found in the 
literature (see Table 4). 
 
Table 4 Definitions of compliance, adherence, concordance and persistence (Horne et 
al. 2006). 
Compliance the extent to which the patient’s behaviour 
matches the prescriber’s recommendations 
 
Adherence the extent to which the patient’s behaviour 
matches agreed recommendations from the 
prescriber 
 
Concordance A two-way relationship between patient and 
physician where treatment decisions are 
discussed and the treatment of choice is the 
one most acceptable to both parties 
 
Persistence the continued adherence over time to the 
prescribed medication 
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The word adherence is usually preferred by healthcare researchers as it implies 
patient autonomy, and a willingness to participate and co-operate rather than the 
traditional view of an expert doctor dictating to a naive patient.  It is deemed to be 
a non-judgemental term, a descriptive statement of fact, with blame not 
apportioned to the patient, therapist or treatment (Haynes et al., 2002).   
Successful adherence to treatment is a complicated issue to address.  
Adherence varies between patients and over time.  It is also influenced by many 
factors, with over 200 variables shown to correlate with adherence to exercise 
alone (Sluijs & Knibbe, 1991) including previous experience with exercise, 
motivation, social support and time/economic considerations (Howard & Gosling, 
2008).  In pelvic floor muscle exercise treatment, reasons given for non-
adherence with home exercise programmes include not achieving symptom 
relief, inability to remember the exercises, forgetting to do them, perceiving the 
leakage as not being a priority, concern that the exercises may control but not 
cure the symptoms and uncertainty about ability to execute PFME (Hayn et al., 
2000; Chen, 2001; Dean, Hay-Smith & Elley, 2009).  Other reasons expressed 
for being unable to adhere to treatment programmes include being unable to 
travel to clinic, lack of time, inconvenience, too long-lasting a treatment, or a poor 
relationship with the clinician (Paddison, 2002).    
Urinary incontinence impacts on many aspects of life and a holistic view of 
adherence issues needs to be taken into account (Broome, 2003).  Adherence 
may be described as relating to four main areas: the patient, the condition, the 
treatment and the patient/clinician relationship (Meichenbaum & Turk, 1987). 
 23
Other perspectives identify intentional and unintentional factors or practical and 
perceptual barriers, and disease-related factors and patient beliefs are thought to 
play a particularly important role (Horne et al., 2006). Although practical 
obstacles, such as time, access and cost can be relatively easy to ascertain, 
perceptual issues, such as beliefs, are harder to evaluate (Kane & Robinson, 
2010).  A deeper understanding of adherence is achieved by exploring the 
theoretical foundations of adherence behaviour, and concepts such as self-
efficacy which seem important in mediating behaviour change (Sirur et al., 2009).  
The following section explores the theoretical foundations of adherence 
behaviour and subsequent sections focus specifically on self-efficacy. 
 
3.2  Adherence  
Leventhal & Cameron (1987) identified five theoretical perspectives from which to 
view adherence behaviour: Behavioural, Biomedical, Communication, Cognitive 
and Self-regulatory.  Each of these perspectives may be mapped to several of 
the numerous theories of behavioural change described in the literature (Mitchie 
et al., 2005).   
Behavioural approaches may include daily completion of a diary, posting of 
reminder stickers, and now, more commonly, electronic reminders to exercise 
which can be programmed into a mobile phone or set up to appear on a 
computer desktop.  The rewards and cues used in this approach are useful and 
popular adjuncts to treatment, with reminder systems and diaries commonly used 
in PFME treatment. In one of the few studies testing the effect of these types of 
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interventions on PFME adherence, home audiotapes were shown to improve 
compliance with a home pelvic floor exercise programme (Gallo & Staskin, 1997). 
The Biomedical perspective, perceives the clinician as the dispenser of objective 
advice and patients as (compliant) passive receivers, absorbing information and 
unquestioningly following instruction. Patients can respond well to the approach 
of the traditional authoritative health professional offering diagnosis and 
prescriptive treatment (Savage & Armstrong, 1990).  Positive responses seen in 
patients may be attributed to the demonstration of referent or expert power 
(Stanton, 1987) or input from powerful others (Wallston & Smith, 1994).  
However, it seems unlikely that direct instruction alone will result in optimal 
adherence behaviour.  The biomedical approach to adherence focuses on the 
body or condition and poor adherence is usually attributed to characteristics such 
as age, gender, socio-economic status or the severity of symptoms.  Symptom 
severity certainly plays a role. Patients with less problematic symptoms and 
patients suffering with long-term chronic conditions are shown to be more likely to 
demonstrate reduced adherence levels (Damrosch, 1995).  In incontinence, 
perhaps unsurprisingly, improved adherence to PFME is noted in those with 
more severe leakage (Alewijnse et al., 2003; Shishani, 2003; Chen & Tzeng, 
2009).  Absence of symptoms in many asthma patients can result in a lack of 
recognition about the necessity to continue to take regular medication (Halm, 
Mora & Leventhal, 2006).  Moreover, where no disease or symptoms are present 
at all, as is the case in health promoting strategies such as cervical smear 
screening, regular dental flossing, maintaining healthy dietary habits or attending 
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for mammograms (Luszczynska & Schwarzer, 2003), adherence behaviour 
seems especially difficult to achieve.  This is also evident in incontinence 
prevention programmes where uptake of post-natal PFME instruction (Gillard & 
Shamley, 2010) and adherence to PFME programmes in asymptomatic 
undergraduate women (Tremback-Ball, 2006) is found to be poor.  
Older studies indicate that one quarter of patients forget Information given to 
them about their condition, including instructions about ‘how’ and ‘how long’ to 
take medication (Bain, 1977; Crichton, Smith & Demanuele, 1978).  Information-
giving about bladder habit and PFM function forms a central component of 
continence health promotion with knowledge of risk factors shown to be important 
in self-management of UI (Holroyd-Leduc et al., 2011).  Knowledge and 
education also features in guidelines and recommendations for the physiotherapy 
treatment of SUI (Laycock et al., 2001b; NICE, 2006).  However studies 
examining adherence to PFME also demonstrate that knowledge alone is 
insufficient in improving adherence (Alewijnse et al., 2003; Tremback-Ball, 2006; 
Messer et al., 2007) and indicates that additional factors, other than merely 
knowing more about a condition or treatment, are important in adopting treatment 
advice.  
How information is presented and delivered seems to make a difference (Ley, 
1989), with compliance (the term used by Ley), directly predicted by the 
satisfaction with the clinical consultation, and the understanding and 
remembering of information given.  Patient satisfaction with the consultation can 
be difficult to define.  It is affected by information, for example whether this is 
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individualised or generic (Berry, Michas & Bersellini, 2003), how much 
information is given (Ley, 1989), how it is delivered, the perceived competence of 
the clinician giving it, as well as the emotional support and understanding shown 
by the clinician (Haynes, Sackett & Taylor, 1979; Ley, 1988; Sala, Krupat & 
Rother, 2002).   In a meta-analysis of research looking at recall (Ley, 1981; 
1989), age was found to have no bearing on accuracy of memory; but medical 
knowledge, intellect, information importance and quantity of information all seem 
to affect ability to remember information given during a consultation.   
Clinicians treating incontinence make use of different types of information-giving 
in order to enhance remembering and understanding.   Giving written instructions 
reinforces salient points and acts as a reminder.  The patient can take the 
information sheet home and consult it again.  Anatomical models, leaflets, 
analogy and imagery also help with this process.  Locating the pelvic floor 
muscles on a model or diagram provides important visual information helping to 
achieve understanding which is not always possible through verbal or written 
explanation alone.  Similarly, imagery and visualisation help the teaching of 
pelvic floor muscle exercises; for example, the muscle response may be likened 
to a high speed lift going up to the top floor of a building in order to visualise and 
establish a brisk, high intensity contraction.  sEMG gives a visual representation 
of pelvic floor activity and can be used as a further way of giving information.   
lllness cognition beliefs help patients understand and cope with their illness, as 
well as form implicit common-sense beliefs about their condition.  Patient beliefs 
and perceptions of their illness impact on their motivation and adherence 
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(Leventhal, Meyer & Nerenz, 1980; Leventhal et al., 1997).  For the clinician this 
underlines the importance of establishing coherence between a patient’s Illness 
beliefs and treatment beliefs. Beliefs around the success/prognosis of treatment 
and the health consequences of non-compliance have been shown to influence 
adherence (Friedman et al., 2008).  Moreover, better adherence to medicine-
taking is found if patients believe both that their condition is serious but that it can 
also be controlled (Brewer et al., 2002).  Unsurprisingly, successful adherence is 
linked to a greater belief in the effectiveness of the medication (Senior & 
Marteau, 2007), with doubt about the necessity for treatment (and the 
effectiveness of the treatment) found in poor adherers (Horne & Weinman, 2002; 
Llewellyn et al., 2003).  These findings further highlight the importance of 
evaluating patient perspective and attitude, as well as awareness of their 
condition, and the range and effectiveness of treatments available.  Correction of 
misconceptions about incontinence, and accurate information about treatments, 
are crucial. Therefore clinician appraisal of patient perspective is vital to 
successful management.  Exploring these beliefs with patients requires effective 
communication, which can be assisted by adopting an interactive, patient-centred 
consulting style (Byrne & Long, 1976; Emmons & Rollnick, 2001).   
Reasons for poor PFME adherence have been studied before (Chiarelli, Murphy 
& Cockburn, 2003; Paddison, 2002: Alewijnse et al., 2001 and 2003) and 
theoretical underpinnings related to PFME adherence have also been discussed 
(Broome, 1999; Alewinjnse et al., 2001; Chen, 2004; Chen & Tzeng, 2009). 
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Cognitive models encompass psychological theory and help understanding of the 
multiple levels of influence in adherence behaviour. These models share the 
assumption that the person is cognitively aware; that is, a person has foresight, 
planning, and decision-making capability and can also goal-orientate and self-
regulate their responses (Brawley & Culos-Reed, 2000).    Self-efficacy appears 
in different guises in many cognitive models of health behaviour, mainly because 
belief in personal efficacy not only affects health behaviour directly, but also 
indirectly by influencing goals, outcome expectations, and the individual factors 
which obstruct and assist change (Bandura, 2004).   Incontinence impacts on the 
physiological, psychological and sociological aspects of women’s lives, so it is 
important that any theory or model of adherence encompasses these 
dimensions.  Self-efficacy is an important construct in adherence, and has been 
identified as important to optimal PFME adherence in UI (Chen, 2001; Alewijnse 
et al., 2003; Demain et al, 2006; Hay-Smith, Ryan & Dean, 2007).   
 
3.3   Self-efficacy  
Personal efficacy or self-efficacy first appeared in self-efficacy theory developed 
by Bandura in 1977, however it is also found in Protection Motivation Theory 
(Rogers, 1983), as perceived behavioural control in the Theory of Planned 
Behaviour (Ajzen, 1985) and forms the central concept of Social Cognitive 
Theory (SCT) (Bandura, 1986).  Self-efficacy is also important in progression 
through ‘stages’ of behavioural change (Prochaska and DiClement, 1984; 
Schwarzer, 1992), in self-regulation (Morrison & Bennett, 2009), and goal-striving 
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(Locke & Latham, 2002).   The presence of self-efficacy in so many health 
models indicates the overall significance of this construct in behavioural change 
and theories of adherence.  This is because motivation to exercise is cognitively 
generated, and motivation is enhanced by self-efficacy (Bandura, 1997).   
Self-efficacy is one of the main and most consistent factors predicting 
behavioural change (Morrison & Bennett, 2009, p.158) and a more powerful 
predictor of exercise adherence than either self-motivation or locus of control 
belief (Sallis et al., 1988; Dishman, 1994). The construct, sources and relevance 
of self-efficacy to this study is explored in the following sections. 
3.3.1 Definition of self-efficacy 
Self-efficacy is defined as ‘the belief in one’s capabilities to organise and execute 
the sources of action required to manage prospective situations’ (Bandura, 
1986).  It assumes that human motivation and action are based on three beliefs: 
situation-outcome, if I do nothing my situation will worsen; action-outcome, if I 
take action my situation will improve; and perceived self-efficacy, I am able to 
perform the required action correctly and for long enough to be effective.  Apart 
from self-efficacy, other dimensions of SCT with regards to health include, 
knowledge of lifestyle habits and their influence on health, health goals, costs 
and benefits of lifestyles, the value placed on outcomes and environmental 
facilitators and constraints.  Self-efficacy also affects these other SCT factors by 
influencing motivation through shaping goals and outcome expectancy (OE).  
Self-efficacy is largely influenced by self-referent thought, which in turn is 
affected by our concern of how others judge our capabilities (Bandura, 1977). It is 
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a belief in personal competence and capability, and as such affects the choices 
and courses of action pursued by the individual to:  
 
“engage in tasks in which they feel competent and confident and avoid those in 
which they do not” (Pajares, 1996 p2).  
Therefore the role of the pelvic floor physiotherapist should be aimed at 
promoting engagement in PFME, and helping patients to be competent and 
confident in their PFME performance. 
 
3.3.2 Sources of self-efficacy 
Self-efficacy is behaviour specific (Maibach & Murphy, 1995), and use of specific 
self-efficacy measures is recommended by Bandura and supported by studies 
such as Lyons (1985). This study studied aerobic exercise, and demonstrated 
poor correlation between general self-efficacy scores and exercise adherence, 
but positive and significant correlation between exercise self-efficacy and levels 
of exercise adherence.  Cultural and wider political/social influences also play a 
role in self-efficacy appraisal.  
 
There are four sources of self-efficacy: 
1. Enactive attainment or performance accomplishment 
2. Vicarious experience or social learning (modelling) 
3. Verbal persuasion 
4. Physiological state such as high anxiety or stress. 
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Performance accomplishment or personal mastery is thought to be the most 
important source of self-efficacy.  In high level sport/skills those with low self-
efficacy often devalue their own accomplishments, often because performance 
standards are high. In this situation personal mastery can be helped using 
participant modelling, that is, experience of skill success through initial 
demonstration followed by guided performance (Bandura, 1977).  This involves 
breaking down a task into sections until success in the completed sequence is 
achieved.  Participant modeling in gymnastics and other sport has been shown to 
increase self-efficacy measures (Felz, Landers & Raeder, 1979; McAuley, 1985).  
An additional source of performance accomplishment is achieved with 
performance feedback, which may be false (deception feedback) or true 
feedback.  Feedback is shown to change self-efficacy and may be used to 
manipulate performance, for example by informing (falsely) that a competitor’s 
time has not been achieved in order to raise performance, or by giving the 
performer a falsely inflated score to boost morale or self-confidence. It therefore 
seems that the key to building self-efficacy is perceived success.  It is speculated 
by Burns et al (1993) that biofeedback used for feedback in pelvic floor muscle 
exercise may give this sense of accomplishment. 
As well as one’s own achievements, self-efficacy can be influenced to a lesser 
extent through viewing other’s efforts on a task, that is, through vicarious 
experience (Bandura, 1986).  This is the basis of the popularity of support groups 
such as exercise groups and slimming clubs and this principle is also used by 
physiotherapists in cardiac rehabilitation and post-surgery exercise groups.  The 
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strength of influence is shown to be further increased if the person closely 
resembles the individual’s own ability, experience and skill (George, Feltz & 
Chase, 1992).  Verbal encouragement also raises self-efficacy and has the most 
influence when encouragement is delivered immediately after a performance 
accomplishment (Wise & Trunnell, 2001).  Joint viewing of exercise performance 
by patient and clinician allows encouragement to be given to the patient during a 
biofeedback session.  Physiological and emotional states affect self-efficacy with 
positive states such as happiness, associated with raised self-efficacy while 
negative states (depression) associate with low levels of self-efficacy (Maddux & 
Meier, 1995). Optimistic self-belief about ability or self-confidence creates 
positive affective states (Schwarzer & Fuchs, 1996), while pessimistic views of 
anticipated performance gives rise to anxiety or depression as perceived 
inefficacy results from trying to control prized outcomes.  This may occur when 
outcomes are highly valued, outcome expectancy is high and performance 
expectation is low (Bandura, 1986).  However Initial high levels of self-efficacy 
may also be associated with reduced performance if goals are controlled and not 
revised (Vancouver & Kendall, 2006).  This is because high self-efficacy may 
give rise to complacency, causing decline in adherence and poor outcomes.  
These sources and influences self-efficacy would seem to indicate that clinician 
contact, involving the support and guidance offered during usual physiotherapy 
treatment would present an ideal opportunity to enhance and support self-
efficacy.  In a review of studies aiming to target the four sources of self-efficacy 
(Ashford et al., 2010), feedback was given in less than one third and very few 
 33
looked at vicarious activity or affective states.  General goal setting, verbal 
encouragement and identifying barriers were common.  sEMG biofeedback 
involves the woman viewing a representation of her own muscle activity and 
receiving verbal feedback and endorsement of this physiological response.  This 
experience, as well as using the biofeedback to highlight aspects of performance 
and concentrating on achievable components of the exercise, would be expected 
to further enhance pelvic floor muscle exercise self-efficacy through goal setting 
and affective response to the progress achieved.  Biofeedback should also help 
address issues of complacency (Vancouver & Kendall, 2006) by allowing 
visualisation of performance and the re-setting of goals.   
 
3.4 Conclusion  
Understanding the theory of adherence behaviour helps identify factors 
associated with adherence and informs the development of interventions to 
improve adherence in patients. Nearly all more recently developed health 
behaviour models incorporate measures of personal efficacy, acknowledging 
self-efficacy as an important factor in adopting health behaviours. Self-efficacy is 
shown to be the most important predictor of adherence behaviour, and a valuable 
process indicator, especially important as actual adherence to home exercise is 
difficult to measure accurately.  
Various factors impact on adherence.  Some, for example condition or symptom 
severity, are not easy to directly influence. Others, such as the clinician-patient 
relationship, education, information-giving and goal-setting can be enhanced.  
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Approaches thought to improve adherence include using reminders to exercise, 
employing a patient-centred approach to consultation and having awareness 
about how information can be given.  Clinical contact helps ascertain 
understanding (Ley, 1989) and written information plays a role in supporting oral 
advice (Ley & Morris, 1984).  Self-efficacy theory would predict that high levels of 
self-efficacy enables good self-management and treatment adherence for women 
with urinary incontinence, with research confirming positive correlation between 
PFME self-efficacy and PFME adherence (Chen, 2001) as well as identifying 
self-efficacy as a major influence on exercise adherence (Chen & Tzeng, 2009).  
Therefore intervention studies aimed at improving self-efficacy have potential to 
augment adherence and treatment outcomes.    
Authors to date acknowledge the difficulty of building and maintaining levels of 
self-efficacy in patients and intervention studies designed to improve self-efficacy 
in UI seem thin on the ground.  Self-efficacy is thought to be influenced in four 
ways, through performance experience, vicarious experience, verbal 
encouragement and affective/emotional influences.  Physiotherapists often adopt 
a problem-solving and skills-based approach in encouraging health promoting 
behaviour.  This may include facilitating the learning of exercises and the 
adoption of exercise regimens, targeting health information and advice as well as 
teaching patients self-management strategies.  Information (both oral and written) 
and education are important. Improving patient knowledge of pelvic floor muscle 
function, and education regarding the benefits of exercise, also play a role in 
improving self-efficacy (Hay-Smith, Ryan & Dean,  2007).  However, information 
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and education alone seem insufficient in guaranteeing PFME adherence for long 
enough to give symptom relief.  Regular contact and feedback on progress gives 
opportunity for reassurance and encouragement to continue with an exercise 
programme, as well as providing motivation to exercise independently at home.  
Confidence in ability to perform the exercises correctly (task self-efficacy) is also 
an essential component to pelvic floor muscle exercise adherence (Messer et al., 
2007) and use of biofeedback in PFME clinic sessions has been suggested to 
improve motivation to exercise and help adherence.  This thesis proposes that 
this is achieved by improving PFME self-efficacy, as sEMG biofeedback imparts 
information and enhances confidence in performance.  This assistance with 
learning, is proposed to provide reassurance of correct performance during early 
contact with the patient, and the setting of exercise goals.   
How biofeedback is used in pelvic floor muscle rehabilitation is outlined in the 
following chapter.   
CHAPTER FOUR   BIOFEEDBACK 
 
4.1 Introduction 
Biofeedback is ‘the technique by which information about a normally unconscious 
physiological process is presented to the patient and/or therapist as a visual, 
auditory or tactile signal’ (Peschers et al., 2001).  As previously mentioned, in 
pelvic floor physiotherapy this is purported to assist pelvic floor muscle 
rehabilitation by helping the patient to learn the exercise and is also believed to 
help motivation to exercise in patients (Mørkved, Bø & Fjortoft, 2002). This 
definition of biofeedback may include muscle palpation, real-time ultrasound 
images and manometric pressure (Haslam, 2008b).  Another common 
biofeedback tool is surface electromyography (or sEMG).   
EMG can be defined in a wide sense as analysis of bioactivity of muscle through 
monitoring myoelectric signals. Electrical potentials, generated by the 
depolarisation of muscle, undergo amplification, rectification and ‘smoothing’ to 
produce a screen image. In this way, electrical activity of muscle can be 
monitored as a representation of muscle function (Haslam, 2008b).  Traditionally 
in EMG, muscle response is measured after an artificial electrical stimulus is 
applied; this is called ‘neurological EMG’. The term EMG may also be used to 
describe ‘needle EMG’ a more invasive technique where motor units are 
monitored by insertion of a needle electrode into the muscle.  This is mainly used 
in research and has no practical application in day-to-day pelvic floor treatment 
and rehabilitation. In the context of pelvic floor physiotherapy (and this study), the 
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term EMG refers to kinesiological EMG, the surface recordings (sEMG) of muscle 
activity. 
4.2 sEMG biofeedback: modalities and use  
Neuromuscular activation is recorded through surface or skin placement of a 
sensor or probe. Surface EMG (sEMG) detects the overall pattern of concurrent 
activity of motor units (motor unit action potentials) through the skin, in the area 
of the sensor (Cram & Kasman, 1998).  This is therefore less selective than 
needle EMG, meaning that ‘crosstalk’ (activity from other concurrent muscle 
activity) may be detected (Carrière, 2006, p.209).  Electrical activity arising from 
muscle activity (during exercise and voluntary effort) is recorded in microvolts 
and displayed as a visual, and sometimes auditory, signal for both patient and 
therapist to view/hear (see figure 4) 
 
 
Figure 4 sEMG biofeedback output graph (demonstrating a 10 second muscle 
contraction) 
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This feedback of physiological or ‘bio’ information gives rise to the name 
‘biofeedback’.  In general rehabilitation, this can be used solely as a research 
evaluation tool, but it is also commonly used by many physiotherapists to help 
patients to view their training effort and to assist in exercise goal setting.  In 
pelvic floor training, sEMG biofeedback is used as part of the rehabilitation 
process aiming to improve pelvic floor muscle strength and function. In this way it 
is an adjunct to a home programme of pelvic floor muscle exercises.  
 
4.3 sEMG biofeedback in pelvic floor rehabilitation 
In this thesis the term ‘biofeedback’ will refer to surface EMG (sEMG) although 
the terms are used interchangeably throughout the text.  Since the advent of well-
designed and comfortable intra-vaginal probes, the popularity of using sEMG in 
pelvic floor rehabilitation has increased.  The internal vaginal probe detects 
electrical information from pelvic floor muscle through surface recordings.  The 
probe is connected by cables to a biofeedback unit (see diagram, figure 5).  
Three electrodes are necessary: two for recording and one for reference.  With 
internal vaginal probes, the two recording points are conveniently integrated into 
the probe design.  The reference electrode is usually a self-adhesive electrode 
applied to a local superficial bony point, for example the patient’s pelvis or knee.   
Probe or electrode condition, conducting gel, skin condition and cables and 
connections can all affect the signal quality (Haslam, 2008b). 
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Figure 5  sEMG signal path to equipment 
 
The sum of the motor unit action potentials is detected by the electrodes and 
amplified (by the differential amplifier) in the sEMG equipment (Figure 6).  The 
equipment compares this recorded activity to the reference electrode activity and 
allows only unique signals from the recording electrodes to be processed further 
(Cram & Kasman, 1998).  The common mode rejection ratio (CMRR) is a 
measure of how successfully the common mode signal (electrical ‘noise’ from 
environmental sources), is filtered out by the differential amplifier.  Signal then 
passes through a notch filter, which is very narrow in width (49-51Hz in the UK, 
or 59-61 Hz in the United States) and works specifically to eliminate mains 
frequency (50hz in the UK, 60Hz in the United States) (Haslam, 2008b).  The raw 
sEMG activity passes through a band-width filter, to enable only stable 
frequencies within a specified range to be processed further.  Raw EMG signal is 
graphically displayed as an oscillation from positive to negative around a baseline 
and would be difficult to interpret.  Therefore the signal is further amplified and 
displayed as a rectified signal which is uni-directional (appearing only above the 
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graph baseline) (see figure 4, p38).  If necessary the clinician can further smooth 
the trace to reduce jumpiness and better facilitate interpretation of muscle 
activation by both the therapist and patient (Figure 6). 
 
Bandwidth 
filter 
Raw 
sEMG Rectifier 
Time-line  
graph 
display 
Bio-electric 
Signal 
Differential 
Amplifier 
and notch 
flilter 
 Figure 6  sEMG equipment processing of signal 
 
 
4.4 The monitoring process 
The vaginal probe is easily inserted by either the patient or clinician following a 
digital vaginal assessment.  Biofeedback can be used in any position, however 
reproducibility of readings is helped by standardising patient position (Haslam, 
2008b).   Information, both graphic representation and numerical readings (in 
microvolts), regarding the resting state of the muscle, responsiveness during 
initiation of contraction, endurance, co-ordination, release of muscle activity 
(onset of relaxation), and the number of repetitions achievable in an exercise 
session can all be monitored during the treatment session (Carrière, 2006, 
p.214).  As pelvic floor muscle activity increases (such as when the patient 
contracts the pelvic floor muscles) increasing levels of microvolt activity are 
displayed, represented by a rising graphical trace.  Relaxation of the pelvic floor 
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muscles produces a fall in muscle activity and a fall of the graph trace (see figure 
4, p.38).  
  
4.5 sEMG equipment  
‘Cross-talk’, electrical activity from other muscle groups, can occur when using 
sEMG (Mørkved, Bø & Fjortoft, 2002).  For this reason clinic-based treatment 
(rather than use of home biofeedback units) allows the therapist to monitor 
extraneous muscle activity as well as to give individual correction and 
encouragement.  Clinician monitoring also ensures consistent electrode 
placement and patient positioning thereby helping reproducibility of readings. 
 
The surface EMG (sEMG) monitoring equipment used in clinic, and for this study, 
is a PRS 7300 EMG biofeedback (Neen Healthcare) (Figure 7), with an internal 
vaginal Periform® or Anuform® (small vaginal) surface electrode (Figure 8).  The 
Neen PRS 7300 is a long-established piece of equipment designed specifically 
for use in pelvic floor muscle rehabilitation.   
 
 
Figure 7  sEMG biofeedback equipment 
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The monitoring electrode, Periform® (or Anuform® a smaller vaginal or anal 
electrode) detects PFME activity vaginally.   The probes are single patient, multi-
use and are designed to be used for a six month period of treatment before 
needing to be replaced. The Periform® probe is made of high impact polystyrene 
and incorporates two medical grade stainless steel electrode plates. The surface 
area of each electrode plate is 4.9cm².   
 
 
                                                       
Figure 8   Periform® probe and Anuform® (small vaginal) probe (not pictured to scale) 
 
The shape of the probes is designed to minimise displacement/movement within 
the vagina, and, as they record non-selectively, this helps to enable good test-
retest reliability and content validity (Vodušek, 2007, p.61).  Water-based gel 
(such as Aquagel) is the conducting medium used to coat the plates and assist 
vaginal insertion.  Coupling gel also helps to create good contact between the 
electrode plates and muscle tissue surface also ensuring that a strong and valid 
signal is detected from the muscle.  The probes are lightweight (19g), easy to 
insert, and can be used in a variety of functional positions (for example, standing 
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up, sitting down and lying down).  This type of non-selective surface monitoring 
has two main advantages in the clinical rehabilitation setting.  Firstly, it is less 
invasive, and therefore acceptable to patients, than placement of an intra-
muscular needle electrode.  Secondly, it detects activity from all parts of the 
source muscles, that is, it monitors motor unit activity from the muscle in contact 
with the electrode plates and from the surrounding source muscle tissue not in 
direct contact with the probe, as muscle fibres from one motor unit may not be 
adjacent to each other (Vodušek, 2007).   The Periform® probe has 
demonstrated good-to-high between-trial reliability (Auchincloss & McClean, 
2009).  
  
sEMG is thought to produce a valid and reliable signal (Glazer, Romanz & 
Polaneczky, 1999; Vodušek, 2007)  and is sensitive to even small changes in 
muscle activation.  Reliability and validity of the signal is improved by using the 
same equipment and clinic room, to minimise variation in electrical interference 
impacting on the sEMG signal. sEMG displays a good representation of patient 
exercise effort and has shown good retest reliability in non-symptomatic 
volunteers when ability to correctly contract the PFM is controlled for (Grape, 
Dedering & Jonasson, 2009). Reliable data display is needed for participants to 
accurately assess their performance so that the readings can be trusted and 
used to base self-efficacy judgements.  Therefore the EMG equipment should be 
regularly serviced and the signal output checked.  This occurs in the 
physiotherapy clinic every six months. In addition, and in order to ensure that 
sEMG provides a meaningful indication of source muscle activity, it is important 
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that interpretation of the trace is linked to actual muscle ‘events’ (Vodušek, 2007), 
in other words, output traces are interpreted in the light of patient effort and 
actual muscle activity occurring at the time.  For this reason, clinic-based 
treatment with therapist involvement should be a key requirement in ensuring 
valid sEMG monitoring. 
 
Chapter Five presents a review of the literature relating to self-efficacy used as 
an outcome measure and the efficacy of biofeedback, compared with PFME 
alone, in the treatment of UI. 
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CHAPTER FIVE    Review of the Literature 
 
5.1 Search strategy  
The areas of literature searching relevant to the research presented in this thesis 
are sEMG biofeedback in augmenting physiotherapy treatment in SUI, PFME 
adherence and self-efficacy. The literature review specifically examines the 
efficacy of sEMG biofeedback in the treatment of SUI in women, the concept of 
self-efficacy, as well as appraising the evidence for linking self-efficacy and 
adherence behaviour.  Studies looking at the impact of SUI treatment 
interventions on self-efficacy and PFME adherence are evaluated, and the 
theoretical role of sEMG biofeedback in increasing PFME self-efficacy and PFME 
adherence is explored.  
 
This chapter gives an integrative review of the relevant literature critically 
evaluating current theory, practice and evidence relating to the key areas of this 
research.  As the research conducted as part of this thesis is a randomised 
controlled trial (RCT) looking at intervention effectiveness, a detailed review of 
RCTs comparing biofeedback plus pelvic floor muscle exercises using ‘pelvic 
floor muscle exercises alone’ as a comparator was also conducted.  A number of 
databases were searched and search terms or MesH headings that were used 
were formulated with help from the acronym ‘PICO’ (Participants, Intervention, 
Control, Outcome). See Table 5. 
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Table 5   Databases and search terms 
Data bases  Search Terms
OVID Medline (R) In-Process & Other Non-
Indexed Citations  
OVID Medline (R) 1950-present CINHAHL 
 AHMED 
Cochrane 
PEDro 
Self efficacy 
Patient compliance 
Treatment adherence 
Pelvic floor 
Biofeedback 
Urinary incontinence, Stress/ 
 
 
Limits used were English Language, Human studies, Adult and Clinical trials.   
Additional research literature was obtained from the Cochrane database, PEDro, 
EBM reviews, NICE and also extracted from reference lists of known articles and 
clinical textbooks. A search of grey literature was performed using ProQuest, with 
dissertations and theses obtained as online abstracts located through GOOGLE 
scholar and conference presentations.  Email correspondence with authors 
(Aleijwinse, Chen, Demain and Hay-Smith) was useful. 
 
5.2   Adherence and self-efficacy for pelvic floor muscle exercises 
The evidence for education and Information giving in PFME studies is mixed.  
While lack of knowledge about PFME has been identified as a barrier to PME 
adherence (Hayn et al., 2000; Chen, 2001; Chiarelli, Murphy & Cockburn, 2003), 
and is endorsed by Kim (2001) who demonstrated that giving educational 
information achieved greater PFME adherence (and improved levels of self-
efficacy), Alewijnse et al. (2003) concluded that addition of a health education 
programme had no impact on UI treatment adherence. Similarly, Messer et al. 
(2007) found knowledge self-efficacy a poor predictor of PFME adherence.  
 47
PFME adherence seems to be enhanced by adopting a formalised routine for 
home PFME practice rather than an ‘ad hoc’ approach (Hines et al., 2007) and by 
using audiotapes (Gallo & Staskin, 1995).  Confirming to the patient that they can 
contract their muscles effectively and establishing that a correct PFM contraction 
is being performed is recommended as best practice (Bø, 2007), and PFME task 
self-efficacy is associated with good adherence (Messer et al, 2007).  Other work 
has highlighted the importance of an initial assessment incorporating individual 
exercise instruction (Konstantinidou et al., 2007; Felicissimo et al., 2010).  
Follow-up clinics and regular treatment sessions (more than once a week contact 
with the therapist), allow opportunity to reinforce the benefits of PFME 
compliance, as well as giving ongoing reassurance and individual feedback 
regarding correct exercise technique (Bø et al., 1990; Bø, 1995, Hayn et al., 
2000; Alewijnse et al., 2001; Chiarelli, Murphy & Cockburn, 2003).  Kim (2001) 
claims similar support is achieved through telephone contact.  The importance of 
support is further evidenced by studies where no assessment of PFM 
contraction, or contact with the clinician occurs.  Ramsey & Thou (1990) reports a 
poor adherence rate of 15% of the requested exercise level, and a Cochrane 
review concludes that control groups receiving reduced or no supervision with 
PFME are linked to poorer outcomes (Dumoulin & Hay-Smith, 2010).   
In the longer term following a period of formal PFM training, a decline in PFME 
practice is observed, to the extent that only a third of participants were still 
exercising at 5 years, reducing further to 25% at 15 years (Bø & Talseth, 1996; 
Bø & Sherburn, 2005).  Factors which enhance long-term PFME adherence 
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include positive intention to adhere, good levels of short term PFME adherence, 
high levels of self-efficacy and greater severity of leakage symptoms (Chen, 
2001, Alewijnse et al., 2002; Alewjnse et al., 2003; Shishani, 2003; Chen & 
Tzeng, 2009).  Evidence disagrees as to whether age is a significant influence on 
PFME adherence (Chen, 2001; Chiarelli, Murphy & Cockburn, 2003). 
Self-efficacy appears to be vital to treatment success and several studies call for 
interventions to build and support levels of self-efficacy in a bid to improve pelvic 
floor muscle exercise adherence, self-management and treatment outcomes 
(Chen, 2001, Alewijnse et al., 2001, Demain et al, 2006, Dean, Hay-Smith & 
Elley, 2009).  Chen & Tzeng (2009) further developed a three stage theoretical 
model to test which factors directly affected PFME adherence, and which 
indirectly affected adherence when mediated by PFME self-efficacy.  Path 
analysis of this model suggests that PFME self-efficacy directly influences PFME 
adherence and that age, leakage severity also directly predict adherence (Chen 
& Tzeng, 2009).  Attitudes, dyadic cohesion and perceived benefits of performing 
PFME were found to be associated with increase in self-efficacy which indirectly 
affects adherence, that is, these factors seem to be mediated by self-efficacy. 
Pelvic floor muscle exercise self-efficacy is a behaviour specific construct, that is, 
it relates to the ability to perform pelvic floor muscle exercises correctly and 
regularly as advised and despite barriers.  Self-efficacy is of particular importance 
in PFME because the action of contracting the muscles can only be sensed, as it 
takes place internally and is not directly visible.  During vaginal examination by 
the clinician, women are usually reassured that they are indeed performing a 
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correct contraction. This is important as women may doubt that they are 
performing their exercises correctly, affecting confidence in performing PFME 
(Chen, 2004).  High self-efficacy is important in short-term and long-term PFME 
adherence, but seems difficult to maintain (Alewijnse et al., 2001; Kim, 2001; 
Alewijnse et al., 2003; Demain et al., 2006; Gillard & Shamley, 2010; Dumoulin & 
Hay-Smith, 2010).  This could have a detrimental impact on both adherence and 
motivation.  
 
 
5.3 Appraising PFME self-efficacy  
Developing and validating questionnaires and measurement scales have been 
crucial in the studying of pelvic floor muscle exercise self-efficacy. Validation 
studies for pelvic floor self-efficacy scales have been conducted in Japan (Kim & 
Kanagawa, 1998), in the United States (Broome, 1999; 2001), in Taiwan (Chen, 
2004) and in Canada (Tannenbaum et al., 2008).   One of the stated aims of 
scale development is to identify women with low self-efficacy levels in order to 
focus interventions to improve self-efficacy and achieve success with 
conservative treatment; however it appears very few studies have measured self-
efficacy (as a mediating concept to adherence) in response to a physiotherapy 
intervention in urinary incontinence.  The studies identified are reviewed in the 
following section. 
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5.4 UI intervention studies measuring self-efficacy (Table 6) 
Studies researching UI treatment interventions measuring self-efficacy as an 
outcome are set out in Table 6.  These studies have a variety of methodologies 
and aims.  Studies to develop, test and validate self-efficacy measurement tools 
are not included in this summary. 
 
Table 6 Summary of UI research studying interventions and their effect on self-efficacy   
Author 
 
Design  Intervention Outcome 
measures 
 
Results Conclusions 
Svengalis et 
al., 1995 
Cohort study 
Women with UI,  
n=71 
 
16 dropped out 
55 completed 
 
3 month PFME 
course 
Evaluation of 
the 
relationship 
between 
perceived SE 
and treatment 
outcome after 
treatment with 
PFME  
UI episodes 
per day 
measured at 3 
months. 
 
SE measured 
at baseline 
and 3 weeks 
using a scale 
devised for 
the study. 
Initial high SE 
associated 
with poor 
treatment 
outcome.  
 
Improved SE 
‘weakly’ 
associated 
with reduction 
in leakage 
episodes  
r= .31 p<0.07 
(so not 
significant) 
 
Initial unrealistic 
expectations 
reflected in high SE 
scores at baseline. 
 
 
Author concludes 
improved SE over 3 
weeks is associated 
with good clinical 
outcomes at 3 
months, but the result 
was not significant. 
 
 
 
Kim, 2001 RCT:  
Women with 
SUI 
3 groups 
n=48   
 
5 dropped out 
43 completed 
3 visits in 3 
months: 
1.Continence 
Efficacy 
Intervention 
Programme 
2. Info sheet 
and initial 
PFME 
teaching 
session  
3. No 
treatment 
control. 
 
No 
confirmation 
of PFM 
contraction by 
the therapist, 
self- palpation 
advised. 
 
SE measure 
(Continence 
Self-efficacy 
Scale 
developed for 
the study). 
5 point ordinal 
symptom 
improvement 
scale 
Significant 
difference in 
improvement 
for the CEIP 
group 
compared 
with the 
controls for 
SE, 
adherence 
and 
symptoms  
 
Author concludes that 
encouragement and 
accurate information 
helped PFME 
adherence.  
Phone interviews 
helped this process.  
 
Lack of muscle 
assessment/palpation 
in all groups. 
 
Small sample number
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Demain et 
al., 2006 
Cohort study 
n=26 
Women with UI 
Does self-
efficacy change 
over a 
treatment 
period and is 
there an 
association 
between 
baseline self-
efficacy and 
outcome? 
 
One initial 
physiotherapy 
session 
followed by 
self-managed 
physiotherapy 
treatment for 
a 6 week 
period. 
 
SE and 
outcome 
expectancy 
measure,  
Vaginal 
assessment 
and symptom 
severity, 
Kings health 
questionnaire  
 
Measures 
performed at 
baseline and 
at 6 weeks. 
 
Significant 
reduction in 
SE over the 
treatment 
period. 
Greatest 
improvement in 
symptoms in women 
with high initial SE 
and high outcome 
expectations. 
 
Significant and 
positive correlation 
found between 
outcomes and SE. 
Messer et 
al., 2007 
Cohort of  post-
menopausal 
women n=164 
 
Prevention of 
UI 
 
 
A 2 hour 
behavioural 
modification 
program 
session plus 
one follow-up 
session at 2-4 
weeks. 
Aim to 
prevent onset 
of UI 
 
12 month 
study 
 
Adherence 
and SE 
measured at 2 
weeks post-
intervention 
and at 3 
month 
intervals until 
12 months. 
 
Regression 
analysis to 
see what 
types of self-
efficacy 
predict PFME 
adherence. 
 
Modest 
decline of S.E 
over time 
 
Establishes 
the link 
between SE 
and 
adherence 
over time 
SE may be an index 
of motivation. 
 
Knowledge SE not a 
factor in PFME 
adherence but 
regulatory and task 
SE  is important  
 
  
Kim (2001) conducted the only RCT measuring self-efficacy as a response to a 
treatment intervention in UI. She tested an intervention programme called the 
Continence Efficacy Intervention Program (or CEIP) designed to address 
obstacles to exercise adherence, evaluated exercise continuity (adherence) and 
self-efficacy.  The control groups received conventional care consisting of one 
assessment session where the women were trained to do pelvic floor exercises 
and given an information sheet. The CEIP intervention group received follow-up 
clinic sessions, telephone follow-up to ascertain understanding and encourage 
adherence, an instructional audio-visual tape, an adherence/exercise reminder 
diary and more detailed muscle training advice.  It is difficult to deduce from the 
 52
published information whether PFM palpation was used to confirm a correct 
muscle contraction.  The results at the end of the 12 week study period found 
significantly greater adherence and self-efficacy scores in the intervention group 
who had received the CEIP, however it was difficult to attribute this success to a 
specific aspect of the programme, such as support, contact sessions or exercise 
training. The sample number was small. 
A small cohort study (26 women with SUI) conducted by Demain et al. (2006) 
measured levels of self-efficacy following initial assessment and instruction over 
a period of self-managed physiotherapy treatment.  Initial high self-efficacy and 
improvement in pelvic floor muscle strengthening was found, but decline in both 
self-efficacy and outcome expectancy ratings occurred over the treatment 
course.  This study demonstrates the difficulty of maintaining self-efficacy levels, 
and perhaps indicates the importance of supported treatment in maintaining self-
efficacy and adherence. Similarly an earlier cohort study (a sample of 71 women) 
conducted by Svengalis (1995), demonstrated that supported rather than self-
managed treatment is associated with improving levels of self-efficacy,  agreeing 
with Demain et al (2006) that observed high initial self-efficacy scores were not 
associated with improved symptom outcome over the longer term.  This contrasts 
with Broome (1999) who concluded that initial high PFM self-efficacy predicted 
positive clinical outcomes.  A possible explanation for Svengalis et al.’s findings 
may be women’s initial unrealistic expectations of the demands of treatment.  
Overall these findings should caution against drawing conclusions about likely 
successful outcomes based on very high pre-treatment self-efficacy scores.  
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Kassandra Messer et al. (2007) looked at self-efficacy in a group of 
asymptomatic women (n=164) on a UI prevention programme.  Her study found 
good adherence to PFME, and although self-efficacy ratings revealed a modest 
decline over a 12 month period, ‘task’ and ‘regulatory’ self-efficacy rather than 
‘knowledge self-efficacy’ contributed to the adherence levels seen.  
Current guidance (NICE, 2006) recommends supervised exercises, and, as 
previously stated, return clinic visits (whether group or individual) seem to be 
associated with improved outcomes, and fewer clinician visits associated with a 
decline in self-efficacy scores.  It is unclear what aspect of clinician contact may 
be responsible for improvement in self-efficacy.  Clinical sessions enable the 
patient to report benefit in terms of symptom reduction and the clinician to give 
confirmation of progress in terms of muscle strengthening. Sessions also allow 
opportunity for problem-solving and allow discussion of set-backs, or perhaps 
function very simply to provide verbal encouragement to remain motivated and 
continue with the exercise programme.  Both Messer et al (2007) and Whitfield 
and Jones (2011) advocate confidence in correct pelvic floor contraction as 
important to overall self-efficacy. 
 
5.5 Measuring PFME adherence 
Studies measuring PFME adherence generally show good exercising levels 
(Berghmans et al., 1996; Bø, Talseth & Holme, 1999; Hay-Smith et al., 2001; 
Alewijnse et al., 2002), which is often attributed to the intensive nature of the 
interventions and the enthusiasm of research trial participants, but is suspected 
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of bearing no relation to the realities of clinical practice.  Given the belief that 
treatment adherence is believed to be difficult to achieve, these findings call into 
question the accuracy, and highlight the challenge, of measuring adherence. 
Self-reported adherence may overestimate to convey a socially acceptable 
impression, that is women report what they should be doing rather than what they 
actually did (Dumoulin & Hay-Smith, 2010), and clinicians may be equally guilty 
of over-estimating adherent behaviour in their patients (Gross, 2001).  Objective 
measures are not always possible to implement in trials, especially when 
evaluating home exercise programmes.  Self-completion of daily diaries can be 
onerous for the participant leading to the possibility of inaccurate recording or 
retrospective completion.  Daily diaries also may, in the act of completing them, 
promote adherence (Myers & Midence, 1998), and remembering exercise 
behaviour after a period of time presents difficulty with accuracy of recall.  
Questionnaires completed while in the waiting area prior to each follow-up 
attendance reduces the likelihood of forgetting to bring the diaries to clinic. This 
method also addresses the possibility of associated inaccuracies through being 
too busy to complete a day-to-day diary, or the temptation for retrospective (and 
hurried) last minute completion (Hay-Smith 2007, correspondence). Although 
there remains the possibility of memory bias or inaccurate recall there is no 
evidence that this approach is less reliable than daily completion. 
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5.6   Measuring PFME self-efficacy  
Although self-efficacy dimensions can be evaluated by interviewing participants, 
standardised scales and measures are desirable in an experimental study 
design.   Generalised self-efficacy (GSE) is measured with a general self-efficacy 
scale, however behaviour specific scales are necessary to measure behaviour 
specific self-efficacy such as self-efficacy for performing pelvic floor muscle 
exercises.  Appraising scales should include checking how the scale was 
developed.  This includes the intended ‘aim’, definition of a priori considerations 
and methods for identification and selection of items (Frei et al., 2009). Scales 
may be constructed with different aims in mind and it is important to ensure that 
any instrument selected fulfils the needs of the study design; for the purpose of 
treatment/ intervention evaluation, the scale needs to detect changes over time 
and have longitudinal validity.  
The three self-efficacy scales identified through literature searching were devised 
by Broome (1999), Chen (2004) and Demain et al. (2006).  Tannenbaum et al.’s 
(2008) measure for use in elderly women was published after this study 
commenced and Kim’s (2001) scale was published in Japanese so was unable to 
be used.  The Demain scale (Demain et al., 2006) was not validated and the 
Broome scale (Broome, 1999) although validated, has an item relating to 
discouragement of abdominal muscle use, arguably thought to play a role in 
PFME (Neumann & Gill, 2002; Sapsford et al., 2001), and still in current debate 
(Bø et al., 2009).  The Chen pelvic floor muscle exercise self-efficacy scale was 
validated in Taiwan in 2003 (Chen, 2004) and is shown to have solid 
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psychometric properties.  Despite the cultural difference between Taiwan and the 
UK, the Chen scale specifically reflected the parameters studied in this 
intervention, that is, pelvic floor muscle exercise self-efficacy, with items relating 
to outcome expectancy and confidence in ability to perform the exercises. The 
potential for cultural difference causing difficulty with comprehension of the scale 
items was overcome by initially piloting the tool on a small sample of UK women 
with SUI.  As an evaluation tool, Chen recommends using it at different stages in 
pelvic floor rehabilitation to see if self-efficacy is maintained, and as such it 
matched the aim of this research.  It is considered in more detail in later sections. 
 
5.7 Evidence for biofeedback efficacy 
Glazer & Laine (2006) performed a single database search (Medline 1975 to 
2005) for studies examining the evidence for using biofeedback in any type of 
urinary incontinence.   At first glance, the evidence for the benefits seem 
encouraging, with no studies producing worse outcomes than exercises alone. 
Other studies confirm that biofeedback is effective when compared to ‘no 
treatment’ for SUI (Henella et al., 1989, Largo Janssen et al., 1991; Bø, Talseth & 
Holme, 1999), however the evidence for adding this treatment modality to pelvic 
floor exercises instruction needs to be examined more closely.  The following 
section will explore the evidence for biofeedback use alongside PFME (in women 
with SUI) in more depth. 
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5.7.1 Rationale of the biofeedback literature review 
The aim is to evaluate the evidence for the efficacy of machine biofeedback as 
an intervention in augmenting a PFME programme of treatment.  For this reason, 
the comparison needs to be made with ‘standard’ conservative treatment for 
Stress Urinary Incontinence (SUI) which is unsupplemented PFME or ‘PFME 
alone’.  
A systematic review is considered to be the most reliable source of evidence to 
guide clinical practice (Clarke, 2011).  It examines existing research and aims to 
give a detailed account of all the available primary research (in response to a 
research question) in order to establish the state of existing knowledge.  
Systematic reviews of RCTs are performed when investigating questions of 
effectiveness.  According to the Cochrane Handbook, a systematic review should 
state clear aims and eligibility criteria, transparent methods, involve rigorous 
searching, assess the validity of studies findings, and synthesise and present the 
findings (Higgins & Green, 2011). Where possible, meta-analysis also helps in 
the synthesis process by pooling data from primary studies and producing a 
statistical summary to establish if an effect exists. Systematic reviews have 
appraised biofeedback in the treatment of urinary incontinence.  Glazer & Laine 
(2006) and de Kruif & van Wegen (1996) did not specifically examine either SUI 
or women in their reviews.  As part of a wider review of interventions for SUI in 
women, Berghmans et al. (1998) concluded that biofeedback did not offer added 
benefit to ‘PFME alone’, and although Weatherall’s (1999) meta-analysis of three 
studies in the Berghmans’ review supported the addition of biofeedback, the 
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confidence intervals were wide. These reviews do not therefore provide 
conclusive evidence.  Studies have also been published since this last review.  
Therefore a review was conducted in order to examine randomised controlled 
studies and establish the current evidence for use of biofeedback. 
5.7.2 Outcomes considered 
The standardisation committee of the International Continence Society (ICS) 
(Lose et al., 1998) recommends that research investigating the effectiveness of 
treatments for urinary incontinence in women should incorporate outcome 
measurements in the following five areas:  
1. the patient’s observations (symptoms) 
2. quantification of symptoms  (leakage of urine) 
3. the clinician’s observations (anatomical or functional) 
4. quality of life 
5. socioeconomic measures. 
 
Outcomes may be assessed through subjective reporting of symptom severity by 
the patient (patient perception of symptoms, for example bothersomeness, cure 
or improvement) and quantitatively by measuring of leakage, for example by 
using a pad test, counting the number of absorbent pads used in a 24 hour 
period or daily diary recording the number of incontinent episodes.  Pelvic floor 
muscle strength and function is clinician-assessed by palpation of the muscle, 
recording of vaginal squeeze pressure or making surface EMG recordings of 
muscle electrical activity.   Quality of life is deemed by incontinence sufferers to 
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be the most important outcome (Herbison et al., 2009).  It is usually assessed 
through self-completed questionnaire and there is an array of validated tools 
available, some developed specifically for use in UI.  Socioeconomic 
measurement is a relatively new area of assessment in health research and 
signifies the increasing importance now placed on the impact of incontinence in 
all areas of an individual’s life.   
For this review, treatment efficacy is assessed primarily in terms of a reduction in 
urinary leakage or symptom severity, for example improvement in incontinence 
episodes (either self-reported or demonstrated through objective testing). This is 
evaluated through patient perception of cure or improvement, patient recorded 
leakage episodes, symptom-specific patient completed questionnaires, pad test 
weight or an increase in pelvic floor muscle strengthening or function. Any 
monitoring of treatment compliance or adherence is also reported as this is of 
particular interest and relevance to the study being conducted. Additional 
outcomes, such as impact on social activity, economic measures and general 
quality of life were noted.  
5.7.3 Type of study reviewed.  
The purpose is to establish whether prior to conducting a randomised controlled 
trial, if any RCTs had been conducted on biofeedback effectiveness especially in 
terms of enhancing exercise adherence.  A screening tool (Appendix 1) was used 
to help identify studies which fitted the inclusion criteria and this also helped to 
track the reasons for rejecting papers.  
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 5.7.4 The search process 
The bibliographic databases searched are listed in Section 5.1.  A combination of 
search terms were used including  ‘biofeedback’, ‘pelvic floor muscle exercise’ 
‘EMG biofeedback’ ‘myofeedback’ ‘pressure biofeedback’ ‘vaginal pressure 
biofeedback’ ‘perineal biofeedback’ combined with ‘stress incontinence’ ‘stress 
urinary incontinence’ ‘urinary incontinence’ ‘urodynamic stress incontinence’ 
‘genuine stress incontinence’.  Results were screened to exclude studies on men, 
children and dysfunctions other than SUI.  Ultrasound studies were not included.  
Reference lists from relevant papers were hand-checked and grey literature and 
conference presentations searched electronically through the International 
Continence Society (ICS) online search facility.  Electronic database searches 
were repeated every three months until no new papers were identified.  The last 
search was conducted in May 2011. 
 
5.7.5 Quality rating 
Using likely sources of bias identified in the Cochrane Handbook (Higgins & 
Green, 2011) as a guide, a quality scoring tool was developed and each included 
study scored.   
 
Quality rating took into account the randomisation method, whether concealment 
of allocation was achieved, the baseline equality of groups, the equal treatment 
of groups, blinding of outcome assessment, robust outcome measures, rigour of 
outcome reporting, participant ‘drop-out’ rate and how the data was analysed. As 
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research involving therapeutic complex packages of care does not usually allow 
for blinding of clinician/researcher or participant, these are not scored.  
 
1.  Randomisation: not described=0, partial description=1, full description=2 
2.  Concealment of allocation was achieved: Yes =1, no=0 (‘unclear’=0) 
3.  Blinding of outcome assessors: Yes=1 No=0  
4.  Assessment made of baseline differences between groups: Yes=1, No=0 
5.  Equality of groups at the start: Yes=1, No=0, Don’t know=0 
6.  Apart from the intervention all groups are treated equally; Yes=1, No=0, 
don’t know=0 
7.  Main outcomes are robust: Yes=2, Partially=1, No=0 
8. Main outcomes fully reported: Yes=2, Partially=1, No=0 
9. Drop outs less than 10% or analysis of data by ITT: Yes=1, No=0  
  
Total possible score is 12.  
 
The quality of the studies were then further categorised as:  High quality: scores 
9 and over.  Moderate: scores 5-8.  Low quality: Scores of 4 and under. 
5.8 Results of the review 
The electronic healthcare database search identified 160 unique references of 
which 140 were excluded by screening the titles and abstracts.  A further 10 were 
obtained through reference lists and conference abstracts.  Full paper screening 
of 30 studies resulted in exclusion of a further 18.  Studies were excluded if they 
were not randomised, were cohort or cross-over studies (Castleden, Duffin & 
Mitchell, 1984; Burgio, Robinson & Engel, 1986; Wilson et al., 1987; Burton et al., 
1988; Dannecker et al., 2005;  Capelini et al., 2006; Rett et al., 2007; Yoo, Kim & 
Kim, 2011), if they were not predominantly looking at biofeedback in the 
treatment of SUI in women ie were studying men or studying mainly urge urinary 
incontinence (Burgio et al., 2002) or if they combined biofeedback with other 
modalities such as electrical stimulation (Knight, Laycock & Naylor, 1998; 
Parkkinen et al., 2004).  They were also excluded if they did not include ‘PFME 
alone’ as a comparison group (Wyman, 1998; Dougherty, 2002; Huebner et al., 
2011), if they compared two types of biofeedback (Wilson et al.,, 1987; Wong et 
al., 2001; Aukee et al., 2002; 2004; Schmidt, 2009) or used an intra-vaginal 
resistance device (Ferguson et al., 1990; Klingler et al., 1995). Non-English-
language papers were also excluded from this review.   
The details of the 12 included studies are summarised in Table 7 (Appendix 2). 
 
The 12 included studies (Table 7, Appendix 2) involve a total of 818 women and 
were conducted between 1983 and 2003.  All appear to be single centre research 
except one, which was conducted across 4 countries in UK, New Zealand, 
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Ireland and Australia (Laycock et al., 2001a).  One is limited in detail as it is a 
conference abstract.   
 
5.8.1 Characteristics of the samples 
Ages ranged from 18 to 79 with two studies specifically targeting post-
menopausal women (Burns et al., 1993 and Taylor & Henderson, 1986).  The 
symptoms of SUI were determined by assessment of symptoms reported by the 
women and/or by urodynamics testing.  Exclusion criteria were given in most 
studies.  Common exclusions were neurological conditions, (Taylor & Henderson, 
1986; Pages et al., 2001), urinary infections (Taylor & Henderson, 1986; Burns et 
al., 1993; Mørkved, Bø & Fjortoft, 2002; Goode et al., 2003), previous surgery 
(Glavind, Nohr & Walter, 1996; Wong et al., 1997; Mørkved, Bø & Fjortoft,  2002), 
previous failed exercises (Wong et al., 1997), mainly symptoms of urgency or 
bladder overactivity (Glavind, Nohr & Walter, 1996; Sherman, Davis & Wong,  
1997; Mørkved, Bø & Fjortoft,  2002), continuous leakage (Goode et al., 2003), 
high residual urine (Burns et al.,  1993, Mørkved, Bø & Fjortoft,  2002, Goode et 
al., 2003), pregnancy (Mørkved, Bø & Fjortoft, 2002), medication affecting 
bladder function (Pages et al., 2001), specified medical conditions, faecal 
impaction and atrophic vaginitis (Goode et al., 2003).  Interestingly, only one 
study stipulates a minimal strength of pelvic floor contraction as an inclusion 
criterion (Pages et al., 2001). Exclusion criteria were not reported in three studies 
(Shepherd, Montgomery & Anderson, 1983, Laycock et al., 2001a and Aksac et 
al., 2003). 
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5.8.2 Designs 
Although most were 2 group RCT designs, some involved a third group (Burns et 
al., 1993, Laycock et al., 2001a, Goode et al., 2003, Aksac et al., 2003) and even 
a fourth (Taylor & Henderson, 1986) where additional interventions, a different 
treatment modality or a non-treatment control group were also included.  
 
5.8.3 Interventions 
Biofeedback monitoring was achieved either through recording vaginal or anal 
pressure (Shepherd, Montgomery & Anderson, 1983, Taylor & Henderson, 1986, 
Laycock et al., 2001a, Mørkved, Bø & Fjortoft, 2002, Goode et al., 2003) or 
surface EMG via an intra-vaginal electrode (Burns et al., 1993; Berghmans’ et al., 
1996; Sherman, Davis & Wong, 1997; Wong et al., 1997; Pages et al., 2001; 
Aksac et al., 2003). Four studies used home biofeedback units, five used 
biofeedback in clinic sessions only and four used both home and clinic 
biofeedback in their designs.  Of note is that some studies also used the 
biofeedback equipment to obtain muscle contraction strength measurements for 
all the participants including the control group (Burns et al., 1993; Shepherd, 
Montgomery & Anderson, 1983), and while some state that the biofeedback was 
only used for clinician measurement ie the patient was unable to view the screen 
or be ‘fed back’ information, others do not.  Sham biofeedback (using a probe not 
connected to the equipment or screen) was given to the control group in the 
Sherman, Davis & Wong (1997) study. Pelvic floor exercise programmes (the 
number of exercises performed in a ‘set’ and how many sets per day) were 
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diverse and it was not possible to compare regimens across studies.  The control 
and intervention groups in each study did perform the same programme.  
Supervision or clinician contact also varied.  Sherman, Davis & Wong (1997) 
Laycock et al. (2001a) and Goode et al. (2003) used one session per fortnight, 
however other regimens included one session per week (Shepherd, Montgomery 
& Anderson,  1983; Taylor & Henderson 1986; Burns et al., 1993; Mørkved, Bø & 
Fjortoft, 2002), twice a week (Wong et al., 1997), three sessions a week 
(Berghmans’ et al., 1996) and even five times a week (Pages et al., 2001).  
Glavind, Nohr & Walter (1996), Goode et al. (2003) and Aksac et al. (2003) used 
different clinician contact frequency for each group, while Pages et al. (2001) saw 
participants at the same intervals but gave individual treatment sessions to the 
biofeedback group and group PFME classes to the control group. 
 
5.8.4 Risk of bias (see Table 8, Appendix 3) 
Areas of possible bias are described in Table 8 (found in Appendix 3).  Sample 
sizes ranged from 200 to 13.  Power calculations and even statistical analysis 
were missing from many studies.    Power calculation was evident in three 
studies, Laycock et al. (2001a), Mørkved Bø & Fjortoft (2002) and Goode et al. 
(2003), with the remaining nine giving no indication of a desired sample size.  As 
previously mentioned, equal clinician contact time was evident in all studies 
except four (Glavind, Nohr & Walter, 1996; Pages et al., 2001; Goode et al., 
2003; Aksac et al., 2003).  Not surprisingly, blinding of clinicians and participants 
is difficult in this type of study and does not usually occur, although one study 
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(Burns et al., 1993) was stated as single-blind as it had managed to blind the 
researcher to which group was the experimental treatment.  Two studies used 
blinded outcome assessors (Berghmans’ et al., 1996 and Mørkved, Bø & Fjortoft, 
2002) with one also blinding the data analysis (Berghmans’ et al., 1996).   
 
Not all studies stated primary outcomes or data analysis a priori. A variety of 
outcome measures were used across the studies and although common 
measures were found, for example pad test weight, no standard pad test method 
was common to all studies, with some using a 48 hour test, 1 hour test, 24 hour 
test and one conducting a standard activity stress test measuring pad weight 
using a pre-defined bladder volume.  All studies used the types of outcomes 
recommended by ICS such as subjective/patient reported outcomes and some 
measure of urine loss however none used outcomes from all five recommended 
domains. Broad and condition specific Quality of Life was measured in many 
studies, but was poorly reported.  Use of measures, instruments and equipment 
was generally not reported in sufficient detail to allow evaluation of consistent use 
across groups in an individual study or to enable study replication.  There was 
some use of validated questionnaires, such as Kings Health Questionnaire, 
Social Activity Index and Incontinence Impact questionnaire (IIQ) but most 
studies used measures such as self-rating ordinal scales or VAS type measures 
developed specifically for each study. Most studies reported the percentage of 
‘drop outs’ but only three stated that data analysis ‘Intention to Treat’ 
(Berghmans’ et al., 1996; Mørkved, Bø & Fjortoft, 2002; Goode et al., 2003), 
although Mørkved, Bø & Fjortoft (2002) stipulate that missing data were 
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substituted with baseline values, and Goode et al. (2003), used last value carried 
forward.  Both of these practices for handling missing data are contentious (Lane, 
2008).  
Results are reported inconsistently and a general lack of detailed reporting (as 
per Consort guidelines) was noted across all studies. Some results were 
presented as percentage cure/improvement, others were mean/median scores 
‘before and after’, some without measures of dispersal such as standard 
deviation or range; most included statistical analysis. Percentages as in 
‘percentage cure’ or ‘percentage still exercising’ were also used but with no 
further analysis regarding statistical significance of the result.  Many give before 
and after scores and the statistical significance of the change for each group (that 
is, they compare the ‘p values’), however only Wong et al. (1997);  Morkved, Bø 
& Fjortoft  (2002) and Goode et al. (2003), compare the change difference of the 
groups and analyse this for significance. Most studies use ‘p values’ as an 
indication of statistical significance, but only Glavind, Nohr & Walter (1996) and 
Morkved, Bø & Fjortoft (2002) also give the confidence intervals.  Berghmans’ et 
al. (1996) calculates a ‘combined measure of effect’.  
  
Table 8 (Appendix 3) details the main sources of bias in each study.
5.8.5 Outcomes used in high and moderate quality studies 
Quality scoring of the studies is shown in Table 9.  Following further classification 
of scores, studies are categorised as high, moderate or low quality.  Four studies 
(Burns et al., 1993; Berghmans’ et al., 1996; Goode et al., 2003; Mørkved, Bø & 
Fjortoft, 2002) are scored as high quality with five studies rated as moderate and 
three studies rated as poor.  No studies used PFME adherence as a stated 
outcome, but six studies report that encouragement and/or monitoring of 
adherence behaviour had occurred. In four of these (Glavind, Nohr & Walter, 
1996; Sherman, Davis & Wong, 1997; Laycock et al., 2001a; Mørkved, Bø & 
Fjortoft, 2002) some compliance data was reported, for example ‘percentage still 
exercising’, however adherence data was not analysed further nor were 
adherence levels for each group compared. Meta analysis of data was not 
possible due to the variety of outcome measures used, how they were rated and 
the insufficient detail in the reporting.  Evaluation of the high and moderate 
quality studies, nine studies, is given below. Biofeedback group size varied from 
10 to 54 (median of 20, mean of 30). 
1. Symptom severity  
a) % subjective cure/improvement 
Three studies used this outcome.  Mørkved, Bø & Fjortoft, (2002) showed no 
difference in subjective cure overall, with Pages et al. (2001) reporting no 
difference between groups by three months.  However Glavind, Nohr & Walter 
(1996) reported 26% cured, 42% improved in biofeedback group, versus none 
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cured and 29% improved in control group.  The significance of this is not 
reported.  
b) Rating scale 
This outcome was used by four studies.  Three authors (Berghmans’ et al., 1996; 
Laycock et al., 2001a and Mørkved, Bø & Fjortoft,  2002) showed no difference 
between groups, however Wong et al. (1997) reported a significant difference 
(p<0.05) in favour of the Control group. 
 
2. Urinary loss 
     a)  Pad test (weight change in grams over 48 hour/ 24 hour/1 hour 
Six studies used pad tests.  Although Berghmans’ et al. (1996) found significant 
difference in favour of biofeedback at two weeks, at four weeks (the study end), 
there was no difference between groups reported.  No difference between groups 
was also reported for Wong et al. (1997), Mørkved, Bø & Fjortoft (2002) and 
Aksac et al. (2003). 
Glavind, Nohr & Walter (1996) reported significant improvement (p<0.02) in 
favour of the biofeedback group.  Cure rates (determined by pad test) were in 
favour of the biofeedback group, however they just failed to reach significance 
(p<0.057). 
     b)  Number of pads used 
Only Laycock et al., (2001a) used this outcome and showed the control group 
used significantly less pads per day by the study end. 
 
 70
  c)  Number of leakage episodes (diary) in 24 hours/7 days  
Five studies used this measure.  Burns et al. (1993) showed no difference in 
urinary leakage episodes or in % improvement from the completed diary.  
Berghmans’ et al. (1996), Wong et al. (1997) and Laycock et al. (2001a) also 
demonstrated no difference between groups. Using ITT, Goode et al. (2003) 
demonstrated a significant change difference between groups in percentage 
reduction of incontinence episodes over a 7-day diary, however there was a very 
high attrition rate in this study, and when just analysing ‘completers’, there was 
no difference shown between the groups. 
Other measure:  4 point ordinal scale of incontinence frequency 
Used by Aksac et al. (2003) and reported no difference between groups. 
 
3. Muscle Strength        
a) Perineometer/EMG (cm water/microvolts)    
Five studies used this outcome.  Burns et al. (1993) and Aksac et al. (2003) 
found significantly higher recordings in the biofeedback group compared with 
exercise group (p<0.001) while Pages et al. (2001) reported significantly higher 
contraction strength in the biofeedback group at four weeks compared with the 
control but no difference was noted at three months.  Laycock et al. (2001) and 
Mørkved, Bø & Fjortoft (2002) found no difference between groups. 
 
b) Digital palpation, for example Oxford Grading   
All studies which used this outcome (Pages et al., 2001; Mørkved, Bø & Fjortoft, 
2002 and Aksac et al., 2003) showed no difference between groups. 
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4. Adherence scores       
Exercise adherence was reported in three studies. Mørkved, Bø & Fjortoft, (2002) 
found 88.9% in the biofeedback group and 85.3% in the Control were exercising 
more than three times a week at six months.  Laycock et al. (2001) reported 79% 
were compliant in biofeedback group compared with 81% in control group at 3 
months.  Glavind, Nohr & Walter (1996) showed 89% of the biofeedback group 
and 50% of the control group were still exercising at 2-3 years.  None of these 
results were analysed for significance. 
 
5.  Quality of Life and other measures  
The Kings Health Questionnaire was used by Laycock et al. (2001a) and showed 
no difference between groups.  The Short Form 36 Health Survey, Incontinence 
Impact Questionnaire and Hopkins Symptom Checklist 90-R used by Goode et 
al. (2003) showed improvement for all participants but were not fully reported by 
group.  The Social Activity Index was used by Mørkved, Bø & Fjortoft (2002) and 
Aksac et al. (2003) and showed no difference between groups.   
5.8.6 Evaluation of high and moderate quality studies  
A probable lack of power in most studies gives the possibility of a type 2 error in 
the results reported. Unfortunately three studies demonstrating biofeedback as 
beneficial in terms of Increase in sEMG values (Glavind, Nohr & Walter, 1996; 
Pages et al., 2001; Aksac et al., 2003), and two studies showing difference in 
exercise adherence and symptom improvement (Glavind, Nohr & Walter, 1996; 
Goode et al 2003) are flawed in terms of equality of treatment given to each 
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group, meaning that a difference in training or supervision levels may actually be 
responsible for the improvement seen.  Among other studies, only Burns et al. 
(1993) showed significantly higher strengthening (demonstrated by higher sEMG 
values) in the biofeedback group with Berghmans et al. (1996) indicating early 
improvement in urinary leakage by pad test in the biofeedback group.  All other 
outcome parameters in the studies indicate no difference between groups. The 
highest quality scoring study (Mørkved, Bø & Fjortoft, 2002) demonstrated no 
difference between groups for all outcomes measured. 
Two high quality studies (Burns et al., 1993 and Berghmans et al., 1996) indicate 
some benefit in using biofeedback, however the highest rated study (Morkved, 
Bø & Fjortoft, 2002) found no support for use of biofeedback.  The 
methodological issues found in many of the studies (Glavind, Nohr & Walter, 
1996; Pages et al., 2001; Goode et al., 2003; Aksac et al., 2003) makes it 
impossible to conclude that the biofeedback intervention itself is responsible for 
the improvements seen.  This is in contrast to the meta-analysis conducted by 
Weatherall (1999) and the reviews by de Kruif & van Wegen (1996) and Glazer & 
Laine (2006) which conclude that biofeedback is more effective than PFME 
alone, and recommends (with Berghmans’ et al., 1998 and Neumann, Grimmer & 
Deenadayalan, 2006), that additional higher quality studies need to be conducted 
in order to clarify biofeedback effectiveness.  The variety of biofeedback delivery 
and intensity of treatments offered in these studies highlights the different 
rehabilitation uses of biofeedback.  Reasons for use include facilitation of 
teaching/learning of the exercises and use as a training aid in daily PFME home 
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practise. Although it is suspected that biofeedback may motivate patients and 
create enhanced adherence to a home exercise programme, this review shows 
this has not been specifically compared, reported or analysed in RCT studies to 
date.  
Enhancing successful self-management is encouraged in wider policy, and 
should be enabled.  If not, patients are left unmotivated and demoralised and 
conservative treatment will fail. Research has not examined use of biofeedback 
as a learning tool, or in terms of affecting exercise adherence and behavioural 
change in women with SUI.  If biofeedback can add value to clinical contact, use 
of this asset could mean fewer clinic visits for patients.  Apart from the 
convenience for patients, especially important if a specialist physiotherapist 
practises some distance away, this would also reduce overall treatment costs per 
patient and free more time for additional patients to be seen. 
Limitations of this review include the possibility that not all papers and reviews 
may have been identified in the search process.  Resources were also 
unavailable to involve independent assessors to review the papers.  Other 
limitations are the exclusion of papers not written in English and the exclusion of 
studies other than RCTs.   In addition, the use of a scoring method to assess 
quality is controversial; although in defence of this method, it assisted in the 
process of appraising the various aspects of study design, areas of bias and 
overall quality of the research conducted. 
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This review shows there is a lack of high quality research investigating the use of 
biofeedback to support individual pelvic floor exercise instruction in the treatment 
of women with SUI. Quality assessment of the studies in the review highlighted 
methodological flaws and also the use of intensive (and clinically unrealistic) 
clinic-training regimens.  In addition, these studies have not specifically 
measured self-efficacy for PFME and have failed to analyse home PFME 
adherence levels. It therefore seems that despite suspecting that biofeedback 
helps motivation to perform PFME, no studies have analysed the impact of 
biofeedback on pelvic floor muscle exercise adherence or self-efficacy in women 
undergoing conservative treatment for SUI highlighting a gap in the current body 
of evidence. 
 
5.9   Conclusion to the review of the literature 
Pelvic floor muscle exercises have already been demonstrated as efficacious in 
the treatment of SUI in women (Dumoulin & Hay-Smith, 2010), however clinical 
effectiveness may be compromised by poor exercise adherence. As high levels 
of patient self-efficacy are required to maintain adherence to a pelvic floor 
exercise regimen (Hay-Smith, 2007), appraising interventions to raise self-
efficacy would seem to be a way of promoting PFME adherence.  Perception of 
self-efficacy is self-evaluation achieved through self-reflection.  It is ‘belief in 
one’s own capabilities to organize and execute the courses of action required to 
manage prospective situations’ (Bandura, 1997).   
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There are four main sources of self-efficacy and various components of the 
physiotherapy treatment of incontinence, such as exercise instruction, education, 
supervision and consultation style may all play a part in self-efficacy promotion. 
Separating and testing modalities from packages of care is not easy. Results of 
studies are difficult to interpret as many have compounding influences and the 
biofeedback has been used in different ways.  sEMG biofeedback is an 
intervention used in treatment to augment PFME as it is thought to improve 
motivation and adherence to PFME however the literature shows this has not 
been specifically tested.  sEMG biofeedback, used as part of clinic-based 
physiotherapy treatment sessions, may enhance pelvic floor muscle exercise 
self-efficacy and improve PFME adherence in women with urinary incontinence 
trying to adopt a conservative treatment approach in their day-to-day lives.   
Although guidelines do not support sEMG biofeedback in offering increased 
benefit over pelvic floor exercises alone for patients who can already actively 
contract their pelvic floor muscles (NICE, 2006), and PFME treatment has been 
studied before in terms of the impact of self-managed treatment on self-efficacy 
(Demain et al., 2006), adding sEMG biofeedback to routine physiotherapy 
treatment to determine effects on PFME self-efficacy and PFME adherence 
levels has not previously been investigated.   It is proposed that sEMG acts to 
raise self-efficacy through learning the correct contraction.  This is achieved by 
means of feeding back the pelvic floor muscle response to the patient.  Figure 9 
shows how biofeedback may influence self-efficacy through the known sources of 
self-efficacy.   
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Figure 9 sEMG biofeedback and sources of self-efficacy 
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Self-efficacy sources are derived from observation of the muscle response (graph 
pattern) and the modification of patient effort to give instant feedback, verbal 
encouragement and physiotherapist feedback/endorsement.  In turn this may 
serve to heighten effort (exercise practice), resulting in improvement in the sEMG 
traces and creating an affective response (women are pleased with their effort); a 
further source of self-efficacy.  This study hypothesises that in allowing all 
patients to gain insight and knowledge regarding own pelvic floor function 
through use of sEMG in routine clinical practice, PFME self-efficacy and 
adherence will be improved.  To date these outcomes have not been explicitly 
explored in a comparison trial. 
The study design uses sEMG for periodic clinic-based biofeedback and 
monitoring of home exercise programme (HEP) progress in clinic rather than as a 
daily home training/strengthening aid.  The aim of this pragmatic study is 
therefore to determine whether adding clinic-based sEMG biofeedback in this 
way, enhances PFME self-efficacy and PFME adherence in the conservative 
treatment of women with stress urinary incontinence.  Secondary aims include 
evaluating symptom change and muscle strength as well as checking the 
reliability of using the Chen PFME self-efficacy scale in an intervention study in a 
sample of UK women with SUI.   
Chapter Six details the methods of the study conducted. 
 
CHAPTER SIX    Methodology 
 
6.1 The research question  
Is the use of clinic-based biofeedback in women with stress urinary 
incontinence associated with improvement in pelvic floor muscle exercise self-
efficacy and pelvic floor muscle exercise adherence? 
 
6.2 Aims and Objectives  
The aim of the study was to examine whether biofeedback could improve self-
efficacy and exercise adherence to a pelvic floor exercise regime in women 
with urinary incontinence.  The hypothesis was that giving clinic-based 
biofeedback on muscle activity while women performed pelvic floor muscle 
exercises in clinic would improve PFME self-efficacy and PFME adherence to 
a home exercise regimen. The objective was to test this hypothesis by 
conducting a randomised controlled trial to compare the effects of sEMG 
biofeedback plus standard treatment (pelvic floor muscle exercise instruction) 
with standard treatment alone on pelvic floor muscle exercise self-efficacy and 
PFME adherence in women with stress urinary incontinence.  The dependent 
variables (DV) were PFME Self-Efficacy and PFME adherence. The 
Independent Variable (IV) was clinic-based sEMG biofeedback treatment. 
 
6.3  Hypotheses 
Null Hypothesis:  There will be no difference in PFME self-efficacy or PFME 
adherence scores.  Incontinence symptoms and other clinical outcome 
measures will be no different as a result of using clinic-based sEMG 
biofeedback. 
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Hypotheses 
1. PFME self-efficacy levels, as measured by the Chen PFME self-
efficacy scale, will increase over the treatment period for both groups, 
but the group using biofeedback will increase more than the control 
group. Internal consistency (as measured by Cronbachs alpha) for the 
Chen PFME self-efficacy scale will be demonstrated in this sample of 
women with SUI. 
 
2. Daily and weekly self-rated home exercise practice scores as 
measured by a self-completed adherence questionnaire will increase 
over the treatment period in both groups, but the group using 
biofeedback will increase more than the control group. Exercise recall 
as measured on the self-completed adherence questionnaire will be 
more accurate in the group using biofeedback than the Control group. 
 
3. A relationship between self-efficacy and PFME adherence will be 
demonstrated.  Increase in PFME self-efficacy scores will be 
associated with increased levels of PFME adherence over the study 
period. 
 
4. Muscle strength as measured by the Modified Oxford Scale will 
increase for both groups but the group using biofeedback will increase 
by more.  Symptoms severity and bothersomeness of symptoms, as 
measured by the ICIQ-UI SF, will decrease in both groups over the 
treatment period, but there will be a greater decrease measured in the 
intervention group than the control. 
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6.4 Design 
A randomised controlled trial (RCT) was chosen to test the effects of sEMG 
biofeedback on PFME self-efficacy and adherence.  This was compared with 
usual treatment practice, in women with SUI who were able to contract their 
pelvic floor muscles.  Participants were seen on a one-to-one basis in line with 
routine clinic practice. The study design comprised two treatment groups:  
Group A, Control (standard treatment) and Group B, Intervention (standard 
treatment plus sEMG clinic-based biofeedback).  
 
6.5 Participants 
6.5.1 Inclusion and exclusion criteria. 
Women with SUI symptoms (with or without additional urgency or urge 
incontinence symptoms), as established through clinical history taking, were 
recruited.  This study seeks to establish whether routine use of biofeedback 
has benefit for women who can already contract their muscles.  Therefore 
only women able to contract their pelvic floor muscles were eligible for 
recruitment.  Women who were referred to the continence physiotherapy clinic 
at Tameside NHS Foundation Trust between December 2008 and February 
2010 were recruited.    The service accepts patients referred by a GP, 
gynaecologist, urologist, the Continence Advisory Service (CAS) or other 
health care professional.   
 
The exclusion criteria ensured that results could be attributable to the 
treatments used and not to extraneous factors, and also to comply with the 
ethics of conducting research.  They were kept to a minimum in order to 
maximise generalisability of the findings.  
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Exclusion criteria were: 
• Women unable to give informed consent. 
• Women with limited English language skills who were unable to 
complete the questionnaires, as no resources were available to enable 
translators or interpreters to be used.   
• Women with insufficient cognitive or communication skills to complete 
the questionnaires, as assessed by the clinical team. 
• Women with urgency or urge incontinence as their predominant 
complaint, as, although, women often present with mixed symptoms, 
the study primarily evaluated the intervention for women with SUI. 
• Women with a fluctuating condition likely to affect their continence such 
as Multiple Sclerosis.  
• Women who were unable to attend clinic, as the intervention was clinic-
based. 
• Women who could not tolerate use of an internal vaginal sensor probe 
as this was the method by which sEMG biofeedback was given. 
• Women who, on vaginal examination, had no pelvic floor muscle 
contraction, as this study sought to establish whether biofeedback adds 
benefit for women who can already contract their pelvic floor muscles.   
 
6.5.2   Ethical Considerations 
All necessary ethical and R&D approvals including permissions from the 
University of Salford and Tameside NHS Trust R&D committee were obtained 
before the study started. Local chaperoning and infection control policies were 
adhered to.  Ethical consideration was given to the information available to 
women about the study, the time needed for women to complete the 
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questionnaires used in the study, depriving the Control group of access to 
biofeedback treatment (for the study duration) and the acceptability and 
invasive nature of using an internal probe for biofeedback in the Intervention 
group.    The study’s focus was whether routine use of biofeedback added 
benefit for women who could already perceive a pelvic floor muscle 
contraction.  sEMG biofeedback is already a recommended treatment option 
for women unable to perceive a pelvic floor muscle contraction.  Including 
these women would risk them being allocated to the control group, resulting in 
a delay to treatment which was considered unethical by the researcher, as the 
biofeedback equipment was usually available for these women in this clinic.  
Neuromuscular electrical stimulation would be the treatment option of choice 
for women with no identifiable contraction on clinical examination (Laycock et 
al., 2001b).   
 
Discussion with the women ensured they were fully informed of all aspects of 
the study, potential risks and benefits.  They were given written information in 
the form of a patient information leaflet, and contact details of independent 
information sources should they needed further advice. The questionnaires 
were brief, requiring just a few minutes to complete. The principles of 
informed consent, data protection and anonymity were adhered to.  Women 
were informed they could leave the study at any time and that their care would 
not be adversely affected by their decision.  They were also made aware that 
the purpose of the research study was to generate new knowledge about the 
benefits of existing treatments, which are in common use.  The researcher 
was trained in good practice in research and undergone research ethics 
training.  At the final visit, women in the Control group were given the option to 
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receive sEMG biofeedback following discussion with the 
physiotherapist/researcher. 
 
6.5.3   Power calculation and sample size    
Normative data from the author of the primary outcome measure (personal 
communication, Chen 2007), and scores from the women who piloted the 
questionnaire prior to the main study, were used to calculate the effect size.  
This information estimated that a 10 point difference between groups on the 
pelvic floor muscle exercise self-efficacy scale (17 minimum and 85 maximum 
possible score) would be considered a clinically significant effect.  Power and 
sample size were calculated using data from Chen (2004) and based on 
normality.  This indicated that 25 patients per group would be needed to 
detect a clinically important difference of 10 points at the 5% significance level 
with 80% power, and assuming a control mean (standard deviation) of 64 
(14).  To allow for drop-out, a final sample of 60 was identified.  It was 
expected that three new participants could be recruited each week, meaning 
recruitment would take 25 weeks and recruitment and delivery of the 
intervention would be completed within 12 months. 
 
6.5.4 Recruitment process and randomisation  
Women attending for their first physiotherapy appointment were seen by the 
researcher/physiotherapist.  Those fulfilling the inclusion and exclusion criteria 
had the study explained to them and if they were interested in participating 
were given a written information leaflet and consent form (Appendices 5 and 
6).  A further appointment was given for two weeks time, along with a phone 
number and email address, allowing them to gain additional information if 
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needed. At the second visit there was further opportunity to ask questions and 
discuss any issues.  If women agreed to participate, consent was obtained.  A 
copy of the consent form was given to the participant and a copy was also 
attached to the patient record, after which baseline assessment 
questionnaires were completed and participants were randomised into either 
the intervention or control group. 
 
To ensure adequate concealment of allocation, the participants were not 
randomised until after the baseline assessments had been completed. 
Randomisation was blinded.  An independent statistician undertook this 
process and produced serially numbered, sealed opaque envelopes from the 
randomisation schedule, which was produced using a specially designed 
computer package (Stata version 8) incorporating randomly varying block 
sizes to prevent block size determination.   After baseline tests were 
completed, the researcher opened the next numbered envelope to find out the 
allocated group for each participant.  Due to the nature of the intervention it 
was not possible to blind the physiotherapist or the patient to the treatment 
received, however the data analysis was checked by staff blind to group 
identity. 
 
6.6   Research Procedure  
6.6.1   Pre-study screening assessment  
Although this assessment occurs before consent and randomisation, this visit 
should be considered as forming part of the clinical intervention received by 
participants. Normal clinical assessment (a continence assessment) was 
performed.   A symptom severity and ‘bothersomeness’ (ICIQ-UI SF) 
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questionnaire and 3-day frequency-volume chart was given to each woman to 
be completed and returned at the next visit in two weeks time. 
Inclusion/exclusion criteria for the study were checked and eligible women 
invited to participate in the research.  They were then given the study 
information sheet and consent form. The participants’ journey is depicted in 
Figure 10.   
 
6.6.2 Second appointment: Baseline assessment (study week 0) 
Consent was confirmed by the researcher.  Two questionnaires, Chen PFME 
self-efficacy scale (Appendix 10) and Hospital Anxiety and Depression scale 
(Appendix 13) were completed by the participant. An internal vaginal 
examination was undertaken to evaluate muscle function and muscle tone.  
Participants were then randomised into either the control or the intervention 
group and the treatment session proceeded depending on group allocation.  
Although both groups received pelvic floor exercise instruction, the 
intervention group also received a session of sEMG biofeedback.  All 
participants were given the written information sheet (see Appendix 5), an 
individually written prescription for exercise and an exercise diary (Appendix 
8).  Individualised information about bladder habit, fluid intake and bladder 
habit re-training advice was given as appropriate. 
 
 
 86
Potentially eligible patients referred for physiotherapy 
Pre-study assessment and eligibility screening   
Consent Visit   
Refusals Excluded, not 
meeting criteria 
Baseline questionnaires and examination completed 
Randomisation
Intervention group 
 
Individual PFME instruction 
and advice plus sEMG 
biofeedback session 
Control group 
 
Individual PFME instruction 
and advice 
6 week assessment 
Adherence questionnaire completed 
Vaginal examination to check progression of exercises 
 
Intervention and control groups treated as per last visit 
 
12 week assessment 
                        Final questionnaires completed 
(Self-efficacy, adherence and symptom severity) 
              Vaginal examination to assess PFM strength 
 
 
Figure 10   Participant Journey 
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6.6.3 Third appointment:  week 6 (mid-point of the study) 
An adherence questionnaire (Appendix 12) was completed by all participants 
on arrival to the clinic waiting area.  During the treatment session, all 
participants were asked about their understanding of the treatment and any 
problems encountered and a vaginal examination was performed to decide 
whether the pelvic floor muscle exercises should be progressed (see 
treatment algorithm, Appendix 9)  Any difficulties were discussed and all 
women were encouraged to adhere to the exercises and given bladder habit 
advice.  In addition, the ‘intervention’ group performed pelvic floor muscle 
exercises with biofeedback monitoring as at Week 0. 
 
6.6.4   Final attendance: week 12 (data collection only)  
Adherence, PFME self-efficacy and symptom severity questionnaires (see 
Appendices) were completed in the clinic waiting area on arrival.   In clinic, the 
physiotherapist ascertained patient understanding of the treatment and any 
difficulties encountered with each participant. A vaginal examination was 
performed and muscle strength assessed.  Further advice was given and the 
exercise regimen progressed or changed as necessary.  All women were 
encouraged to continue to adhere to exercise and bladder habit advice and 
thanked for their participation in the study.   
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6.7   Outcome measures 
6 7.1 Self-efficacy 
Measured using the PFME self-efficacy scale (Chen, 2004) detailed in 
Appendix 10. 
The pelvic floor muscle exercise self-efficacy questionnaire is a 17 item scale, 
each with a 5-point Likert type scale.  Each item is a statement about different 
aspects of pelvic floor muscle exercise self-efficacy, for example belief in 
ability to perform the exercises correctly, overcome barriers, belief that the 
exercises will provide benefit.  Each statement starts ‘I believe ….:  and asks 
for a response category box 1-5 to be marked with a cross, for each 
statement. 1=not very confident to 5=extremely confident.  The maximum 
score possible for the scale is 85 and the minimum is 17.  High scores show 
high levels of pelvic floor muscle exercise self-efficacy.   
 
The Chen PFME self-efficacy scale (Chen, 2004) was developed and 
validated in Taiwan on 106 women with urinary incontinence.  Exploratory 
factor analysis identified two factors explaining 66.71% of the total variance.  
Construct validity was established through examining the concurrent validity 
against 3 other scales:  the general self-efficacy scale (GSE) (Schwarzer, 
1993), the incontinence impact questionnaire-7 (IIQ-7) (Shumaker et al., 
1994) and a two item perceived PFME benefits scale (developed for the 
validation study).  The scale shows high internal consistency (Cronbach’s 
alpha of 0.95) and good test-retest reliability (over 6-30 days, r=0.86, 
p<0.001).  This indicates good stability.  Responsiveness was not evaluated in 
the validation study.  To help establish whether the scale was able to be used 
by women in the UK (having been developed in Taiwan) the scale was tested 
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with patients who met the inclusion criteria during the preparation stage of the 
study and consultees were asked whether the items could be easily 
understood.  As a result of patient feedback, an adjustment was made, 
without changing the meaning, to the wording of an item (see Appendix 11 for 
wording before and after this adjustment).   
 
6.7.2   PFME Adherence  
Adherence to PFME was measured using patient-reported recall of adherence 
behaviour from the previous day and the previous seven days (Alewijnse et 
al., 2003 Appendix 12).  One week was chosen as a period likely to reflect 
fluctuation in exercise behaviour, but not too long in order to ensure accurate 
recall.  It is short and user-friendly and comprises six items which attempt 
succinctly to capture actual exercise behaviour and self-evaluated success 
(on a scale of 0 to 10). Whether the exercises had been remembered and 
understood was evaluated using a 7-point Likert scale (+3 to -3) as well as the 
number of days the exercises were performed, how many times a day and the 
reasons for non-adherence.  Understanding and recall of the exercises was 
assessed by asking participants to provide a written description of the 
exercises they performed.  Completion in the clinic waiting area prior to 
treatment reduced the likelihood of forgetting the diary, impact of social 
desirability, and ensured that participants had time to concentrate on 
completing them accurately (Hay-Smith 2007, personal correspondence). 
 
6.7.3 Depression 
The Hospital Anxiety and Depression Scale (HAD) (Zigmond & Snaith, 1983 
Appendix 13) was used in this study to contribute to the descriptive 
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information presented for each group at baseline.  This is because depression 
levels are thought to influence PFME self-efficacy (Broome, 2003).  It is a 
commonly used 14-item ordinal scale used to detect anxiety and depression 
independent of somatic symptoms.  It consists of 2 sub-scales (7 items in 
each) measuring anxiety and depression.  A 4-point response scale from 0 
(absence of symptoms) to 3 (maximum symptoms) is used.  Possible scores 
for each sub-scale range from 0 to 21. Higher scores indicate greater levels of 
anxiety or depression. 
 
6.7.4 Symptom Severity 
The International Consultation on Incontinence questionnaire or ICIQ-UI SF 
(Avery et al, 2004) is a participant-completed questionnaire which provides a 
quick and simple measure of the severity and impact of urinary incontinence 
on the individual (see Appendix 14).  It demonstrates high reliability, validity 
and responsiveness to change, and, has good correlation with other more 
cumbersome objective measures such as the pad test (Karantanis et al., 
2004) and urodynamics findings (Seckiner et al., 2007). As a result, it is 
widely used internationally.  It comprises 4 items, three of which (frequency of 
leakage, amount of leakage and interference with everyday life) are 
summated to give a single score.  The fourth item diagnoses the participants’ 
perceived causes of the incontinence. The score range is 0 to 21, high scores 
indicating greater severity of incontinence. 
 
 
 
 91
6.7.5 Pelvic floor muscle strength 
The modified oxford scale (MOS) (Messelink et al., 2005) evaluates strength 
of the pelvic floor muscles assessed by vaginal examination at week 0 and 
week 12.  The 6-point ordinal scale (0-5 described in Figure 11) is easy to 
perform and also establishes whether a correct muscle contraction and ‘lift’ is 
occurring (which is an important part of the treatment process).  The MOS 
shows inter-rater reliability (Bø, 2001) but greater reliability if performed by a 
single assessor (Laycock et al., 2001b). 
 
 
 
 
 
 
 
 
 
 
0 No contraction 
1 Flicker of a contraction 
 
2 Weak contraction 
3 Moderate contraction (with lift) 
 
4 Strong contraction (with lift) 
5 Very strong contraction (with lift) 
                                                                                                
                                                                                                  Messelink et al., 2005 
 
Figure 11   Modified Oxford Scale to measure strength of the pelvic floor muscles 
 
 
6.7.6 About data collection 
All questionnaires were completed at clinic attendance to maximise return 
rates.  They were self-completed in privacy in the waiting area, sealed into 
envelopes and returned to the clinic receptionist before having contact with 
the researcher and starting the treatment session.  They were coded and 
anonymous to encourage the provision of accurate information. Completed 
questionnaires were stored unopened in a locked filing cabinet so the 
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physiotherapist/researcher had no knowledge of the questionnaire responses 
while the participant was undergoing treatment.   
 
6.8 Interventions received: usual care 
To standardise the interventions received in the study, one clinician (the 
researcher) provided the treatment for both groups.   Guidelines for good 
practice in treatment of SUI, recommended by the Chartered Society of 
Physiotherapy clinical guidelines (Laycock et al., 2001b), and NICE (NICE, 
2006), were adopted in order to standardise the assessment and exercise 
protocol and offer the most effective interventions. Usual care consisted of an 
individualized PFME regimen, education and advice delivered on a one-to-
one basis. All participants received verbal information about the basic 
anatomy and physiology of bladder and pelvic floor muscle function.  The 
purpose and aim of treatment, patient goals and expectations were also 
discussed.    
 
Patients were taught how to perform PFME through vaginal palpation and 
verbal instruction incorporating individualised visualisation techniques.  A 
regimen of home exercises to produce effective contraction and strengthening 
of the muscles was prescribed (see treatment algorithm Appendix 9).  In line 
with current recommendations (Staskin et al., 2005), each woman completed 
a 3-day frequency volume chart (see Appendix 15) to record types, volumes 
and frequency of fluids consumed, frequency of bladder voiding and amounts 
of urine passed, which gives insight into bladder function/dysfunction and is 
used in discussion to illustrate, inform and educate about bladder habit and 
function.  The results of the chart form the basis for talking about strategies 
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and treatment which can help in symptom management, such as bladder 
habit retraining, fluid intake advice and strategies to help control bladder 
urgency.  Advice regarding managing constipation, exercise and general 
lifestyle advice such as diet and weight loss was also given as appropriate. 
Key messages were established (and repeated) and realistic goals set.  
Patients were also encouraged to talk about any ambivalence and discuss 
reasons (or not) for adopting advice (Mattick & Jarvis, 1993).  
 
 
6.8.1 Components of usual care: pelvic floor muscle exercises 
Women with SUI need to perform at least 24 daily contractions over a 
minimum of 6 weeks to reduce incontinence (Choi, Palmer and Park, 2007) 
however a 12-week period is the minimal training period recommended by 
NICE (2006) and was therefore chosen as the standard for this study.  
Participants were instructed how to produce an effective PFM contraction with 
elevation of the pelvic floor; to tighten the muscles as if trying to stop passing 
wind from the back passage or as if to stop the passage of urine.  Pelvic floor 
muscle palpation through vaginal examination was also used for every 
participant at each treatment session to give feedback and reassurance about 
the effectiveness of the muscle contraction and improvement made. This 
enabled progress to be monitored and changes to the exercise regimen and 
revision of treatment goals to be instigated.  Full informed and valid consent 
was obtained prior to examination.   
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Participants in both groups practiced the exercises in the following way: 
• High intensity (maximal) contraction ‘holds’ at their individual maximum 
duration (to a maximum of 10 seconds) for an individually determined 
number of repetitions to improve strength and endurance. 
• An individually determined number of ‘fast’ contractions (to a maximum 
of 10 repetitions) for muscle responsiveness 
• Sub-maximal contractions during functional activities throughout the 
day to improve ‘carry-over’ into everyday activities. 
 
In addition the participants were instructed to: 
• Use PFM contraction to inhibit urinary urgency 
• Contract PFM before and during coughing, lifting and any exerting 
activity.  This is known as counterbracing, pre-contraction or ‘the 
knack’.  
• Relax muscles adequately in between PFM contractions, to prevent 
excessive muscle fatigue and ensure effective strengthening 
training can be achieved. 
(Miller, Ashton-Miller & DeLancey, 1998; Bø, 2007; Haslam, 2008a; 
Carriere, 2006) 
 
Each participant was also advised how and when to progress the exercises in 
between clinic attendances as depicted by the treatment algorithm (Appendix 
9) by increasing the number of repetitions and shortening the relaxation 
period between contractions, aspiring to 10 repetitions holding each at  
maximum intensity for 10 seconds and 10 fast maximal contractions. 
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6.9   Biofeedback 
The intervention group received the usual care (described in Section 6.8) plus 
sessions of biofeedback at week 0 and week 6.  Each biofeedback session 
lasted 10-15 minutes using electromyography (EMG) equipment (described in 
Chapter 4) to produce a real-time display of PFM activity during maximal, sub-
maximal and fast contractions according to the following procedure:  
Following vaginal examination, biofeedback monitoring was explained and the 
vaginal probe inserted and connected to the computer system.  Participants 
were treated in crook supine lying which was modified as necessary to gain 
maximum comfort.  Pelvic floor muscle activity was monitored at rest and this 
trace was discussed and relaxation encouraged.  The participant then 
performed maximum contractions, and the onset time, release time, level and 
endurance of the contraction and relaxation of the muscles were monitored 
and discussed.  Fast contractions were then performed to help improve 
speed, co-ordination and effective relaxation between contractions.   
 
Effort was encouraged.  Feedback and explanation was given regarding 
changes to the graph shape, however precise sEMG readings were not 
discussed or used to rate performance. Accessory movements and other 
muscle use were corrected as necessary throughout the session.  The vaginal 
probe was removed and written exercise instruction and advice (based on the 
biofeedback session performance) was given.  During the treatment session 
at week 6 the same procedure was followed.  PFM relaxation was monitored 
and exercises were progressed or changed as indicated by individual 
assessment and performance. 
 
 96
 97
6.10   Statistical Analysis 
Questionnaire scores and other descriptive data were logged onto an SPSS 
(version 16) spreadsheet by the researcher after the final visit.  Missing data 
was identified on the spreadsheet.  Participants were analysed in their original 
allocated groups (Fergusson, 2002).  First, all completed cases were 
analysed and then sensitivity analysis was performed for the main outcomes 
using substituted worse and best sample scores for those who dropped out.    
Comparison of groups for exercise recall was analysed using the chi-square 
test. ICIQ-UI SF, bothersomeness scores, Self-rating of adherence and 
Modified Oxford Scale ratings were analysed using the Mann-Whitney U test.  
As the PFME self-efficacy scale was validated using parametric measures 
(Chen, 2007 personal communication), and scores in the sample showed 
normal distribution, the unrelated t test was used to compare PFME self-
efficacy total scores for each group at baseline (week 0) and again at the end 
of the study (week 12).  PFME adherence scores for each group (at 6 weeks 
and 12 weeks) were also compared using the unrelated t. Within each group, 
changes in self-efficacy from baseline to week 12 and change in adherence 
levels from 6 weeks to 12 weeks were analysed using the related t test. 
Chapter Seven details the results of the study. 
CHAPTER SEVEN   Results 
 
7.1 Introduction 
This chapter presents the results of the study.  It was expected that clinic-based 
sEMG biofeedback would enhance self-efficacy, adherence and clinical 
outcomes which would be evidenced by the Intervention group scoring 
significantly better for these measures. Analysis was carried out by the 
researcher using the statistics computer package SPSS (version16). 
 
Total PFME self-efficacy scores were checked for normality at baseline and then 
compared for each group at the end of the study (week 12).  Change in PFME 
self-efficacy over the study period for each group was also compared.  PFME 
adherence for each group is reported for week 6 and week 12 as well as change 
in exercise adherence levels for each group over the research study period.  A 
description of the participants and baseline descriptive data is summarised for 
each group (see Section 7.2, 7.3 and Table 10a and b) and drop-outs described 
(Section 7.4 and Table 11). Inferential analysis of the main outcome measures 
(as described in Chapter 6 Methodology, Statistical analysis) are presented in 
Section 7.5, 7.6, 7.7, Tables 12 and 13.  Clinical outcomes, that is 
‘bothersomeness’ of urinary leakage, urinary incontinence symptom severity and 
pelvic floor muscle strength results are presented in Section 7.8 together with 
analysis of age, referral source and depression ratings.   The Chen PFME self-
efficacy scale is assessed for internal reliability in this study (Section 7.5.2). 
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7.2 Description of participants (see Consort flow chart, Appendix 16) 
Out of over 400 referrals for UI over a two year period, one hundred and sixty 
potential participants (women with SUI) were identified.  85 did not meet the 
inclusion criteria, five did not want to participate in a study and ten declined for 
other reasons.  Of the 60 consented, 29 were randomised to the Control group 
(Group A) and 31 to the Intervention group (Group B).  All those randomised 
completed intervention according to their group allocation at week 0.  
Demographic characteristics of included participants are depicted in Table 10a. 
 
Table 10a   Demographics of participants (n=60) 
Characteristic Mean/Median (SD/IQR) n (%) 
   
Age 43.8 (12.7) 
Ethnicity:  White British 
 
60 (100%) 
 
Parity 2 (1) 
BMI 24.1 (3.2) 
Smokers 2 (3%) 
 
Work: 
 
Paid employment or 
maternity leave 
 
Not in paid work 
 
Retired 
 
 
48(80%) 
 
 
3 (5%) 
 
9 (15%) 
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Over the twelve week study period, a total of 10 women dropped out.  Three from 
the Control Group and four from the Intervention Group by week 6, and a further 
one from the control group and two from the Intervention Group by week 12.  
Therefore, 50 participants completed the study, 25 for the Control Group and 25 
for the Intervention Group 
 
7.3 Analysis of baseline data  
There was no significant difference in measured characteristics between the 
control and intervention groups at baseline.  This demonstrates group parity and 
successful randomisation.  The Control Group contained 19 (65.5%) consultant 
and GP referrals and 10 (34.5%) continence nurse referrals. The Intervention 
group had 16 (51.6%) consultant and GP referrals and 15 (48.4%) continence 
nurse referrals.  The mean age of participants was 41.76 (SD11.15) for the 
Control Group and 45.84 (SD14.06) for the Intervention Group.  Analysis of 
PFME self-efficacy scores revealed normal and symmetrical distribution of 
scores in both groups.  Other descriptive data is summarised in Table 10b.  
PFME adherence was not measured at baseline. 
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Table 10b   Baseline measures for each group  
Baseline Summary Measures Control (Group A) Intervention (Group B) 
  (n=29) (n=31) 
Incontinence Severity 
Median (IQR) 11 (5) 12 (4) 
‘Bothersomeness’ 
Median (IQR) 7 (4) 6 (2) 
Anxiety Scores 
Mean (SD) 9.85 (3.91) 9.44 (2.71) 
Depression Scores 
Mean (SD) 7.15 (3.56) 6.85 (2.09) 
PFM strength 
Median (IQR) 3 (0) 3 (1) 
PFME Self-efficacy 
Mean (SD) 48.76 (15.44) 48.94 (14.29) 
 
 
7.4 Participants who dropped out of the study 
It is possible that those who dropped out may have been unrepresentative of the 
sample. In other words, they may have been less compliant, had more severe 
symptoms or poorer muscle function at baseline compared with the rest of the 
sample.  Therefore it is important to compare the characteristics of completers 
and drop-outs at baseline.  This data is displayed in Table 11.  Reasons for drop-
out by week six were: medical reasons (one in each group), personal reasons 
(one in each group), ‘did not attend’ (one in the control group and two in the 
intervention group).  At week 12 one further participant ‘did not attend’ in the 
control group and two in the Intervention group.  Of the ten who dropped out, two 
were referred by continence specialist nurses and eight were referred by 
consultant or GP.  Of the 50 completing the study, 27 (54%) were referred by 
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continence specialist nurses and 23 (46%) by Consultants or GPs. Other 
baseline measures are compared in Table 11. 
 
Table 11  Baseline measures of completers and non-completers 
Baseline Characteristics Failed to completen=10
Completed cases 
n=50 
  mean (SD) mean(SD) 
 
Incontinence Severity 
 
11.2 (2.4) 12.2 (3.5) 
‘Bothersomeness’ 
 6.1 (1.6) 6.2 (2.3) 
Anxiety Scores 
 10.2 (2.4) 9.6 (3.5) 
Depression Scores 
 6.7 (2.3) 7.0 (2.9) 
PFM strength 
 2.6 (0.7) 3.1 (0.7) 
PFME Self-efficacy 
 46.6 (12.2) 49.3 (15.2) 
Age 37.4 (8.8) 45.2 (13.1) 
 
 
Data for those who dropped out was not statistically analysed as numbers lacked 
enough power to detect significance.  Examining Table 11, all measures 
appeared to be broadly similar, except age.  Those who dropped out seemed to 
have a lower mean age than those who completed the study.   Participants were 
analysed in the groups to which they were randomly allocated and any missing 
values were identified on the SPSS datasheet.  Only participants with available 
data were analysed (complete case analysis).  However, as those who dropped-
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out may have constituted a biased subset, additional sensitivity analysis was 
carried out for the primary outcomes for the sample randomised. 
 
7.5 PFME self-efficacy analysis  
Hypothesis 1: PFME self-efficacy levels, as measured by the Chen PFME self-
efficacy scale, will increase over the treatment period for both groups, but the 
group using biofeedback will increase more than the control group. Internal 
consistency (as measured by Cronbachs alpha) for the Chen PFME self-efficacy 
scale will be demonstrated in this sample of women with SUI. 
 
Final self-efficacy scores (week 12) for the sample were checked to see if they 
formed a normal distribution (see Figure 12).  The maximum score was 83 and 
minimum 24.  The range was therefore 59 points.  The range of values 
resembled a normal distribution, with a mean of 60.64 and a median of 60.50. 
 
Table 12 details the complete case analysis of PFME self-efficacy scores 
recorded at baseline and week 12 with standard deviations, p values and 
confidence intervals.   
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 Figure 12 Distribution of total self-efficacy scores for the sample at week 12  
 
The related t test was used for within-group analysis and group scores were 
compared using the unrelated t test.  The Intervention group scored 61.68 and 
the Control Group scored 59.60 at the end of the study (week 12), a difference 
between the groups of -2.080, p = 0.575 (95% CI -9.49, 5.34). This result was not 
statistically significant.  The relative effectiveness of the two interventions was 
then compared.  The change in Control group PFME self-efficacy scores from 
baseline to week 12 was -9.96 points (16.48), p=0.006 (95% CI -16.76, -3.16) 
and -12.72 (11.29), p=0.0001 (95% CI -17.38, -8.06) for the Intervention group.  
The Intervention group changed by 2.76 points more than the Control, but this 
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difference between groups was not statistically significant p=0.493 (95% CI -
10.79, 5.27).  
 
Table 12   PFME self-efficacy score results (Complete cases) 
 
PFME 
Self-efficacy 
 
Control  
Mean (SD) 
 
 
Intervention  
Mean (SD) 
 
 
Difference between 
groups 
(95% CI) 
 
p 
value 
 
At baseline 
 
At 12 weeks 
 
Change in 
score from 
baseline to 
12 weeks 
 
 
P value 
(95% CI) 
 
48.76 (15.44) 
 
59.60 (14.82) 
 
-9.96 (16.48) 
 
 
 
0.006 
(-16.76, -3.15) 
 
48.94 (14.29) 
 
61.68 (10.98) 
 
-12.72 (11.29) 
 
 
 
0.0001  
(-17.38, -8.06) 
 
-0.177  
(-7.86, 7.51) 
 
-2.080  
(-9.49, 5.34) 
 
-2.76 
(-10.79, 5.27) 
 
 
0.963 
 
0.575 
 
0.493 
 
 
7.5.1 PFME self-efficacy sensitivity analysis 
Using best and worse sample scores for total PFME self-efficacy at week 12, 
missing values for those who dropped out were substituted to allow analysis of all 
those randomised (total sample number of 60).  This was done to assume a 
worse case/best case scenario for the participants who failed to complete the 
study and give an analysis forecast based on the original randomised sample.   
Inputting Total PFME self-efficacy worse sample score, revealed a 6 point 
increase for the control group and a 5.5 point increase for the intervention group. 
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Neither of these changes in self-efficacy reached pre-set clinical significance of 
10 points and the difference between these scores (0.5 points) remained 
statistically insignificant (p=0.922, CI -9.27, 10.22).  Comparing the group scores 
at week 12 confirmed there was no significant difference between the groups 
(p=0.949, CI -9.15, 9.76).  For best sample score substitution, the control group 
scores increased by 15 points and the intervention group increased by 17 points.  
The 2 points difference in effectiveness induced by the treatment remained non 
significant (p=0.518, CI -11.43, 5.82).  Comparing the group total self-efficacy 
scores at week 12 confirmed there was no statistical difference between groups 
(p=0.434, CI -10.49, 4.53). 
 
7.5.2   Reliability of the Chen PFME self-efficacy scale  
Chen’s 17 item PFME self-efficacy scale was tested for internal consistency in 
this study sample.  It produced a Cronbach alpha of 0.929, indicating good 
internal consistency and comparing well with Chen (2004). 
 
7.5.3   PFME self-efficacy results conclusion 
For the participants completing the study, there was no significant difference in 
levels of PFME self-efficacy between the groups at week 12 (the study end). 
Both groups showed significant change in PFME self-efficacy, with the 
Intervention group also exceeding the clinical significance level set pre-study at a 
10 point difference.  Sensitivity analysis showed that even when substituting best 
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and worse sample scores, no significant difference in self-efficacy scores would 
be seen between the groups at 12 weeks.   
 
7. 6   PFME adherence results  
Hypothesis 2:  Daily, weekly and self-rated home exercise practice scores as 
measured by a self-completed adherence questionnaire, will increase over the 
treatment period in both groups, but the group using biofeedback will increase 
more than the control group. Exercise recall as measured on the self-completed 
adherence questionnaire will be more accurate in the group using biofeedback 
than the Control group. 
 
Adherence was high in both groups.  Looking at the whole sample, nearly all 
participants (52 out of 53) had exercised ‘in the last week’ at the half-way point of 
the study (week 6), only falling to 92% (46/50) by the study end (week 12).  At 6 
weeks, 77% of participants in the control group and 82% in the intervention group 
stated that they had exercised ‘yesterday’, however analysis using the chi-square 
test showed the difference between the two groups was not significant (p=0.682).  
This level of exercise adherence was maintained over the course of the study for 
both groups, with 19/25 (76%) in the Control group and 21/25 (84%) in the 
Intervention group reporting ‘exercising yesterday’ at week 12 (p=0.480). 
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Exercise sessions per day and days exercised per week were compared for the 
groups at week 6 and week 12 using the unrelated t-test.  These results are 
reported in Table 13. 
 
7.6.1 How many times a day did participants exercise? 
Women were instructed to exercise three times a day.  The Control Group 
exercised 2.3 (SD1.6) times a day at week 6 (n=26) and 2.1 (SD1.8) times a day 
by week 12 (n=25), a change of 0.2 (SD 2.6) p=0.695, 95% CI -0.84, 1.24). The 
Intervention Group exercised 2.5 (SD 1.4) times a day at week 6 (n=27) and 2.6 
(SD1.7) times a day by week 12 (n=25), a change of -0.16 (SD1.8) p=0.668, 95% 
CI -0.92, 0.60).  The change in number of times exercised a day from week 6 to 
week 12 for each group was compared using the unrelated t test.  As can be 
seen in Table 13, the difference in change induced was -0.36 exercise sessions 
per day (p=0.566, CI -1.61, 0.89), a non significant result. 
 
7.6.2. How many days a week did participants exercise?  
Women were asked to exercise every day (seven days a week).  For the Control 
Group the mean number of days a week exercised at week 6 (n=26) was 5.0 
(SD1.8) and 4.4 (SD2.1) at week 12 (n=25), a fall of 0.68 (2.2) days, the related t 
test shows this as insignificant, p=0.137 (CI -0.23, 1.59).  For the Intervention 
Group, the number of days a week exercised at week 6 (n=27), was 5.0 (SD1.8) 
and 4.9 (SD1.8) at week 12 (n=25), a change of 0.12, an insignificant difference 
on related t testing, p=0.749 (95% CI -0.65, 0.89).  The score change from week 
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6 to week 12 for each group was then compared using the unrelated t test.  As 
can be seen in Table 13, the difference in change between the groups was -0.56, 
a non-significant difference p= 0.486 (95% CI -1.72, 0.60). Figure 13 illustrates 
adherence scores for each group at 6 and 12 weeks. 
 
Figure 13   PFME adherence levels for each group at week 6 and 12 
 
7.6.3   Sensitivity analysis of self-reported actual adherence 
Calculations were repeated to include those who dropped out. Their missing 
days per week and sessions per day scores at 6 and 12 weeks were substituted 
with worse and best sample scores.  Sensitivity analysis performed in this way 
did not change the significance of the results which remained statistically non-
significant, demonstrating no difference between groups for actual adherence of 
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PFME, either in terms of sessions per day or numbers of days per week they 
were performed (see table 14). 
 
Table 13  PFME adherence results for completed cases 
 
PFME 
Adherence 
 
 
Control 
 
Mean (SD)
 
Intervention 
 
Mean (SD)
 
Difference between 
groups  (95% CI) 
 
p-value 
 
Sessions per 
day: 
 
At 6 weeks 
At 12 weeks 
Change in 
number of 
exercise 
sessions per day 
(from week 6 to 
week 12) 
 
(P value  
95% CI) 
 
 
 
Days per week: 
 
At 6 weeks 
 
At 12 weeks 
Change in 
number of days 
exercised per 
week ( from 
week 6 to week 
12)  
 
(P value 
95% CI) 
 
 
 
2.3 (1.6) 
 
2.1 (1.8) 
 
 
 
-0.2 (2.6) 
 
0.695 
-0.84,1.24 
 
 
 
5.0 (1.8) 
 
4.4 (2.1) 
 
 
 
 
0.68 (2.2) 
 
0.137 
-0.23, 1.59 
 
 
 
2.5 (1.4) 
 
2.6 (1.7) 
 
 
 
0.16 (1.8) 
 
 
0.668 
-0.92, 0.60 
 
 
 
5.0 (1.8) 
 
4.9 (1.8) 
 
 
 
 
0.12 (1.8) 
 
0.749 
  -0.65, 0.88 
 
 
-0.16 (-1.00, 0.68) 
-0.52 (-1.5, 0.47) 
 
 
0.36 (-1.61,0.89) 
 
 
 
 
 
 
 
 
-0.00 (-1.03, 1.03) 
 
-0.56 (-1.67, 0.55) 
 
 
 
 
-0.56 (-1.72, 0.601) 
 
 
0.705 
0.298 
 
 
0.566 
 
 
 
 
 
 
 
1.000 
 
0.316 
 
 
 
 
0.337 
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Table 14 Sensitivity analysis of PFME adherence (sessions per day and days per week). 
 
PFME 
Adherence 
 
 
Control 
Mean (SD) 
 
Intervention 
Mean (SD) 
 
Difference between 
groups  (95% CI) 
 
p-value 
 
Sessions per 
day: 
 
At 6 weeks: 
Best 
Worse 
 
At 12 weeks: 
Best 
Worse 
 
 
 
Days per week: 
 
At 6 weeks: 
Best      
Worse 
 
At 12 weeks: 
Best   
Worse 
 
 
 
 
 
2.7 (1.9) 
2.0 (1.6) 
 
2.9 (2.6) 
1.8 (1.8) 
 
 
 
 
5.2 (1.8) 
4.7 (1.9) 
 
 
4.7 (2.2) 
3.8 (2.5) 
 
 
 
 
2.9 (1.8) 
2.1 (1.5) 
 
3.6 (2.7) 
2.1 (1.9) 
 
 
 
 
 
5.2 (1.7) 
4.6 (1.9) 
 
 
5.3 (1.8) 
4.0 (2.5) 
 
 
 
 
 
 
 
-0.2 (-1.19, 0.69) 
-0.1 (-0.91, 0.72) 
 
-0.75 (-2.1, 0.62) 
-0.30 (-1.25, 0.65) 
 
 
 
 
 
0.08 (-1.0, 0.84) 
0.05 (-0.95, 1.04) 
 
 
-0.56 (-1.62, 0.43) 
-0.21 (-1.5, 1.09) 
 
 
 
 
0.599 
0.817 
 
0.279 
0.528 
 
 
 
 
 
 
0.856 
0.929 
 
 
0.248 
0.749 
 
 
7.6.4   Self-rating exercise adherence  
Participants were asked to circle a number on a scale of 1 to 10 (worse=1, 
best=10) to rate their own exercise efforts at week 6 and 12.  
Control group self-rating score reduced from 5.88 (2.4) to 5.36 (2.3).  Intervention 
reduced from 6.20 (2.3) to 6.16 (2.4).  Comparing group scores at week 6 and 
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week 12 using the Mann-Whitney U test, no significant difference between 
groups was found (p=0.602 and p=0.293 respectively).  
  
7.6.5   Remembering the exercises: accuracy of recall  
Only 13 out of 24 in the Control Group could correctly remember the exercises 
while 17 out of 20 in the Intervention group could recall the exercise instructions 
accurately at week 12, the study end (see Table 15).   
 
Table 15   Accuracy of remembering PFME at week 12 
Remembering 
PFME 
Control 
N=25 
 
Intervention 
N=25 
Unable to 
remember or 
inaccurate 
description 
 
11 3  
Accurate recall 
of PFME 
 
13  17  
Missing 
responses to 
this item 
 
1  5  
 
 
Comparing the groups using the Pearson Chi-square (asymptomatic 2 sided) 
reveals this difference as significant (p=0.029). However 6 participants did not 
complete this item. 
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7.6.6   PFME adherence conclusion 
Throughout the study, PFME adherence was good for all participants and the 
groups showed no statistical difference in actual or self-rating of PFME 
adherence.  However, recall of the exercises at week 12 was significantly better 
in the intervention group. 
 
7.7 Relationship between PFME adherence and PFME self-efficacy 
Hypothesis 3 Increased levels of PFME self-efficacy will be associated with 
increased levels of PFME adherence over the treatment period. 
 
Pearson correlation analysis of sample data taken at 12 weeks revealed a 
positive and significant correlation between PFME adherence measures and total 
self-efficacy (r= .373 p=0.008 ‘exercise sessions per day’ and r= .448, p=0.001 
for ‘days exercised per week).  Group analysis at 12 weeks showed no significant 
relationship between these variables in the Control group, however, the 
Intervention Group demonstrated a positive and significant correlation between 
‘PFME self-efficacy measured at 12 weeks’ and ‘number of exercise sessions 
performed per day’ r= .434, p=0.049 and also with the ‘number of days exercised 
per week’, r= .523, p=0.007. 
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7.8 Analysis of clinical outcomes 
Hypothesis 4: Muscle strength as measured by the Modified Oxford Scale will 
increase for both groups, but the group using biofeedback will increase by more.  
Symptoms of incontinence and bothersomeness of symptoms, as measured by 
the ICIQ-UI SF, will decrease in both groups over the treatment period, but there 
will be greater decrease seen in the intervention group compared with the 
control. 
Change in Modified Oxford Score (grading for pelvic floor muscle strength, 
ordinal 0-5) over the study period was calculated for each group using the 
Wilcoxon signed rank test.  At week 0, median score (IQR) for Control group was 
3 (0), range 2 to 4.  Median score for the Intervention group was also 3 (1), range 
2 to 5. Median score for the Control group at week 12 was 4 (0), range 3 to 5 and 
Intervention group recorded 4 (1), range 3 to 5.  Although, both Control and 
Intervention groups showed significant change in muscle strength (p<0.001) over 
the period, comparison of the groups at week 12 using Mann-Whitney U, 
revealed no significant difference in muscle strength between the groups at the 
study end (p=0.147). 
Symptom severity improved for both groups over the study period.  Wilcoxon 
signed rank test showed ICIQ UI SF scores decreasing significantly from week 0 
to week 12 for each group (Control from 12.36 (0.741) to 10.28 (0.840) p=0.004, 
Intervention, from 12.00 (0.620) to 8.88 (0.759) p=0.002). However, comparing 
scores at week 12, Mann-Whitney U showed no significant difference in symptom 
severity between the groups (p=0.192).  A positive and significant correlation 
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(Spearman rho) of HAD depression scores with baseline symptom severity as 
measured by ICIQ UI SF was evident for the sample, r=.371 p=0.006.  
Bothersomeness of symptoms improved in both groups.  Control scores dropped 
from 6.28 (0.485) to 5.24 (0.623) p=0.031 and Intervention Group from 6.12 
(0.424) to 4.62 (0.451) p=0.013. However there was no statistical difference in 
the improvement of bothersomeness scores between the groups at the study end 
p=0.494.  Bothersomeness of symptoms at the end of the study correlated 
negatively and significantly with final self-efficacy scores for all women, r=-0.360 
and p=0.05. 
 
7.9   Results summary 
The results answer the hypotheses laid out in the methodology.  The sample had 
a mean clinical improvement of approximately 11 points on the Chen PFME self-
efficacy scale, demonstrating both a statistically and clinically significant change 
as a result of physiotherapy intervention.  However the difference between the 
groups at the end of the study period was not statistically significant.  In terms of 
self-efficacy this indicates that the intervention group performed equally well as 
the control group.  PFME adherence levels were good in both groups, and 
although a trend of increased adherence levels in the Intervention group was 
noted, there was no significant difference between actual or self-rated PFME 
adherence levels in groups either at the half-way point or at the end of the 12 
week treatment period. This means that adding clinic-based sEMG biofeedback 
did not increase PFME self-efficacy (as recorded by the Chen scale) or exercise 
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adherence more than the levels measured in the group receiving standard taught 
exercises.  The null hypothesis for the study is therefore retained.  Clinical 
outcomes were as good in the Control as the Intervention group, meaning that 
biofeedback added no extra clinical benefit in terms of PFME adherence or self-
efficacy.  Accurate recall of the exercises was greater in the Intervention Group 
than the Control and a positive and significant correlation was also noted 
between final self-efficacy scores and levels of PFME adherence at week 12.  
This finding was absent in the Control group.  
CHAPTER EIGHT Discussion and Clinical Implications 
8.1 Summary of key findings 
The results of this RCT indicate that there is no difference between the 
intervention group and control group in terms of mean PFME self-efficacy scores 
and self-reported PFME adherence levels.  Participants in both groups showed 
significant increases in PFME self-efficacy over the course of the study and 
PFME adherence levels were high in both groups.  In addition, the use of clinic-
based biofeedback appears to be responsible for better recall of PFME and a 
positive and significant correlation between PFME self-efficacy and pelvic floor 
muscle exercise adherence.  
Clinical outcomes improved significantly for all participants.  Urinary leakage 
symptoms improved and bothersomeness of symptoms declined, with non-
significant difference demonstrated between the groups.  Muscle strength 
increased significantly but again no significant difference was demonstrated 
between the groups.  Bothersomeness of urinary leakage positively and 
significantly correlated with both leakage severity and levels of depression.  The 
Chen PFME self-efficacy scale demonstrated good internal reliability in this 
study, helping to standardise the tool for use in women with SUI in the UK.  This 
study has demonstrated good outcomes for the control group, with high PFME 
self-efficacy and good levels of PFME adherence noted in both groups at the 
study end.  Although a trend for higher self-efficacy ratings and adherence levels 
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was noticed in the group receiving sEMG biofeedback, the difference between 
groups was non-significant. 
 
8.2 Explanation and Interpretation of results.  
The results of this study suggest that in terms of PFME self-efficacy and PFME 
adherence, the addition of two sessions of clinic-based biofeedback to a 
physiotherapy treatment programme does not provide added benefit to the usual 
care offered to women who already have some ability to contract their pelvic floor 
muscles.  Both groups received treatment which was equally effective in 
promoting PFME self-efficacy, PFME adherence and improving clinical outcomes 
for the participants.  A revised theoretical mechanism is represented in Figure 14 
below.  
 
Self-efficacy 
Adherence 
Intervention/
control 
Clinical 
Outcomes 
 
Figure 14   A diagram representing the possible relationship between the treatment 
offered by intervention and control groups, PFME self-efficacy, PFME adherence and 
clinical outcomes  
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As in the study conducted by Chen & Tzeng (2009), this study does not confirm 
the direction of influence with regard to self-efficacy, biofeedback, exercise 
adherence and clinical outcomes.  The treatments received by both groups may 
have improved exercise adherence, directly influencing clinical outcome and self-
efficacy which may in turn enhance exercise adherence levels still further.  
Alternatively the treatments may have increased PFME self-efficacy, which in 
turn influences adherence and also clinical outcomes. The diagram (figure 14) 
shows double headed arrows, acknowledging likely relationships between the 
variables.  These interactions may not be linear because other human behaviour 
and influences play a part.  In this way, outcomes are dependent on context 
(Shepperd et al., 2009). 
Although theoretically the treatments may influence all outcomes directly and 
independently, the results from this study indicate relationships between some of 
the variables.  A negative and significant correlation between self-efficacy and 
leakage severity is demonstrated and a relationship is also confirmed between 
PFME self-efficacy and PFME adherence, evidenced by the significant 
correlation noted between final self-efficacy scores and PFME adherence in the 
whole sample and also in the intervention group.  This effect was absent in the 
Control group, so it would appear that the relationship between PFME self-
efficacy and PFME adherence arises in those who receive the intervention.  
However, care must be taken in drawing conclusions.  Multiple testing can give 
rise to spurious results, and relatively weak correlations (r= < .50) can be 
statistically significant but may not be clinically important.  Numbers analysed are 
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important and the correlation for the whole sample (n=50) was strong and 
significant, confirming a likely relationship between PFME self-efficacy and 
PFME adherence (and agreeing with the findings of Chen & Tzeng, 2009).  
However, when analysing the groups separately, modelling a regression of 
adherence against self-efficacy should be performed to establish if there is 
interaction from the biofeedback treatment.  Therefore the group analyses 
presented here should be considered exploratory, as a larger sample would be 
needed to confirm any hypothesis that the relationship between self-efficacy and 
adherence is different for each group.   
The six-week intervals between study visits reflect the reality of pressures on 
treatment provision in current clinical practice.  This design allowed appraisal of 
biofeedback as a learning tool and avoided the clinic exercise sessions 
themselves causing a strengthening or training effect.  Therefore any 
improvement is attributed to improved self-efficacy and adherence to the home 
pelvic floor muscle exercise programme.  Even with limited clinician supervision, 
the results show that good adherence levels and PFME self-efficacy levels were 
achieved, with or without biofeedback, demonstrating that care provided in this 
way is as effective as care supplemented with sEMG sessions.  It is possible that 
sEMG biofeedback benefit has been diluted by the infrequent sessions and that 
more intensive delivery (for example, monthly or more frequent clinic attendance) 
would promote even greater PFME self-efficacy and PFME adherence than seen 
in these results.  
 120
The quality of consultation (palpation, verbal feedback and communication) given 
to all the participants, may mean that the results achieved by the Control group 
were actually too good to improve upon.  However, the self-efficacy scores form 
a normal distribution, with a range of 24 to 83 (59 points).  The maximum score 
possible for the Chen scale is 84 and the mean score at the end of this study was 
61.  These findings do not indicate a ceiling effect and suggests that even better 
self-efficacy could potentially be achieved in this sample.  Although 12 weeks is 
the minimal recommended period for muscle training (NICE, 2006), this study 
period may not be long enough to see a difference between group outcomes.  It 
is possible that biofeedback benefit with regards to maintaining self-efficacy and 
perseverance with PFME may actually be realised over a much longer time-
frame, possibly functioning to ensure that participants continue the muscle 
strengthening programme and gain still further improvement in outcomes in the 
longer term. 
High self-efficacy allows individuals to recover from set-backs and face up to 
challenges (Bandura, 1997), and it is often a struggle for individuals to juggle 
social, personal, behavioural and situational influences, which can impact on 
adherence commitment.  It was hoped that the confidence in exercise 
performance given by biofeedback in the clinic environment would enhance 
commitment to a home exercise programme.  Self-efficacy is known to have four 
main sources;  sEMG biofeedback was expected to increase skill and confidence 
(mastery) in performing the exercises by feeding back muscle effort, give a 
vehicle for verbal encouragement from the clinician, show success in corrected 
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effort (seen on the biofeedback trace) and pleasure in achievement (affective 
influence). These self-efficacy source experiences were acquired through clinic 
visits,  PFME self-efficacy relates to the exercises being performed correctly but 
also in the desired context; that is, when performed routinely at home and 
integrated into daily life.  This relates to phase self-efficacy: scheduling and 
coping (remembering and managing to perform PFME daily) and recovery 
(resuming PFME following a period of poor adherence).   These other phases of 
self-efficacy may be of greater relative importance than task self-efficacy in 
continued PFME adherence and need to be addressed alongside skill acquisition 
(Sallis et al., 1988).  They would not necessarily be directly affected by 
biofeedback use in clinic but could be influenced by other components, for 
example communication style, encouragement and reinforcement of PFME 
benefits, all found in the usual care package which both treatment groups 
received.  
The benefit derived from the biofeedback may not be fully captured by this self-
efficacy scale.  Enhancing confidence in effective execution of the exercises 
involves coaching women in contraction timing, pelvic floor relaxation and noting 
the change in shape and quality of the graphical line displayed on the 
biofeedback.  This quality of contraction is not fully reflected in the questionnaire, 
as the four self-efficacy questionnaire ‘task’ items merely ask participants to 
express confidence in holding the contraction strongly, holding for 5 seconds, 
holding for 10 seconds and sensation of contraction.  To fully assess 
improvement in overall muscle function, a questionnaire assessing additional 
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elements such as responsiveness, speed and relaxation would be desirable.  
Nevertheless the change in quality of contraction should have been assimilated 
into the way the exercises are performed, and, if important, would have made a 
difference either to muscle strength or to leakage symptoms.  However, as there 
was no difference in clinical outcomes it is questionable as to how useful it would 
be to measure additional task indicators, unless clinical benefit due to enhanced 
exercise execution was yet to be realised in this sample. 
Results of the secondary outcomes confirm what would be expected intuitively; 
that depression is associated with greater severity of urinary leakage, and higher 
levels of ‘bothersomeness’ of symptoms are associated with greater leakage.  In 
addition, higher self-efficacy scores are associated with lower levels of 
depression and less urinary leakage.  This finding supports those of Broome 
(2003). 
 
The Chen scale was assessed for internal consistency in this group of women.  
The Cronbach alpha was high at .95, indicating good internal consistency across 
the scale, however may also suggest redundancy of items in the Chen scale.  
The scale could be changed to be more succinct however the balance must be 
made between shortening the scale while ensuring coverage of the dimensions 
of the self-efficacy construct.  Further research could explore the potential for 
changes to the scale, perhaps even the usefulness of separate smaller sub-
scales for phase specific PFME self-efficacy.  
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8.3 Contribution and clinical relevance 
This study supports previous work examining PFME effectiveness and muscle 
strength improvement in the conservative treatment of SUI (Bø, 2007; Dumoulin 
& Hay-Smith, 2010).  Although a no treatment control was not used in this study, 
the improvement in symptom severity and muscle strength scores from baseline 
concurs with studies finding biofeedback use to be as effective as pelvic floor 
muscle exercise instruction alone (Burns et al., 1993; Berghmans et al., 1996), 
and better than no treatment at all (Henalla et al., 1989; Bø et al., 1990; Largo- 
Janssen et al., 1991).  The results also agree with a Cochrane review (Dumoulin 
& Hay-Smith, 2010) concluding that biofeedback offers no extra benefit over 
PFME alone.  However hopefully it also addresses some of the criticism of 
methodology found in other studies.   This study refutes the belief espoused by 
some authors that biofeedback assists adherence, motivation or effort (Kegel, 
1956; Glavind,  Nohr & Walter, 1996; Mørkved, Bø & Fjortoft, 2002) beyond that 
achieved with palpation and instruction alone. 
Other studies investigating motivation and performance have observed decline in 
self-efficacy over time (Vancouver et al., 2002; Vancouver & Kendall, 2006).  
This is thought to be due to initial high self-confidence or ‘miscalibration’ giving 
rise to an unrealistically high self-appraisal of capability (or inflated sense of 
preparedness), which, when subsequently confronted with the actual demands of 
treatment causes a ‘reality check’.  Observations of decline in PFME self-efficacy 
by others (Svengalis et al., 1995; Demain et al., 2006) may endorse this effect.  
Similarly, control theory of self-regulation (Powers, 1973), predicts that highly 
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self-efficacious individuals (those with little self-doubt) see no need to dedicate 
the time to practising their exercises and use their self-efficacy to judge how 
much effort is required to achieve a set goal and tailor their practise accordingly.  
It is possible that biofeedback used in this context may serve to endorse 
confidence and self-belief.  In this situation self-efficacy would be maintained, but 
adherence (exercise practice) would decline.  This study was designed as a 
randomised controlled intervention study (comparing two groups), not a within 
subject design, so the intention was not to assess changes in individual subjects 
with high self-efficacy over time. However there was no decline in mean self-
efficacy scores and neither was there demonstration of a negative relationship 
between self-efficacy and PFME adherence.  This suggests that the needs of 
highly self-efficacious individuals in the sample were served in terms of goal 
revision.  Adherence levels were high for all participants which seems to agree 
with some previous studies (Bo & Talseth, 1996; Alewijnse et al., 2003), although 
as previously discussed, self-rating of adherence is difficult to verify and likely to 
be over-estimated, especially by participants in research studies.   
Since the completion of this research, a Cochrane review has been published 
(Herderschee et al., 2011) which advocates the studying of self-efficacy for 
PFME and the effect of biofeedback in three capacities: as a teaching or learning 
tool, a progress recorder and a training aid.  All dimensions of biofeedback use 
have the capacity to improve self-efficacy.  The research presented here satisfies 
this recommendation in that it examines sEMG biofeedback as a 
teaching/learning tool.  Moreover, the improved recall demonstrated by the group 
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using biofeedback appears to confirm the benefit of sEMG in learning the correct 
execution of PFME.  According to Ley (1989) enhanced recall of instruction is an 
essential prerequisite to adherence.  It is perhaps the different method of 
information presentation made available through biofeedback monitoring which 
helps patients to remember the exercises accurately.  Other capacity for sEMG 
biofeedback use, for example as a training aid or performance measurement 
tool, would need to be explored in future work. 
In terms of overall symptom severity and muscle strengthening, the low 
supervision intervention used in this study produced surprising outcomes, given 
that clinician contact is thought to be a key factor in supporting adherence.  
However these results do agree with a study by Felicissimo (2010) which 
indicates good results can be achieved with low supervision intensity, providing 
comprehensive instruction is given at the outset.  The present study shows 
increased PFME self-efficacy levels over the study period suggesting that even 
limited contact can support confident exercising in patients.  Indeed, King et al. 
(1997) demonstrated that exercise persistence could be achieved unsupervised 
in patients with high exercise self-efficacy.  Further follow-up would be needed in 
order to confirm similar findings in the present sample.  Imamura et al.’s (2010) 
assertion that pelvic floor ‘extra’ can be defined as either extra clinical contact 
sessions or addition of biofeedback to PFME, is not endorsed by the results of 
the present study.  In contrast, the current study demonstrates that adding 
biofeedback to limited supervision did not give ‘extra’ benefit in terms of actual 
clinical outcomes. Moreover the conclusions drawn by Imamura and colleagues 
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(2010) acknowledged the compounding influence of the extra supervision given 
to participants in biofeedback groups.    
More recently published work (Holroyd-Leduc et al., 2011; Whitford & Jones, 
2011) also warrants appraisal in light of the present study findings.  Whitford & 
Jones (2011) found that PFME compliance was predicted by ability to confidently 
and correctly contract the pelvic floor muscles.  This seems to advocate building 
of task self-efficacy in promoting adherence. The present study did not assess 
confidence in correctness of contraction but confidence in ability to exercise 
regularly in daily life despite barriers.  It should therefore be assumed that 
correctness of contraction was achieved by both groups as there was no 
difference in adherence levels.  Whitford & Jones (2011) also acknowledge that 
measures were needed to help maintain the PFME habit (in other words 
scheduling self-efficacy).  Holroyd-Leduc and colleagues (2011) found significant 
improvement in self-efficacy and quality of life in a cohort of older incontinent 
women (n=103) as a result of using an incontinence risk-modification tool to 
promote self-management.  These findings highlight the importance of self-
initiated strategies based on condition knowledge and their effectiveness in 
condition management.  
 
8.4 Strengths and weaknesses of the study  
8.4.1 Study Design  
The design used was an RCT.  No design is perfect, however an RCT remains a 
powerful methodology to evaluate the effectiveness of a treatment as it controls 
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for threats to internal validity (Bø & Herbert, 2009).  Confounding variables are 
dispersed through the groups by the randomisation process, to produce groups 
similar in characteristics, with the goal of producing results which are 
generalisable.  The study presented here featured a design adequately powered 
and successful in creating two groups with equal characteristics.  External validity 
of the results is believed to be high as women were recruited through the usual 
physiotherapy referral process from a wide range of referrers, and exclusion 
criteria were kept to a minimum.  In this way the sample was representative of 
the population studied. However, women were not able to self-refer to 
physiotherapy and could only access treatment via a health care practitioner. As 
the women had all undergone some sort of initial screening appointment prior to 
a physiotherapy referral being initiated, these women may have had different 
experiences and expectations compared with women seeking out treatment 
through a self-referral mechanism.   
The randomisation process aims to ensure that group allocation is free from 
selection bias. All patients referred through any source were considered eligible 
for the study and a log of patients fulfilling the inclusion criteria was kept. 
Reasons for not wanting to participate were documented. Employing an 
independent statistician to prepare the randomisation schedule and sealed 
envelopes, which were opened at the clinic attendance, assisted in ensuring 
allocation was concealed.   However, other potential sources of bias must be 
acknowledged in this study.  Blinding is not usually possible in a physiotherapy 
delivered intervention and in this case it was not possible to blind the researcher 
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or patient to receiving biofeedback.   One person conducting the study raises the 
potential for researcher bias through recruitment, outcome assessment, data 
collection and inputting.  This is difficult to mitigate in an educational study as 
usually there is no research team and not enough funding to employ independent 
assistance. Following CONSORT guidelines, attending good research practice 
(GCP) training, sharing data spreadsheets with supervisors, using an 
independent statistician, feedback from conferences and peer review sessions all 
aimed to help transparency in the process.  
As pelvic floor muscle exercises are already an established and recommended 
treatment for SUI in women, a no treatment control was considered unethical as 
this would have meant withholding access to an established treatment service.  
However, as the physiotherapy waiting list at the time of this study was running at 
16 weeks, baseline measures were actually made after a period of what was 
effectively a no treatment period.  Study visits at 6 and 12 weeks reflected the 
number of contact sessions possible at this time due to waiting list pressures and 
restricted resources, and has relevance to the wider pressures experienced by 
clinicians in other fields.  Twelve weeks is the minimum time recommended for 
muscle change due to training, and based on the expectation that PFME 
adherence at 12 weeks would be a predictor of longer lasting commitment to the 
regimen (Alewijnse et al., 2003). Had time permitted, follow-up at 4 months, 6 
months or even one year would have been desirable in order to ascertain any 
biofeedback benefits over a longer study period and to establish whether long-
term adherence was maintained.  
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Although health interventions can be evaluated in other ways, such as 
observation and interview, RCTs still provide some of the most reliable evidence 
for therapeutic decision-making and a well-designed and appropriately used RCT 
is still widely recognised as producing one of the highest levels of research 
evidence (Moher et al., 2010).  However, quantitative study design does not 
focus on the recording of individual experience of treatment and this study design 
did not set out to achieve this.  Nevertheless, patient acceptability of sEMG 
biofeedback treatment is important and exploring women’s experience of using 
this equipment may have provided insight into possible undisclosed reasons for 
study drop-out and benefits not fully captured in questionnaires.  Moreover it may 
be interesting to explore through interview how biofeedback may have influenced 
insight into exercise performance, confidence in ability and desire/intention to 
adhere to the exercises.    
 
8.4.2 Measures 
Methods and measures were considered robust.  Return of questionnaires and 
completion of items within the questionnaires was excellent.  No questionnaires 
were not returned or not completed at all.  Items not completed were related to 
‘recall of exercises’ on the adherence questionnaire (six participants) and 
confidence in practising exercises during sexual activity on the Chen self-efficacy 
questionnaire (one participant).    
PFME self-efficacy was measured with a self-completed questionnaire which was 
shown to be a valid and reliable behaviour-specific scale (Chen, 2004).  It was 
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validated, however had not been used before in a UK population or as a before 
and after measurement in an intervention study.  Although PFME self-efficacy 
scale stability is known (Chen, 2004), the responsiveness to change of the Chen 
scale had not been tested before.  An effect size of 10 points was estimated by 
the researcher to be the minimal difference to be clinically important enough to 
change practice. This estimate was based on scores from a small sample of 
patients (pre-treatment) who tested the questionnaire for readability and 
comprehension prior to study commencement.  Data from the initial validation 
study was shared by Chen and revealed good comparison with initial pre-study 
data collected from women receiving physiotherapy treatment.  Piloting the 
PFME self-efficacy questionnaire in this way highlighted a problem with the 
wording of one of the Chen PFME self-efficacy questionnaire items, which was 
changed after seeking opinion and consent from the questionnaire author.  This 
alteration did not affect the meaning of the item.  The author of the scale did not 
think the change would influence scale validity (Personal communication, Chen 
2007), however further testing was not undertaken to confirm this.   
Adherence was measured with a self-completed questionnaire derived from 
another study and shared by the author (Alewijnse et al., 2003).  However it had 
not previously been validated and was not piloted prior to use in this present 
study.  This is regrettable as it was noticed that giving a written description of the 
exercises to establish recall/remembering of the exercises requires the ability for 
to describe concisely and accurately using written description.  Participants may 
have been put off completing this section (six women failed to complete this 
 131
item).  Recall of the exercises could have been more accurately captured (and 
from more participants) if a voice recording of the participants’ spoken description 
of the exercises had been used instead.   
As previously stated, accuracy is a concern when using self-reported measures 
especially adherence questionnaires. Completing the questionnaires at clinic 
attendance, albeit in a waiting room and posting the questionnaires 
anonymously, may still have created a desire to please the therapist, causing 
inflation in the questionnaire responses.  There is also the potential of memory 
bias associated with recalling behaviour from the last week.   In addition there 
may be a Hawthorne Effect, a phrase coined by French (1953) and derived from 
initial results of experiments called the Hawthorne Studies. The term refers to the 
improvement seen in participants thought to occur as a result of being 
researched and measured as part of the study process.  This is a problem 
recognised by researchers, however as each group received the same clinician 
contact, any effect should be lessened and dispersed across both groups. A 
postal questionnaire may have resolved some of these issues, but without help to 
chase up missing questionnaires, the method used seemed a compromise in 
ensuring an excellent questionnaire return, while giving the best chance of 
reliable data.  These issues were discussed with an experienced researcher 
(Hay-Smith, 2008, personal communication), and the chosen format and 
questionnaire timing seemed to be the best that could be achieved given these 
concerns.   There is also no evidence that retrospective use of a questionnaire to 
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evaluate exercise adherence is any less reliable than other methods 
(Herderschee et al., 2011). 
Severity of leakage was measured using a validated tool (the ICIQ-UI SF 
questionnaire, Avery et al., 2004) both pre- and post-intervention. This is a brief, 
robust and easily completed questionnaire. Several studies have assessed the 
psychometric properties of the questionnaire, including content, construct and 
convergent validity, reliability and responsiveness to change. It has demonstrated 
good reliability, ‘moderate’ to ‘very good’ stability in test-retest analysis and a 
final Cronbach’s alpha of 0.92 showing very good internal consistency (Avery et 
al., 2004).  It is recommended for measuring outcomes both in research and 
clinical practice in assessing the effectiveness of interventions on severity and 
impact of incontinence.  
Muscle strength assessment does not give a complete evaluation of total muscle 
function and does not indicate the quality of the contraction produced.  The 
modified Oxford scale (Laycock, 1994; Messelink et al., 2005) is commonly used 
in clinical practice and assesses strength and lift.  Vaginal palpation is used to 
assess muscle condition and function; the need for this only very rarely debated 
(Bardsley, 2007).  However some studies have found that muscle strength is not 
differentiated by palpation scores using the Oxford grading Scale (Bo & 
Finckenhagen, 2001; Ferreira et al., 2010).  Although intra-rater reliability in a 
scale is good for clinical evaluation and the modified Oxford scale has been 
appraised as showing good reliability when used by one assessor (Laycock & 
Jerwood, 2001; Frawley et al., 2006), this scale is probably not discriminating 
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enough to be used as an outcome measure in studies where muscle strength is 
being compared across groups in research studies (Ferreira et al., 2011). Other 
options include using sEMG (millivolts and seconds) to assess participants which 
may have helped evaluate other dimensions of muscle function such as muscle 
responsiveness (onset of contraction) and relaxation levels.   However the 
intention of this study was to restrict use of sEMG to the Intervention group in 
order to prevent confounding influence.  Use of other methods, such as 
ultrasound to measure muscle hypertrophy could have provided an additional 
outcome measure and is becoming more widely available. This may be a useful 
addition to the design of future studies. 
 
8.4.3 Intervention delivery 
In the present study the same person performed both the assessments and 
treatment for both groups. This had the advantage of minimising inter-rater error 
of measurement and maximising consistency in delivering the intervention. The 
disadvantage is that, in effect, it examines the effectiveness of a single person 
delivering the intervention. As the intervention delivered was highly standardised 
one could argue that similar results would be found if delivered by other suitably 
qualified professionals but it cannot be assumed that other people delivering the 
intervention (or the assessments) would do so with the same effect. This could 
be overcome by having a larger team of people delivering the intervention and 
undertaking the assessments possibly within a multi-centre trial. However this 
was not possible within the resources available.  Assessment and advice about 
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exercise progression, fluids and bladder habit were all given in line with national 
clinical guidelines (Laycock et al., 2001a; Laycock et al., 2001b; NICE, 2006). 
Use of exercise reminder diaries with emphasis placed on planning scheduled 
time (three times a day) for exercise sessions rather than using an ad-hoc 
approach was also given (Hines et al., 2007). 
Biofeedback may be employed in different ways to achieve various aims 
(Herderschee et al., 2011).  Millivolts were not recorded in this study as 
measuring performance quantitatively was not the intention of this research.  
Instead the shape of the graph/trace and duration of contraction was used to 
teach and improve muscle contractions.  Despite this, graph calibration was not 
hidden from the participants, which may have given the impression that ‘higher’ 
microvolt readings were desirable.   In the context of improving self-efficacy, care 
must be taken to avoid the consequences of trying to aspire too soon to an ideal 
performance, as the setting of overambitious goals (by the therapist or the 
patient) may have a detrimental effect on self-efficacy.  If possible, removing 
calibrations from the sEMG display may have helped focus attention on the 
graph shape, that is, correctness and quality of muscle response rather than the 
amplitude achieved.   Each clinic session was performed in the same clinic room 
in order to provide the same clinic environment for all participants.  This also 
minimised fluctuations in background noise from equipment in concurrent use 
and maximized reproducibility of the sEMG trace.  Individuals kept their probes 
and brought them to each session.  The same amounts of conducting gel and 
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positions for treatment/ monitoring were used, with each participant and in each 
session, in order to help ensure standardisation in treatment delivery. 
8.4.4 Recruitment. 
The source of referral could impact on patient management and expectations 
prior to attending for physiotherapy.  Patients were referred from different 
sources; some had already been given exercise leaflets, had undergone a pelvic 
floor examination, been given advice and some had received no advice or 
instruction at all prior to referral.  Broadly speaking, women referred by GPs do 
not usually receive bladder-specific advice and are less likely to have had started 
treatment for their incontinence.  If referred via the uro-consultants patients may 
have received an exercise leaflet and will have discussed likely treatments.  
Women seen by continence or urology specialist nurses will almost certainly 
have received a baseline continence assessment, PFM examination, exercise 
instruction, initial treatment and advice.  Referral sources were fairly evenly 
distributed between the groups, so these differences in experience prior to 
referral were not considered a potential confounder when interpreting the results. 
 
8.4.5 Analysis 
The drop-out rate of 16% compares well with other studies (Dumoulin & Hay-
Smith, 2010) where drop-out of between 10% and 50% is reported.  Participants 
who failed to complete the study were evenly split between the control and 
intervention groups. This suggests that participants did not drop-out because of 
not being randomised to the intervention group and that the intervention itself 
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was unlikely to be causing drop-out.  Results for participants were analysed in 
the groups in which they were allocated (Fergusson et al., 2002) which is a 
quality standard of data handling for RCTs recommended by the CONSORT 
group (Moher et al., 2010). To further assist transparent reporting, missing data 
was identified and the drop-outs from the study were analysed to see if they 
differed significantly from the completers.   
 
Analysis was undertaken on the completed cases and additional sensitivity 
analysis was performed for the main outcomes.  Intention-to-Treat (ITT) analysis 
causes debate (Altman, 2009) as it includes various options for the handling of 
missing values (Hollis & Campbell, 1999; Gravel, Opatrny & Shapiro, 2007).  
Missing data reduces power, however the main concern is disruption of 
randomisation as incompleteness of data may not be random.  No analysis 
option seems ideal.  Imputation of missing values is complex and also requires 
assumptions to be made about the data, which in itself can cause bias (Lane, 
2008).  Proponents argue that ITT is a cautious approach which minimises Type 
1 error, minimises the influence of those dropped-out as it accounts for all 
participants, preserves balance in the study arms and allows greater 
generalisability (Fergusson, 2002).  CONSORT group recommend reporting all 
analysis so that data handling methods can be appraised (Moher et al, 2010).  
For this study, analysis of those who dropped out (n=10, 16%) is presented and 
revealed no obvious biases.  The number of completed cases (n=50) met the 
recommendation for study power.   A simple evaluation of a ‘best’ and ‘worse’ 
case scenario using substituted main outcome sample scores was decided upon 
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in order to allow a sensitivity analysis to be presented together with completed 
cases for comparison purposes.   All these findings have been presented. An 
independent statistician, blinded to group allocation, provided additional checking 
of the analysis performed by the researcher. 
 
The primary statistical analysis performed was direct comparison of the two 
groups at 12 weeks (two-sample method) and sample size was calculated to 
compare the two groups in this way.  Actual data point differences, p values and 
confidence intervals are given.  In addition, comparison of final scores against 
baseline is also given for each group (Bland & Altman, 2011).  Mean score 
changes for each group are useful, especially as this scale has not previously 
been used pre and post intervention.  However testing within-group changes for 
significance is controversial because of natural changes which may occur over 
time and the potential for regression towards the mean.  There is also potential 
for erroneous conclusions to be drawn about treatment effectiveness by the 
direct comparison of p values (Bland & Altman, 2011). 
 
8.5 External validity 
As mentioned previously, there are often concerns regarding the external validity 
of RCTs.  Despite this, the external validity of this study is thought to be high.  
The study setting is Secondary Care (an acute hospital), where specialist 
continence physiotherapists commonly reside and practice alongside uro-
gynaecology and urology colleagues.  Treatment delivery also reflects the way 
this service usually operates (whether in primary or secondary care) with 
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participants seen in a clinic environment rather than in their own homes, recruited 
to the study through the usual patient referral process and from the usual variety 
of referral sources for this service. The sample is therefore representative of the 
patient population being studied in that they are women with SUI presenting to a 
health care professional for help.  The follow-up frequency and time allocated for 
assessment and treatment also highlights the reality of resource pressures in 
many services. The impact of budget constraints affects equipment purchase/ 
replacement, training, as well as restriction on the number of clinic follow-up 
sessions and time spent per session with a patient.  Restricted follow-up for 
patients is a clinical reality in many health facilities (private and NHS), reflecting 
the compromised service often offered to patients, a concern which helped 
prompt interest in conducting this study.  Funding for services can be a struggle 
and justification to managers and commissioners needs to be made (naturally) 
on grounds of clinical and cost-effectiveness.  Therefore this is a very relevant 
area for research in health services, and, in terms of setting and design, the 
results of this study can be generalised to other continence services as well and 
other physiotherapy settings where treatment adherence, self-efficacy and self-
management are the focus. 
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8.6 Implications for practice and future research 
8.6.1 implications for practice 
The benefits of improving and maintaining pelvic floor muscle function through 
life from early adulthood, child-bearing and into later life means a lifetime of 
PFME self-management.  Many find daily exercise adherence more challenging 
than attending clinic appointments or following other health advice (Evangelista, 
Berg and Dracup, 2001) and this can threaten patient self-management. 
Therefore, regard for concepts such as self-efficacy, which is related to the 
process of behaviour change, is needed in order to help us devise effective 
interventions.  
This is the first RCT to explore the claim that machine-mediated biofeedback, 
such as sEMG, can help motivation and adherence to PFME in the treatment of 
women with SUI.  This research shows that clinic-based sEMG biofeedback does 
not provide enhanced motivation to perform PFME in terms of improved self-
efficacy and exercise adherence when used routinely by women with SUI who 
can already contract their muscles.  Therefore sEMG should not be a substitute 
for individual coaching through palpation. Vaginal muscle palpation is a cost-
effective and sensitive method for establishing correctness of muscle contraction 
and easily integrated into routine vaginal assessment.  In addition these findings 
should reassure clinicians without access to biofeedback equipment that patients 
(who can already contract their pelvic floor) are not missing out. Nevertheless, 
this study demonstrates that using sEMG may help women learn and remember 
the PFME regimen.  sEMG is also shown to be an equally effective modality 
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when used as part of a treatment programme.  Although this research 
demonstrates that sEMG biofeedback does not promote additional PFME self-
efficacy and exercise adherence, self-efficacy and adherence are positively 
influenced even by physiotherapy intervention for SUI. This means that patients 
should have opportunity to access physiotherapy treatment, even if it is a limited 
service, and regardless of their initial self-efficacy screening scores.  
  
While sources of self-efficacy are known, there remains a gap in determining 
which interventions can change self-efficacy.  A systematic review of self-efficacy 
for physical activity tried to identify which intervention approaches impact most 
on levels of self-efficacy (Ashford, Edmunds and French, 2010).  Vicarious 
experience and feedback of past performance seemed to have the most impact 
on self-efficacy while graded mastery, persuasion and identifying barriers had the 
least or most negative effects.  In the present study only women’s current 
endeavour was displayed on the sEMG, therefore the full potential of 
biofeedback monitoring may not have been fully realised.  Verbal encouragement 
from the clinician may have less effect on PFME self-efficacy than allowing 
participants own past performance to be viewed, or modelling a woman’s own 
performance on the graph traces of others.  As there is potential for biofeedback 
equipment to display a patient’s past performance and that of others, further 
studies could explore the value of incorporating this into treatment sessions.   
Belief in ability to perform the exercises correctly and the belief that effectiveness 
of PFME will control the symptoms of UI is the essential starting point in women 
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appraising whether they can adopt UI treatment strategies.  Individual exercise 
instruction helps women experience the accomplishment and confidence in the 
execution of the exercise itself.  Moreover, the regular monitoring of progress 
helps to establish the importance and usefulness of daily exercise performance 
so it is not forgotten. Although the benefits of seeing the sEMG trace (muscle 
effort) is not realised in terms of exercise practise, there may, however, still be 
benefit for women not able to understand the exercises, that is, those with low 
PFME task self-efficacy.  This could be a subject of future study.   
Exploring individual motivations, such as a desire to be rid of bothersome 
symptoms or avoid surgery, as well as identifying individual barriers to self-
efficacy has potential to help tailor treatments for each and every patient.  A 
means of identifying specific reasons affecting PFME adherence in individuals 
(rather than addressing more general factors associated with non-adherence 
across all women with SUI) is therefore important.  In this way, limited time in 
individual clinic consultation is optimised.  Motivational Interviewing (Emmons & 
Rollnick, 2001) and use of program-planning models such as precede-proceed 
(Green & Kreuter, 1991) help identify and explain possible barriers to self-
efficacy or adherence prior to the evaluation of suitable interventions. 
Although learning and teaching research indicates that greater confidence and 
ability in a task or skill can lead to complacency and reduced effort (Vancouver, 
2002), this did not occur in this study.  This is thought to be due, in part, to 
effective revision of exercise targets or goals.  Therefore it is recommended that 
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treatment progression must be a key factor in PFM training sessions.  It is also 
advisable to ensure that, from the outset, women with seemingly high initial self-
efficacy for PFME do not hold mistaken self-efficacy beliefs. Clinicians need to be 
sure women have a realistic sense of what is required in effective treatment, to 
avoid decline in self-efficacy over the treatment period.  
High exercise self-efficacy predicts good compliance with exercise programmes 
(Clark and Dodge, 1999).  Specifically, recovery and action-planning self-efficacy 
allows the anticipation of demands and challenges, and the overcoming of set-
backs.  It is this aspect of self-efficacy which successfully predicts exercise 
adherence behaviour in the longer term (Schwarzer, 2008).  These are therefore 
important considerations in developing and improving interventions.  In this way, 
patients can maintain a life-long commitment to exercise programmes beyond 
mere mastery of the exercises achieved during clinic attendance.   
8.6.2 Future research  
1. Although clinic attendance and closer clinician supervision allows 
monitoring of factors affecting self-efficacy, the proxy efficacy provided by 
the clinician may have the potential to compromise patient independence 
and actually reduce self-confidence in the task (Bray, Brawley and Millen, 
2006).  Self-monitoring via home EMG units, and electronic reminder 
diaries or ‘work-out’ programmes through a smart phone applications 
(‘apps’) may help this process and provide the regular reinforcement 
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needed to maintain longer term adherence.  Exploring the use of these 
systems would seem to be worthwhile areas for future research.  
2. Packages of care should be examined to see what aspects of treatment 
could assist with phases such as coping and scheduling self-efficacy.  
3. Conducting an RCT in a sample of women with poor perception of pelvic 
floor contraction and/or low confidence in ability to perform a pelvic floor 
muscle contraction would assess the usefulness of biofeedback in this 
population of women. Therefore further intervention studies looking at the 
impact of biofeedback on women with low task self-efficacy are 
recommended. 
4. Studying the effect of goal revision on PFME self-efficacy and PFME 
adherence in women with high PFME self-efficacy. 
5. Research into the effectiveness of tools and communication strategies to 
help identify barriers to self-efficacy in individuals in order to enable 
targeted interventions. 
 
 
8.7 Conclusion 
Increased life expectancy will mean people living longer with dysfunctions such 
as urinary incontinence.  As these conditions become chronic, this ultimately 
affects quality of life. If effective health management through personal instigation 
of behavioural change can delay onset of chronic dysfunction, quality of life will 
be extended.  Exercising personal control and making behavioural changes in 
managing health is achieved through self-efficacy: the exercising of personal 
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control itself reducing the likelihood of disease development and progression 
(Steptoe & Appels, 1989). Understanding the theoretical underpinnings of self-
efficacy, can assist clinicians in deciding which interventions are most effective in 
helping individuals succeed with treatment.  Adopting theoretical standpoints 
assists in evaluating previous research (both successes and failures) and helps 
devise subsequent studies (Sirur et al., 2009).   
As the goal for a value-driven health service continues, clinician intervention 
needs to be timely and efficient, and patients are enabled (where possible) to 
manage their own treatment.  Building self-efficacy is vital to this process. Indeed 
the necessity for long-term adherence to PFME therapy inevitably means that at 
some point, women will be discharged from clinician care to self-manage their 
own exercise programme.  Opting for sEMG biofeedback should be a decision 
taken jointly with the patient and must occur against a background of good 
theoretical reasoning and appraisal as to the likely benefits for the individual.  
Routinely used, sEMG is unlikely to provide added benefit for women who can 
already perform PFME.  However, if barriers to PFME adherence are identified 
which include lack of confidence or uncertainty about PFME execution, sEMG 
biofeedback may well assist exercise learning and may indeed be of use in the 
quest for confident self-management of urinary incontinence.  
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Appendix 1                                     Screening tool for papers identified in search 
   
 
Study Identifier:    
 
 
1.Type of Study:     
Randomised study                                               YES   UNCLEAR   NO (exclude) 
 
 
2. Participants:   
Women with predominantly Stress Urinary Incontinence                     
                                                                             YES   UNCLEAR   NO (exclude) 
 
3. Interventions: 
EMG or pressure biofeedback used as an intervention arm  
                                                                              YES  UNCLEAR   NO (exclude) 
 
‘Pelvic floor exercises alone’ used as a control group              
                                                                             YES   UNCLEAR   NO (exclude) 
 
4. Outcomes: 
Does study report one of the following: symptom improvement or cure, reduction 
in leakage or quality of life                                                        
                                                                             YES   UNCLEAR   NO (exclude) 
 
5. Other criteria: 
Published in English                                            YES   UNCLEAR    NO (exclude) 
 
 
 
All 5 items must score ‘Yes’ for inclusion. 
If ‘unclear’ on any of the items then retrieve paper to clarify. 
 
 
 
Decision:       Include □             Reject  □            retrieve paper to clarify  □ 
                                                                                
 
                                                                                   Include    Reject 
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Appendix 2   Table 7 Included studies comparing biofeedback with pelvic floor muscle exercises alone in women with SUI. 
 
  
 
Study 
 
Sample 
Inclusion and 
exclusion 
criteria 
RCT Design Biofeedback 
delivery 
and contact 
visits
Adherence 
measure 
Treatment 
duration and 
assessment 
points 
Outcomes used Data, p-values, CI 
and 
Findings 
Shepherd, 
Montgomery 
& Anderson, 
1983 
 
N=22 
Women with 
SUI (confirmed 
by 
urodynamics) 
matched for 
age and parity. 
Exclusion: 
None 
mentioned 
2 groups 
11/11 
Intervention: 
Biofeedback 
using a 
perineometer 
(pressure 
readings) at 
home plus HEP 
Control: PFME 
only. 
 
Each participant 
had one hour a 
week with 
physiotherapist. 
Not reported 6 weeks  
 
Voiding chart 
completed in 
the week prior 
to the study, 
also 
perineometer 
readings at 
study start. 
 
Assessed 
again ‘after 6 
weeks’ 
Incontinence 
episodes (and 
urinary frequency) 
by self-completed 
voiding chart. 
  
Muscle contraction 
force (cm of water) 
using a 
perineometer 
 
 
 
Range of actual 
and mean values 
for each group, but 
no analysis or p 
values given. 
 
Intervention = 8 out 
of 11 continent 
Control = 3 out of 
11 continent. 
 
Episodes of 
incontinence per 
week, 
mean(range): 
Intervention: Pre 
6.5 (1-18) Post 
1.1(0-8) 
Control: Pre 5.5 (3-
12) Post 4.1 (0-7) 
Muscle 
contraction (cm 
water) Intervention: 
Pre 6.4 (3-12) post 
19.3 (10-30) 
Control: Pre 7.1 (3-
15) Post 11.2 (5-20)
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Taylor & 
Henderson, 
1986 
N=13,  
Symptoms of 
SUI. 
Excluded if 
neurogenic, 
neuromuscular 
disorder or 
urinary 
infection. 
 
Age range 55-
79 (post-
menopausal 
women) 
4 groups. 
 
Not stated 
how many in 
each group 
Intervention1; 
PFME 
programme and 
home visual 
biofeedback 
using a 
perineometer 
and clinic 
biofeedback 
once a week 
Intervention 2: 
PFME 
programme plus 
weekly clinic 
biofeedback. 
Intervention 3: 
PFME 
programme plus 
vaginal probe 
used as a IVRD 
at home without 
visual 
biofeedback and 
clinic 
biofeedback 
once a week 
Control: PFME 
alone. Attended 
clinic weekly. 
 
Compliance 
diary 
8 weeks 
 
X 8 (weekly 
clinic visits) 
Subjective rating  
 
Urinary diary  
 
EMG measures 
No useable data 
presented. 
 
100% ‘continence 
rate’ in Intervention 
group1 
(67% in the other 
groups) 
 
 
Burns et al., 
1993 
N=135 
Female 
volunteers over 
55 years old 
and cognitively 
intact (as 
determined by 
3 groups 
40/43/40 
Intervention: 
biofeedback 
session once a 
week for 8 
weeks. 
2nd Intervention 
Group: 30 
Adherence not 
measured but 
adherence 
promoting 
activity was 
instigated, ie 
exercise 
8 weeks 
Self-reported 
diaries 
completed 2 
weeks prior to 
randomization, 
at 8 weeks 
Muscle contraction 
force (assessed by 
EMG) Quick and 
sustained 
contractions. 
 
Urine loss 
Data pre and post 
treatment, 
percentage 
improvement and p- 
values given (NB 
the ‘no treatment’ 
control results are 
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mini-mental 
state exam) 
with 
predominantly 
SUI a minimum 
of 3 times a 
week (and 
demonstrable 
on 
examination), a 
normal 
urinalysis and 
post-void 
residual urine 
measure of less 
than 50mls. 
minute visits 
with ex 
instruction once 
a week for 8 
weeks,  
Control: no 
treatment and 
no contact. 
  
Both 
intervention 
groups received 
exercise 
instruction and a 
home exercise 
program was 
encouraged 
daily   
 
1 session (30 
minutes) per 
week  
Same contact 
visits for the 2 
intervention 
groups. 
 
reminder cards 
and 
encouragement 
at each visit. 
and then 3 
and 6 months. 
EMG and 
Urethral 
closure 
pressure 
assessed 
before 
randomisation 
and again 2 
weeks after 
the 8 week 
intervention 
period 
 
  
 
(number and 
severity by self-
completed diary) 
 
Percentage  
improvement 
 
(Urethral closure 
pressure (by 
Urodynamic 
testing) 
 
 
not given below) 
 
EMG(mv) Quick 
Intervention: pre 3.5 
(3) and post 
6.0(5.1) p<0.05 
2nd intervention: pre 
2.9(3.2)  and post 
3(3.4)  
Sustained 
intervention: pre 
2(1.5) and post 4.0 
(3.1) p<0.001 
2nd intervention: 
pre1.7(1.6) post 1.8 
(2.0) 
 
Urine losses per 
week: mean (sd) 
Intervention: pre 
13(12) to post 5(6) 
61% improvement 
p<0.001 
2nd Intervention: pre 
18(15) post 8(10) 
54% improvement 
p<0.001 
No difference 
between groups. 
 
No difference 
between treatment 
groups but 
significantly higher 
EMG recordings in 
EMG group. 
Improvement was 
 170
maintained at 3 and 
6 months in women 
with moderate/ 
severe leakage, but 
this was not broken 
down by group. 
  
Berghmans’ 
et al., 1996 
N=40 
Females 
between 18 and 
70 years old, 
referred by 
Urologist or GP 
‘with mild or 
moderate SUI’. 
Excluded 
women taking 
medication 
known to affect 
lower urinary 
tract, with 
pudendal nerve 
lesions or 
neurological 
conditions 
affecting 
bladder 
function, with 
history of 
previous 
urological 
surgery, less 
than 6 weeks 
post-natal, with 
UTI, with 
severe SUI, 
with vaginal 
2 groups 
20/20 
Intervention: 
sEMG 3 times a 
week for 4 
weeks  
Control  
treatment 
sessions 3 
times a week for 
4 weeks  
 
Same contact 
sessions for 
each group ie 
12 sessions 
over 4 weeks. 
Biofeedback 
equipment 
stated as 
reliable and 
valid. 
Reports ‘100% 
compliance’ 
however this 
refers to 
attendance at 
the study 
sessions not 
adherence to 
the home 
exercise 
program as this 
is not assessed. 
 
. 
 
4 weeks 
 
48hr Pad test 
assessed 
before 
intervention 
started, after 2 
weeks and at 
the end of 4 
weeks. 
 
Symptom 
questionnaire 
and diary 
completed 
before each 
treatment. (12 
times). 
Urine loss by Pad 
test 
 
Self-reported 
symptom 
questionnaire and 
bladder diary. 
 
Mean loss of urine 
(g) 
Intervention: pre 
26.6 (24.5) after 2 
weeks: 12.4(10) 
and post 12.2 
(15.4)  
Control :pre 
29(31.7), after 2 
weeks 17.4(17.6) 
and post 12.5(12) 
55% improvement 
for both groups 
(p<0.00) by end of 
treatment. 
Significant 
reduction in urine 
loss achieved by 2 
weeks compared 
with control, but no 
significant 
difference between 
groups at 4 weeks 
(end of the study).   
 
Self-reported 
symptom 
improvement and 
daily incontinence 
frequency Mean 
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irritation, with a 
pacemaker or 
hip prosthesis, 
unable to 
communicate in 
the language or 
fill out forms.  
 
data displayed 
graphically (no 
precise values or sd 
given) Improved in 
both groups but no 
significant 
difference shown 
between groups 
(symptoms, p=0.45, 
daily incontinence, 
p=0.18). 
 
Combined measure 
of effect showed 
slight trend towards 
the Intervention 
group but no 
significant 
difference in 
improvement 
between groups 
p=0.08 
 
Glavind, 
Nohr & 
Walter, 
1996 
N=40  
Women 
demonstrating 
>2g leakage on 
1 hour pad test. 
All women 
assessed by 
digital palpation 
but no 
distinction 
made between 
ability to 
contract with 
regards to 
2 groups 
20/20 
Intervention: 
Clinic 
biofeedback 
once a week for 
4 weeks. 
Control: 
Individual 
instruction 
‘Physiotherapy’ 
2-3 times 
Unclear whether 
the control 
group were 
examined. 
Yes. 
 
Greater 
exercise 
adherence 
levels found in 
the intervention 
group 17/19 
(89%) did their 
PFME regularly 
compared with 
7/14 (50%) in 
the control 
group) at 2-3 
4 weeks. 
  
Pad test 
assessed 
before the 
intervention, at 
4 weeks (end 
of the 
intervention) 
and again 2 
months later. 
Symptom 
severity and 
exercise 
Urine loss by ‘new 
standardised’ Pad 
test (‘cure’<1g) 
 
Symptom severity 
and PFME 
adherence 
questionnaire at 2-
3 years. 
 
 
Raw data, p-values 
and CI given.   
 
Pad weight g (CI) 
Intervention: Pre: 9 
(5, 22), at one 
month: 2.5(1,10), 
Post: 0.8 (0,4).  
Control: Pre: 12.8 
(9,44), at one 
month: 19 (0,51), 
Post: 10 (2, 27) 
p=0.02 found in 
favour of 
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inclusion 
criteria. 
Excluded if had 
previous 
surgery for UI 
or had detrusor 
instability on 
Urodynamics 
testing. 
 
Supervision and 
contact time is 
different for 
each group. 
 
years. 
 
adherence 
assessed (a 
median time 
of) 2.5 years 
later. 
 
biofeedback group 
at 3 months. 
Relative reduction 
of pad weight in 
intervention group 
is 88.4% (78-94%) 
compared with 
53.9% (2.1-78%) in 
the control group. 
Cure rates (<2g 
pad test) were: 
11/19 in the 
intervention group 
and 3/15 in the 
control (P=0.057) 
 
Symptom severity 
at 2-3 years: 
Intervention: 5/19 
(26%) subjectively 
cured and 8/19 
(42%) improved. 
Control: none cured 
but 4/14 (29%) 
improved. 
 
Sherman, 
Davis & 
Wong, 1997 
 
 
 
 
N=46  
 
Women 
soldiers with 
SUI and mixed 
UI 
demonstrated 
on 
urodynamics. 
 
Excluded if only 
2 groups 
23/23 
Intervention: 
‘Urethral 
Biofeedback’  
EMG activity of 
the pelvic floor 
muscles 
Also 
biofeedback 
units for home 
use for the first 
7 days. 
Adherence was 
recorded by 
self-completed 
questionnaire, 
ie how many 
hours of 
exercises did 
they do a week. 
 
Control group 
practiced their 
8 weeks 
 
Urodynamics 
and 
‘subjective 
patient report’ 
before 
randomization 
and after 8 
weeks. 
Outcomes not 
stipulated.  Data 
was gathered from 
Self-completed 
questionnaire, 
urodynamic 
assessment and 
clinical 
examination. 
No validity and 
reliability of 
Actual data and p-
values reported but 
no CI. 
Severity of the 
problem: 
Between group 
analysis of final 
values  
Mann Whitney U 
p=0.95 
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urge 
incontinence 
Control: sham 
biofeedback 
(the same 
equipment and 
timed exercise 
regimen, but not 
connected to 
the apparatus 
and did not view 
a screen). 
One session 
every 2 weeks 
(total 4 
sessions) 
 
exercises 
significantly 
more by the end 
of the study. 
outcome 
measures was 
stated. 
 
18 outcome ‘items’ 
reported including: 
 
self-rating severity 
of the problem 
0=worst to 3= best 
 
Number of leaks 
(per day). 
 
Number of leaks 
per day : 
mean(SD) 
Intervention: before 
7.27 (7.44) after 
2.90 (6.53) p=0.01 
Control: before 
15.72(10.71) after 
5.25(7.24) p=0.03. 
 
Difference between 
groups p=0.06 
 
Wong et al., 
1997 
(abstract 
only) 
Numbers not 
stated. Data 
presented for 
17 women. 
SUI proved on 
Urodynamics. 
Mean age=48.2 
 
Excluded if 
previously 
failed PFME or 
had undergone 
incontinence 
surgery.  
2 groups 
(10/7) 
Intervention: 
PFME plus 
clinic EMG 
biofeedback 
twice a week for 
4 weeks. 
Control: .PFME 
attending twice 
weekly for 4 
weeks. 
 
Not stated 4 weeks Urinary 7-day 
Diary 
 
Urine loss on 1 
hour pad test 
 
Incontinence 
impact 
questionnaire. 
 
 
Not sure if drop 
outs occurred. 
Change scores 
reported for each 
group. 
Leakage episodes 
(per week) 
Intervention: 2.0 
(3.5) Control: 
9.1(12.3)  p> 0.05.   
Pad test weight (g) 
Intervention group: 
7.4(6.1)  Control: 
18.7 (24.8) p>0.05 
IIQ score: 
Intervention: 
8.5(19.9) and 
Control: 24.5(10.8) 
p<0.05. 
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Laycock et 
al., 2001a 
N=101  
women ‘with 
symptoms of 
SUI’ 
3 groups 
41/40/20 
Intervention 1: 
Cone therapy 
10 minutes a 
day 
Intervention 2: 
Biofeedback 
using PFX 
home 
perineometer 10 
minutes per day 
Control: PFME 
10 minutes each 
day 
 
Participants 
completed a 
daily exercise 
diary to record 
adherence to 
the trial 
protocol. 
 
Compliance 
scores 
presented as 
percentages for 
each group:  
Group 1: 77% 
compliant, 
Group 2; 79% 
compliant, 
Control; 81% 
compliant  
These were not 
analysed for 
significance 
3 months 
All seen in 
clinic every 2 
weeks 
(total 6 
attendances). 
 
Assessment 
points were 
before 
randomization 
and after 3 
months 
 
 
Primary 
Outcomes: 
Urinary 
incontinence 
episodes 
(recorded by daily 
diary). 
 
Subjective 
assessment of 
symptom severity 
(by VAS) 
 
Secondary 
outcomes: 
Number of pads 
used per day 
(assessed by 
diary). 
  
Increase in 
contraction 
strength (by 
electronic 
perineometer) 
 
QoL  (Kings 
Health 
Questionnaire) 
 
No VAS score 
results given. No 
measure of 
dispersion, CI or 
change differences 
given. 
(Intervention1 
results have been 
omitted here).  
 
UI episodes per 
day: Intervention 2  
2.04 before and 
1.77 after (p=0.000) 
Control: 1.71 before 
and 0.47 after 
(p=0.003)  
ANOVA 0.465 
Muscle 
contraction force: 
Intervention2: 19.74 
before and 32.10 
after (p=0.001), 
Control: 20.11 
before and 27.75 
after (p=0.004) 
ANOVA 0.690 
Qol: Intervention2: 
33.86 before and 
41.13 after 
(p=0.002), Control: 
28.75 before and 
39.19 after 
(p=0.009)  
ANOVA 0.609  
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Number of Pads 
used per day: 
Intervention2: 3.21 
before and 1.05 
after (p=0.006) 
Control: 2.38 before 
and 0.05 after 
(p=0.002)  
ANOVA 0.043. 
 
Conclusion: All 
groups showed 
significant change 
but there was no 
significant 
difference 
demonstrated 
between groups.  
 
Pages et al., 
2001 
 
 
 
 
 
 
 
N=51 
  
All participants 
had SUI 
confirmed with 
Urodynamics 
and could 
activate their 
pelvic floor 
recording at 
least a Grade 2. 
Exclusion: no 
significant 
coexisting 
medical illness 
especially 
neurological 
problems, and if 
2 groups 
13/27 
(11 withdrew 
after 
randomistion)
Intervention: 
sEMG 5 times a 
week for 4 
weeks (20 
sessions)  
Control: Group 
PFME 5 times a 
week for 4 
weeks (20 
sessions)  
 
All participants 
then followed a 
home exercise 
programme for 
2 months. 
 
Not reported 4 weeks,  
Assessed at 
the start, 4 
weeks and 
also reviewed 
2 months after 
treatment 
finished. 
Subjective 
change was 
only recorded 
at 4 weeks 
and 2 months 
after 
treatment. 
Muscle strength by 
digital grading 
assessment (and 
also ‘speculum 
test’)  
 
Urination 
frequency and pad 
dampness/leakage 
episodes by 
voiding diary   
 
Subjective 
improvement 
report by self-
completed 
standardized 
questionnaire 
Data and p values. 
No CI reported.  
 
Digital PFM 
strength(1-5) 
median(SD) 
Intervention: 2(0.9) 
before, 4(0.8) post 
and 4(0.8) 3 
months after 
(p<0.0001). 
Control: 
3(1.1)before, 
3.5(1.0) post and 
4(1.0) at 3 months 
after P<0.0001). 
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taking 
medication 
thought to 
interfere with 
bladder 
function. 
 
 
Contraction 
strength measured 
with pressure 
biofeedback  
 
 
Pad 
dampness/leakage 
results not stated. 
 
Subjective 
improvement % 
Intervention:  28% 
had no leakage 
after with 62% at 3 
month follow-up.  
68% had improved 
symptoms declining 
to 38% at 3 months. 
4% had no change 
post treatment with 
none reporting 
unchanged 
symptoms at 3 
months(all had 
improved) 
Control: 22% had 
no symptoms post 
treatment improving 
to 69% at 3 months. 
74% had improved 
symptoms post 
treatment declining 
to 31% at 3 months. 
4% had no change 
at post treatment 
but these had 
improved by 3 
months. 
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Contraction 
strength (cm2) 
median(SD) 
Intervention: 
12(5)before, 50(14) 
after and 43(16) 3 
months after 
(p=0.0005) 
Control: 11(7) 
before, 16(10) after 
and 17(14) at 3 
months (p<0.0001) 
 
Initially a significant 
increase in 
contraction strength 
was noted in the 
intervention group 
at 4 weeks, but no 
difference between 
the 2 groups was 
noted at 3 months. 
 
Mørkved,  
Bø & 
Fjortoft, 
2002 
 
N=103 
Urodynamically 
proven SUI>2g 
measured by 
pad test. 
Exclusion: 
Detrusor 
instability on 
Urodynamics, 
residual of 
more than 
50mls, previous 
urological 
surgery, 
2 groups 
53/50 
Intervention: 
clinic vaginal 
pressure 
biofeedback and 
HEP using 
home 
biofeedback unit 
three times a 
day. 
 
Control: Seen 
in clinic for 
individual 
training 
‘motivation’ was 
given in the 
sessions. 
 
88.9% in 
intervention and 
85.3% in control 
group ‘were 
training more 
than 3 x a week’ 
(not significant) 
but it is not 
clear how this 
was assessed. 
6 months 
 
Assessed at 
baseline and 6 
months (end 
of treatment 
period), 
although 
vaginal 
squeeze 
pressure is 
additionally 
reported at 3 
months 
Leakage on Stress 
Pad test (<2g 
cure) 
(Also did 48 hour 
pad test as a 
secondary 
outcome) 
 
Symptom severity 
and Subjective 
cure. 
 
Leakage index. 
 
Statistical analysis 
performed with 
actual data, change 
difference, p values 
and CI reported. 
 
Change difference  
on standardised 
pad test (g) 
Mean(95%CI) 
Intervention: 19.6 
(14.4,24.8) Control: 
18.5(12.2, 24.7) 
p=0.73  
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neurological or 
psychiatric 
disease, urinary 
tract infection, 
use of 
concomitant 
treatments, 
pregnancy, not 
understanding 
instructions 
given in 
Norwegian or 
difficulties 
attending the 
trial sessions  
 
sessions (no 
biofeedback) 
and HEP 3 x a 
day 
 
Both groups 
seen once a 
week for 2 
months and 
once a fortnight 
for a further 4 
months 
 
 
 
Social activity 
index. 
 
Muscle strength 
(assessed by 
vaginal palpation 
and by vaginal 
balloon catheter). 
 
Blinded outcome 
assessment. 
Subjective Cure 
n(%) 
Intervention: 19(40) 
Control: 14(30) 
 
Change difference 
Muscle strength. 
Intervention:12.3 
(9.5, 15.1) 
Control: 11.1(8.1, 
14.1) p=0.57 
 
Change difference 
Leakage index: 
Intervention: 0.9 
(0.7, 1.0) 
Control: 0.9(0.7, 
1.1) p=0.61 
 
No significant 
difference between 
the groups for all 
outcomes. 
 
Goode et 
al., 2003    
 
N=200 
Inclusion 
criteria: age 
>40 years, UI 
for at least 3 
months, 
average 2 or 
more 
incontinence 
episodes/week, 
predominantly 
SUI. 
Exclusion 
3 groups 
66/67/67 
High attrition 
rate 
54/59/42 
completed 
Intervention 1 
PFMT + BF : 
Taught VPFMC 
with anorectal 
pressure 
biofeedback and 
received 
instruction for 
progressive 
PFMT regimen. 
Intervention 2 
PFMT + BF + 
ES: This arm 
High attrition 
rate (18.2%) 
from the 
Intervention 1 
group and 
(37.3%) from 
the control 
group.   
 
Actual 
compliance with 
the exercises/ 
advice was not 
8 weeks: 
Intervention 
groups were 
seen 4 times 
(every 2 
weeks).   
Control group 
seen at the 
beginning and 
end (0 weeks 
and 8 weeks). 
 
Groups did not 
Primary 
outcome: 
% reduction in 
number of 
incontinent 
episodes recorded 
by bladder diary. 
Secondary 
outcome: patient 
satisfaction and 
QoL  
(Incontinence 
Impact 
Mean reduction in 
incontinent 
episodes: % (SD) 
Intervention 1 
68.6%(32.4) 
Control: 
52.5%(42.7) p=0.02 
 
Pt complete 
satisfaction with 
progress: 
Intervention 1: 
31(66%) Control: 
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criteria: 
continual 
leakage, post-
void residual 
volume >150 
ml, severe 
uterine 
prolapse, 
decompensated 
congestive 
heart failure, 
haemoglobin A 
>/= 9, impaired 
mental status. 
UTI, faecal 
impaction, 
severe atrophic 
vaginitis, 
uncontrolled 
diabetes. 
 
not considered 
in this review. 
Control: PFMT 
written 
instructions: 
Received self-
help booklet 
detailing 
isolation of 
PFM and 
progression of 
PFMT 
programme. 
 
 
measured. receive same 
contact. 
Questionnaire, 
Hopkins Global 
Checklist and 
Short Form 36 
Heath Survey) 
20(50%) p=0.01 
 
QoL: Not reported 
for individual 
groups only for the 
whole sample. IIQ 
Scores changed 
from mean 93.1 to 
57.6 p<0.001 
(Other 
questionnaires 
yielded significant 
changes for all 
groups but 
individual groups 
mean scores are 
not given) 
 
Aksac et al., 
2003 
N=50 
Urodynamically 
proven SUI. 
No exclusion 
criteria stated. 
3 groups 
20/20/10 
Intervention: 
sEMG 3 times a 
week for 2 
months 
Treatment 2: 
initial palpation 
and HEP 
instruction  
Control: a no 
treatment 
control group 
 
Groups did not 
receive the 
same contact 
time. 
Not reported 8 weeks 
 
Assessed 
‘prior to and 8 
weeks after 
the treatment’ 
1 hour Pad test 
cure (weight gain 
of 1g or less), pad 
test improvement 
(50%or greater 
reduction 
in pad weight). 
 
Vaginal squeeze 
pressure. 
 
Digital palpation 
score.  
 
Incontinence 
frequency (four 
Statistically tests 
used, but specific 
tests used for each 
outcome not stated. 
%, Data and p-
values reported but  
no confidence 
intervals given. 
 
1 hour Pad test 
%cure/ 
%improvement: 
Intervention: 80/20, 
Treatment2:  75/25  
 
Vaginal squeeze 
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point ordinal 
scale): 
1=once a day, 
2=more than once 
a week,  
3=less than once 
a week, 
4= once a month. 
 
Social Activity 
Index (VAS) 
 
pressure: median 
(SD) cm water 
Intervention: pre 
19.1(4.8) post: 
50.0(11.5) p<0.001 
Treatment2:pre: 
20.3(6.2) post 
37.5(8.7) p<0.001 
 
Digital palpation 
score: 1-5 median 
(SD) 
Intervention: pre 
3.3(0.4), post 
4.9(0.2) p<0.001 
Treatment2: pre 
3.5(0.5), post 4.8 
(0.4) p<0.001 
 
Incontinence 
frequency: 
median(SD) 
Intervention: pre 
2.3(0.6) post 3.6 
(0.4) p<0.001 
Treatment2: pre 
2.3(0.7) post 
3.5(0.5) p<0.001 
Intervention group 
had significantly 
higher perineometry 
readings than 
digital palpation 
group (p<0.001). 
Both treatment 
groups had 
significant 
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improvement in all 
other parameters 
but there was no 
significant 
difference between 
the treatment 
groups. 
 
 Appendix 3  Table 8  Likely sources of bias for included biofeedback studies 
Study Randomisation 
and  Allocation 
Concealment 
Adequate 
power/sample 
size  
Blinding of 
participant, 
clinicians or 
assessors 
Apart from the 
intervention, 
groups treated 
equally 
Data Handling: 
missing data, drop 
outs and ITT  
Outcome assessment 
and  reporting 
Shepherd,  
Montgomery 
& Anderson, 
1983 
 
UK 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Randomization 
procedure not fully 
reported: ‘divided 
randomly’. 
Unclear if 
concealment of 
allocation was 
achieved. 
 
Assessment of 
baseline 
differences 
between groups 
measured but not 
compared or 
evaluated. 
 
No power 
calculation or 
determination of 
sample size 
Not stated Yes.  3 dropped out 
(14%) but it 
appears that data 
for all participants 
(22, 11 in each 
group) is reported. 
   
ITT not stated 
Validity and reliability of 
measures not stated. 
Extra outcomes (not 
stated in the methods) 
also appear in the results 
section: ‘dry’, ‘improved’, 
‘the same’, but it is 
unclear how this data was 
gathered and if it is 
patient reported or 
clinician assessed. User 
acceptability of the 
perineometer was 
reported, but there is no 
evidence of how this is 
assessed and this was 
not an original stated aim 
of the study.  
The primary outcome 
data is presented as 
percentage cure for each 
group but not discussed 
and not statistically 
analysed. There is 
speculation that fewer 
intervention group ‘drop-
outs’ meant that the 
intervention had created 
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‘motivation in 
participants’.  
Taylor & 
Henderson, 
1986 
 
USA 
 
Method of random 
allocation not 
stated 
‘randomly 
assigned’ 
 
Concealment of 
allocation unclear. 
 
No power 
calculation or 
sample size 
estimate given 
Not stated Yes 1 drop out (1 out of 
13=  
 
No useable data 
presented. 
Subjective rating scale, 
urinary diary, compliance 
assessment, EMG 
measures all meet ICS 
guidelines. 
 
Burns et al., 
1993 
 
USA 
 
‘Randomised in 
blocks of 12’. 
Concealment of 
allocation was 
likely. 
Initial measures 
made before 
randomization 
process. 
Baseline checks of 
each group showed 
no differences. 
No power 
calculation or 
determination of 
sample size. 
 
Not stated. 
 
Study 
described as 
‘single-blind’ 
which appears 
to be the 
researcher who 
was blind to the 
‘treatment 
conditions’ 
(deKruif, 1996) 
Yes 
 
10 dropped out 
(7%) 
A further 2 were 
excluded from 
analysis due to not 
completing diaries, 
so results were 
reported on only 
123 out of 135 
 
No mention of how 
missing values 
were handled. 
ITT not mentioned. 
 
 
Reliability or validity of 
outcomes or measuring 
equipment not stated, but 
all measures were 
performed to a described 
protocol using the same 
equipment and comply 
with ICS 
recommendations. 
 
Additional sub-group 
analysis eg correlations 
are also presented, ie 
urethral length 
 
Berghmans’ 
et al., 1996 
 
Netherlands 
Randomised by 
‘sealed envelopes’. 
‘Observer was 
blinded to 
allocation’, so low 
risk of bias. 
No power 
calculation or 
determination of 
sample size 
 
Effect 
measurement 
and data 
analysis was 
blinded. 
 
Yes No drop outs 
reported. 
 
Analysis was 
‘according to the 
ITT principle’. 
Pad test stated as a 
reliable and valid test. 
Measures comply with 
ICS 
Speculation that initial 
improvement in urine loss 
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Baseline 
differences were 
assessed and 
mean fluid intake 
difference was the 
only significant 
difference. 
 
 
No mention of how 
missing values 
were dealt with. 
 
assisted motivation in the 
intervention group, even 
though adherence or 
motivation to perform 
PFME is not assessed. 
 
Glavind,  
Nohr & 
Walter, 1996 
 
Denmark 
Randomized by 
‘sealed envelopes’.  
Unclear if 
concealment of 
allocation was 
achieved. 
 
Groups were 
assessed for 
equality at the start.  
Greater severity of 
leakage was found 
in Control group at 
the start of the 
study. 
 
No power 
calculation or 
determination of 
sample size 
 
Not stated No 
 
6 dropped out 
(15%).  This data is 
not analysed. 
No mention of ITT 
or how missing data 
is handled. 
‘New’ standardized pad 
test used.  Validity and 
reliability not stated. 
Questionnaire validity not 
stated. Measures comply 
with ICS 
 
All outcomes are reported 
and findings match the 
results. 
Sherman,  
Davis & 
Wong, 1997 
 
USA 
Method of 
randomization not 
specified:  ‘subjects 
were stratified 
according to 
diagnosis and were 
then randomised’. 
 
Unclear if 
concealment of 
allocation was 
achieved. 
No power 
calculation to 
determine 
sample size. 
 
Not stated Yes 
 
7 dropped out 
(15%).  These were 
excluded from the 
analysis, therefore 
analysis not ITT.  
Data for 39 was 
analysed  
(23 intervention 
group and 16 
control group) 
 
(it is stated that ‘all 
Outcomes not stated at 
the outset but results 
were presented as 18 
items, with ordinal 
categories such as 
0=never 1= sometimes, 
2=always. 
Some outcomes were 
self-reported ie degree of 
urgency, severity of the 
problem. Some rated by 
the clinician, such as size 
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?how many were 
randomised 
(unclear in the text)  
Baseline similarity 
of groups was 
assessed, but not 
reported. 
 
questionnaires 
were returned and 
filled out to a 
useable extent’) No 
mention of how 
missing values 
were dealt with. 
of ‘paravaginal defect’ 
and some were results 
from urodynamics, such 
as urethral closure 
pressure or bladder 
capacity. All comply with 
ICS 
 
Although designed as a 
treatment comparison 
trial, the findings did not 
report conclusions for 
this. 
 
 
Wong et al., 
1997 
Conference 
presentation. 
Abstract only 
 
Hong Kong 
 
Method of 
randomization and 
number 
randomized not 
stated. 
 
Baseline 
differences 
assessed and 
groups found to be 
‘comparable’. 
 
No power 
calculation or 
determination of 
sample size. 
Not stated Yes Study was 
incomplete  
 
Data presented for 
17 
Not sure if drop 
outs occurred as 
not stated. 
Self-completed Urinary 
diary, 1-hour pad test, 
incontinence impact 
questionnaire (IIQ)are 
valid and reliable 
measures and comply 
with ICS guidance. 
 
Laycock et 
al., 2001a 
 
Multi centre 
international 
(UK, Ireland, 
Australia, NZ) 
 
Randomisation 
using prepared 
random numbers 
tables in the ratio 
2:2:1 
No significant 
difference found at 
baseline in any 
variable, supporting 
the randomisation 
Sample size of 
120 estimated 
by power 
calculation  
Not stated Yes 101 recruited but 
only 68 finished 
(33% drop out). 
 
ITT not mentioned. 
All outcome measures 
were performed in a 
standard way.   
Incontinence episodes by 
bladder diary, 
Subjective symptom 
severity rating scale 
(VAS), Perineometer 
readings and Kings 
Health Questionnaire 
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process. 
 
 
 
 
(validated). 
  
All conformed with ICS 
guidelines. 
 
Pages et al., 
2001 
 
Germany 
 
Randomised using 
a ‘randomization 
table’  
 
Baseline difference 
between groups 
was assessed 
using the 
Kolmogorov-
Smirnov test 
 
 
No power 
calculation to 
determine 
sample size. 
 
 
Not stated  
 
 
No.  Possible 
difference in 
supervision 
intensity as 
Intervention group 
seen individually 
for treatment and 
control group 
received treatment 
as a group. 
 
11 (22%) were 
excluded or 
decided to withdraw 
after randomization. 
This data was not 
analysed, so not 
ITT, and the paper 
says ‘all 
participants 
completed the 
study’. 
Missing data for 
digital contraction 
strength as 7 
participants 
declined a further 
examination. Data 
for this outcome is 
given for only 33 
not 40 participants. 
 
 
Digital palpation and 
speculum test (?) 
performed by same 
assessor. Neither 
measure has reliability or 
validity stated. 
Urination diary, subjective 
reporting and biofeedback 
procedure was 
standardized but not 
stated if validated. All 
comply with ICS 
 
Clear reporting of the 
‘change’ for each group 
(and significance of 
change for each group) 
but unclear when 
reporting comparison of 
change for the groups. 
 
 
Morkved,  Bø 
& Fjortoft, 
2002 
 
Norway 
 
Randomised after 
stratification (by 
participant drawing 
an ‘opaque sealed 
envelope’ from a 
larger one). 
Randomisation 
‘centralized but not 
computerised’. 
 
Yes, power 
calculation and 
sample size 
calculation 
made based on 
estimated 
treatment effect. 
 
Blinded 
assessors 
used. 
 
 
Yes 
 
9 dropped out 
(8.7%) 
 
Data  ‘analysed as 
ITT’ 
‘Missing last values 
were considered as 
equal to baseline 
values’ 
 
Outcome measures were 
all referenced. 
 
Vaginal balloon recording 
of muscle strength was 
stated as ‘a reliable and 
valid method’ and 
referenced.  
The leakage index and 
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Envelopes were not 
prepared by the 
staff involved in the 
research, so 
satisfactory 
allocation 
concealment and 
low risk. 
Baseline measures 
were compared to 
see if there was 
group parity. 
 
Social activity Index had 
been tested for 
reproducibility. 
 
 
Main outcomes reported 
clearly comparing the 
change difference for 
groups and significance.  
Outcomes comply with 
ICS guidance. 
 
 
Goode et al., 
2003 
 
USA 
 
Patients were 
randomised by 
means of a 
computer-
generated 
randomisation 
schedule.  
Stratification for UI 
type, severity and 
race. 
 
Unclear if 
concealment of 
allocation was 
achieved. 
 
Sample size 
determined by 
power 
calculation 
 
Not stated 
 
No 
 
High attrition rate 
(18.2%) from the 
Intervention 1 group 
and (37.3%) from 
the control group.  
 
Analysis is by 
‘intention to treat’ 
but last value 
carried forward is 
used. 
 
 
All outcomes were 
validated and reliable and 
in line with ICS 
guidelines. 
 
Main outcomes were 
reported but the QoL was 
not reported by group. 
 
Percentages, 
Mean/median with 
SD/range given but no 
Confidence Intervals 
given. 
 
Aksac et al., 
2003 
 
Turkey 
 
Participants 
‘allocated at 
random’ by ‘sealed 
envelopes’. Women 
were requested to 
choose an 
envelope. 
 
No sample size 
estimate or 
power 
calculation 
performed 
 
Not stated 
 
No 
 
No drop outs 
reported, although 
ITT not specifically 
stated. 
 
No mention of how 
missing values are 
 
Some outcomes 
standardised eg pad test 
and digital grading of 
muscle strength.  Unsure 
if VAS is self-
reported/completed or 
clinician assessed. 
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Unclear if 
concealment of 
allocation was 
achieved. 
Groups compared 
at baseline in terms 
of severity of SUI 
and no difference 
was found.  Other 
group 
characteristics 
were compared for 
parity at baseline 
and found to be not 
significantly 
different. 
 
handled. 
 
 
No mention of validity and 
reliability of measures 
used. 
 
All outcomes were 
reported and categories 
comply with ICS guidance 
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Randomisation 
 
0 0 1 2 1 0 0 1 1 2 2 1 
Concealed 
allocation 
0 0 1 1 0 0 0 0 0 1 0 0 
Blinded 
outcome 
assessors 
0 0 0 1 0 0 0 0 0 1 0 0 
Assessment of 
group equality 
at baseline 
1 0 1 1 1 1 1 1 1 1 1 1 
Equality of 
groups at 
baseline 
0 0 1 1 0 0 1 1 1 1 1 1 
Groups treated 
equally 
1 1 1 1 0 1 1 1 0 1 0 0 
Robust 
Outcome 
Measures 
(OM) 
1 1 2 1 1 0 2 2 2 2 2 2 
OM fully 
reported 
1 0 1 2 2 0 2 2 1 2 2 2 
Analysis by 
ITT or Drop-
outs less than 
10% 
0 1 1 1 0 0 0 0 0 1 1 1 
 
Total score 
(12) 
 
 
4 
 
3 
 
9 
 
11 
 
5 
 
2 
 
7 
 
8 
 
6 
 
12 
 
9 
 
8 
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Appendix 5                                  information sheet (Version1) 
27.08.07 
 
Does physiotherapy treatment for the management of urinary 
incontinence improve pelvic floor muscle exercise self-efficacy 
and exercise adherence?             
 
Introduction 
You are invited to take part in a research study.  Before you take 
part it is important you understand why the research is being done 
and what it involves.  Please take time to read this information and 
discuss it with others if you wish.  If after reading this leaflet, you 
would like more information or if anything is unclear, please discuss 
this with me at your first appointment or contact me on the 
telephone number at the bottom of the page.  
If you want to participate, you will be asked to sign a consent form 
to show you have agreed to take part, however you would still be 
free to withdraw at any time during the study and this would not 
affect the standard of care you receive.  
 
1. What is the purpose of the research? 
Sometimes we don’t know which way of treating patients is best. To 
find out, we need to compare different treatments. None of the 
treatments in this study are new, and all of them are thought to be 
effective in the treatment of urinary incontinence.   
We put people into groups and give each group a different 
treatment. The results are compared to see if one is better. To try to 
make sure the groups are the same to start with, each patient is put 
into a group by chance (randomly).  
The project will study women experiencing urinary incontinence, 
who have been referred for physiotherapy by their doctor.  This 
research is to see if using different treatments as part of 
physiotherapy helps you to perform your pelvic floor exercises more 
effectively.  
You have a 1 in 2 or 50/50 chance of being allocated into either one 
of the 2 groups. 
 
 
2. What will I have to do? 
You will be required to attend clinic for two 1 hour sessions plus two 
40 minute treatment sessions over a period of 3 months. You may 
also receive biofeedback therapy, asked to follow advice about how 
to manage your leakage and asked to perform exercises at home. 
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You may also be examined at each treatment session. This will be 
no different to attending for Physiotherapy in the normal way.   
 In addition, you will be asked to fill in a short questionnaire at your 
first appointment, a questionnaire at each attendance and 4 short 
questionnaires after the last treatment session.  It is an essential 
study requirement that you attend each clinic appointment and 
complete the questionnaires.  Your answers are very important and 
will be used in the research.  At the end of the 3 months you may 
be contacted for a short interview (held at the clinic) about your 
experiences of taking part in the study. 
 
3. What will the treatments involve?  
Pelvic floor muscle exercises are commonly used in the treatment 
of urinary incontinence.  They need to be practised daily at home. 
Biofeedback is the term given to therapy that more easily allows 
you to ‘visualise’ your muscle contractions.  It involves using an 
internal vaginal sensor to record pelvic floor muscle contractions, 
displaying your efforts on a computer screen.  It is not a new 
treatment and is commonly used in clinics throughout the country.  
There are no known dangers or side-effects associated with using 
it.                                    You may also be given information about 
your bladder function and tips to improve your symptoms, including 
charts and diaries to help record your progress. 
 
All research in the NHS is looked at by an independent group of 
people, called a Research Ethics Committee to protect your safety, 
rights, wellbeing and dignity. This study has been reviewed and 
given favourable opinion by Tameside Research Ethics Committee.  
We will follow ethical and legal practice and all information about 
you will be handled in confidence.  
 
Your name will not appear on any of the questionnaires or 
transcripts of interviews, instead these will be coded. 
Your name will only be known to the researcher and will not be 
passed on to anyone else.  
 
 
4. Why have I been chosen? 
All women with urinary incontinence referred by their doctor to this 
clinic for physiotherapy from October 2007 to October 2008 will be 
assessed and if eligible invited to participate in this research. 
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5. Do I have to take part? 
Participation is voluntary and it is up to you whether you choose to 
take part.  We cannot promise the study will help you but the 
information we get from this research will help improve the future 
treatment and services for people with incontinence.  
If you do decide to take part, remember you can still withdraw at 
any time during the research without affecting your future treatment.   
 
6. What will happen to the results? 
Results will be used in a report and may be presented at 
conferences or published in scientific journals.  Your name will not 
be used and any comments made during interview will not be 
traceable to you.  All questionnaires and interview notes will be kept 
securely in a locked filing cabinet.  A summary of the research 
findings will be made available to participants on request. 
All completed questionnaires and interview transcripts and data will 
be kept for 10 years following completion of the study. 
 
7. What happens next? 
If you wish to take part, please keep this information sheet and 
bring the enclosed consent form to your next physiotherapy 
appointment.  At this appointment you can ask any further 
questions about the project.  If you want to participate in this 
research, you will need to sign the consent form. 
You will then be allocated to one of two groups.  
 
It is important for you to know that group allocation is a random 
process and you cannot choose to go into a particular group.   
However, after the research has been completed, if you feel you 
would like further treatment, this can be discussed and arranged.  
If you do not wish to participate in this study, then your treatment 
will continue as if you had been referred to physiotherapy in the 
usual way. 
If you have a concern about any aspect of this study, you should 
ask to speak to the researcher who will do their best to answer your 
questions (contact number Sue Hallam Tel: 0161 331 6313) 
If you are still unhappy and wish to complain formally, you can do 
this through the NHS Complaints Procedure. Details can be 
obtained from the hospital.  
 
Sue Hallam, Continence Specialist Physiotherapist and Researcher 
0161 331 6313 
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Appendix 6  Consent Form   Version 1  27.08.07          Patient Code: 
 
Does physiotherapy treatment for the management of urinary 
incontinence improve pelvic floor muscle exercise self-efficacy 
and exercise adherence?             
Name of Researcher: Sue Hallam, Continence Specialist Physiotherapist 
 
 
1. I confirm that I have read and understand the                   Initial 
box 
    information sheet dated…………version 1  for   
    the above study. I have had the opportunity to   
    consider the information, ask  questions and                        
    have had these answered satisfactorily.                                  
                                                                                                    
 
2. I understand that my participation is voluntary  
    and that I am free to withdraw at any time without 
    giving a reason, and without my medical care or                   
    legal rights being affected.                                                                                 
                                                                                                                                   
                                                                              
3. I understand that relevant sections of my medical  
    notes and data collected during this study may be  
    looked at by the Researcher and Clinical Audit                      
    Department from Tameside General Hospital,  
    where it is relevant to me taking part in this research.   
    I give permission for these individuals to access my records.                           
 
 
4. I agree to take part in the above study.    
                            
 
---------------------------            --------------------        ------------------------- 
Name of patient                           Date                              Signature 
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Pelvic Floor Muscle 
Exercises 
An Information Leaflet 
                                               
Exercises to Strengthen the Pelvic Floor Muscles 
 
What are pelvic floor muscles? 
 
The pelvic floor is a sheet of muscle extending between your 
legs from the ‘tail bone’ near your back passage to the pubic 
bone (below your bladder at the front).  It makes up the ‘floor’ 
of our pelvis and helps support the bladder, womb and bowel.  
 
Openings to the bladder, vagina and bowels pass through 
these muscles.  Normally, we are unaware of these muscles 
working.  They relax when we want to go to the toilet, and 
contract to help  stabilise our lower body and stop us leaking 
when we are physically active.  They also help us to ‘hang on’ 
when we need the toilet. 
 
Why exercise them? 
 
The muscles can become weak as a result of childbirth,  
straining when constipated, chronic coughing, being over-
weight, persistent heavy lifting and menopausal changes. 
 
Improvement in pelvic floor muscle strength helps prevent 
leakage of urine from the bladder, improves bowel control and 
helps prevent prolapse.  Stronger pelvic floor muscles will also 
help if you suffer heaviness or discomfort in your vagina or 
have piles. 
 
Improving your pelvic floor muscle control may also improve 
your own, and your partner’s enjoyment of sex. 
 
Exercising your pelvic floor muscles after vaginal surgery or 
childbirth reduces discomfort and swelling and helps healing. 
 
It is recommended that all women practise these exercises 
daily and throughout life! 
                                                       1 
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For advice about all aspects of incontinence, please  
contact: 
 
The Continence Advisory Service Tel:  0161 366 4132 
Union Street Clinic  
Hyde 
 
Other useful information is available from: 
 
The Bladder and Bowel Foundation (B&BF)  Tel: 01536 533255 
SATRA Innovation Park 
Rockingham Rd 
Kettering, Northants NN16 9JH 
 
info@bladderandbowelfoundation.org  
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 When you feel the urge to empty your bladder try the following  
delaying techniques: 
 
• Tighten you pelvic floor muscles 
• Sit on something hard, e.g. a chair arm 
• Distract your mind 
 
 
 
Bowel Urgency:  If you have to rush to the toilet to open your  
bowels, you can try using the exercises to help you ‘hang on’. 
Practising this should help you regain bowel control.   
 
Additional Tips 
 
• Trying to get down to your correct weight reduces the strain 
on the pelvic floor muscles and can make a considerable  
improvement. 
 
• Straining when you open your bowels stretches and     
weakens your pelvic floor muscles.  Make sure you are eat-
ing a healthy balanced diet and have an adequate fluid     
intake.  If you still have problems seek help from your GP. 
 
• Lifting puts strain on your pelvic floor.  Remember to tighten 
your pelvic floor before you lift and hold it tight until you have 
lowered the load. 
 
• If you attend fitness training or go to the gym, remember to 
take care with  activities that increase abdominal pressure, 
e.g. sit ups, or any activity with ‘high impact’ such as      
trampolining.  These type of activities may put your pelvic 
floor at risk of becoming weaker.  Use pelvic floor            
contractions to ‘brace’ prior to such exercises, and seek  
specialist instruction.  Failing this, avoid them altogether. 
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How to do the exercises 
 
Get yourself into a comfortable position (sitting, standing or lying 
down). 
 
Start by breathing out; then draw up the front and back  
passages as strongly and intensively as you can  Now relax and 
let go.  It may help to imagine that you are trying to stop yourself 
from passing wind and at the same time trying to stop your flow 
of urine.  The feeling is like a ’squeeze and lift’ sensation.  This 
is a pelvic floor contraction.  
 
Remember to try not to hold your breath, or squeeze your legs 
or tighten your buttocks. Start gently and stop if it hurts. 
 
 
 
 
The feeling of doing the exercise can also be described as “lift 
doors closing and the lift going up to the top floor” or tightening 
up as if you are trying to stop a tampon from slipping out. 
 
You can examine yourself to check if you are doing the          
exercises correctly.   
 
• Use a mirror to see your vagina ‘squeeze and lift’ 
 
• Next time you are in the bath, put your right thumb inside 
your vagina and feel downwards and to the left.  Try a 
contraction and see if you can feel the muscles tense.  
Now try a contraction with your left thumb feeling the   
muscles on the right hand side. 
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 Now try these… 
 
1. Briskly contract your muscles as strongly as you can and see 
how many seconds you can  hold the contraction for. Aim for a 
maximum of 10 seconds. Try to lift higher with each second 
counted.  Release and rest for the same number of seconds. 
 How many times can you repeat this ‘contract, hold and  
         release pattern? ...times. 
 
2. Next see if you can contract your pelvic floor briskly and  
 strongly and then immediately let go. Aim for a maximum of 10   
  How many times can you repeat these?  ...times. 
 These are called ‘quick’ contractions and help your muscles  
         respond quickly, especially useful to prevent leakage of urine  
         when you cough or sneeze! 
 
 Both these types of exercises are important in training and  
  improving pelvic floor muscle function.  Try to perform  these 
 exercises 3-5 times a day …. every day.  No-one can tell you       
are doing them!  You can exercise in any position, standing up, 
lying down or sitting in a chair.  Try them all out and see which 
position suits you best. 
 
 If you can exercise more often, so much the better … see if you 
can do them 5 times day or every 2 hours.  Make sure you rest 
for at least 4 seconds between each contraction to prevent  
         tiring of the muscles. 
   
 The exercises are not difficult, but they do need practising regu-
larly and they are often forgotten if you lead a busy life! 
 
 Think of ways to remind yourself to do your exercises...every 
time you wash your hands, listen to a news bulletin, feed the 
baby, stop at a red traffic light, queue for the checkout at the 
supermarket, after passing urine. 
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Eventually: 
 
You will notice your pelvic floor awareness improve.  You will 
also find that you can hold each contraction for longer and re-
peat more times.  By increasing the exercises in this way, your 
muscles will become stronger. 
 
Try to aim for 10 contractions holding each one for 10 seconds       
followed by 10 quick contractions, at least three times a day. 
 
As with any muscle training, it takes time to build up strength 
and improve your muscle function.  Don’t expect to notice an 
instant improvement; it may take 3-6 months of regular exer-
cises to see a difference in symptoms. 
 
If, however, you have been doing these exercises and your 
symptoms persist, do contact your doctor, continence advisor 
or physiotherapist, as other treatment options are available. 
 
Other Advice 
 
Liquid intake:  You should aim for approximately 6-8 drinks a 
day (1-2 litres or 3-4 pints).  Avoid caffeine e.g. Tea, Coffee or 
Cola, if you can.  Restricting your fluid intake will not help and 
could make matters worse. 
 
Sudden Movements:  Try to tighten and hold the pelvic floor  
muscles prior to coughing, sneezing and lifting.  This will im-
prove your control and reduce leakage of urine or faeces. 
 
Emptying your bladder:   Although it is important to com-
pletely empty the bladder without straining each time you go to 
the toilet, try to avoid doing this too frequently, as this can re-
duce capacity.  If you need to pass water frequently, try to train 
your bladder to wait longer.   
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Appendix 8    
 
Pelvic Floor Exercises     
 
Try: 
             .….   contractions 
 
    Holding each one for  ……   seconds 
 
           Rest for ….. seconds in between each one  
 
Followed by: 
          
             ..…  fast contractions 
 
Do both types of exercises 3 times a day. 
 
In addition: 
 
3. Try a ‘first floor’ (less intensive) contraction 
and see if you can hold it for twice as long as the 
stronger ones. Do these while performing activi-
ties at home or at work e.g.  As you climb the 
stairs, while shopping, when walking around. 
 
4. Remember to contract your pelvic floor    
muscles strongly before coughs and sneezes, and 
also before lifting, and other strenuous activities.  
 
5. Contract your pelvic floor muscles to control 
any bladder urgency. 
 
 
(Version 2, 27.07.07 
 
                      Diary                               
 
 
 
   Week 1 
 
 
 
 
 
 
 
 
    Week 2  
 
 
                                                  
 
 
 
 
 
             
 1 2 3 
 Tick Tick Tick 
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Fri    
Sat    
Sun    
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Weds    
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Fri    
Sat    
Sun    
 1 2 3 
 Tick Tick Tick 
Mon    
Tues    
Weds    
Thurs    
Fri    
Sat    
Sun    
Mon    
Tues    
Weds    
Thurs    
Fri    
Sat    
Sun    
Mon    
Tues    
Weds    
Thurs    
Fri    
Sat    
Sun    
Week 4  
Week 5 
Week 6   Week 3 
Appendix 9    PFME treatment and progression algorithm 
 
 
Confirm correct PFM 
contraction and relaxation is 
achieved 
Vaginal examination 
Brisk onset and 
‘let-go’ 
Use visualisation 
techniques 
Check for pain and 
muscle tone 
Ensure no breath 
holding or 
accessory muscle 
use. 
Rest in between 
each contraction 
 
Participant able to sustain * 
seconds of maximal 
contraction and repeat 5 times 
                          
 
 
 
 
 
Aim for * plus one second, 
repeated 5 times and 5 fast 
contractions, 3 times a day 
Increase by one repetition and 
then one second hold until 10 
contractions, holding each for 
10 seconds is achieved. 
 
Perform this 3 times a day. 
Lift ‘higher’ as 
each second is 
counted 
Adjust rest time 
between 
contractions  
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Pt Code :              Week no: 
 
                               
 Appendix 10             The Chen PFMSE scale                   
 
We would like to know how confident you are in performing pelvic floor 
muscle exercises. Please answer as accurately as you can. 
For each of the following questions, please put an “X” in the response box 
which corresponds to your level of confidence in performing pelvic floor 
muscle exercises at this time. Response range is from (1) not very, to (5) 
extremely confident 
 
 
1 =  not very confident 
2 =  a little confident 
3 =  reasonably confident 
4 =  very confident 
5 =  extremely confident 
 
                                                                                           
1. I believe I can contract my pelvic floor muscles   1      2     3      4      5 
     as strongly as I can                                                                 
 
 
2. I believe I can contract my pelvic floor muscles   1      2     3      4       5 
for a duration of 5 seconds                                                    
 
 
3. I believe I can contract my pelvic floor muscles   1      2      3      4      5 
     for a duration of 10 seconds                                                
 
 
4. I believe I can feel the contraction of the               1     2      3      4      5 
 muscles while I am doing the exercises                             
 
 
5. I believe I can do the pelvic floor muscle              1      2     3       4      5 
exercises daily                                                                      
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                                               1=not very confident, 5=extremely confident            
 
 
6. I believe I can do pelvic floor muscle                    1      2      3     4      5 
     exercises regularly for 3 months                                         
 
 
7. I believe I can remind myself to do pelvic              1     2      3      4      5 
     floor muscle exercises every day                                         
 
 
8. I believe I can do pelvic floor muscle                    1      2      3     4      5 
exercises even when there is a lack of time                        
 
 
9. I believe I can do pelvic floor muscle                     1      2     3      4     5 
exercises even when I lack energy (too tired)                     
 
 
10. I believe I can do pelvic floor muscle                    1      2      3     4      5 
     exercises while doing housework                                       
 
 
11. I believe I can do pelvic floor muscle                    1      2      3     4      5 
exercises while watching TV                                              
 
 
12. I believe I can do pelvic floor muscle 
     exercises any time I think of it, eg when 
     waiting at the supermarket checkout,  
     at red traffic lights,  waiting for the kettle              1     2      3      4     5 
          to boil, washing my hands                                                  
 
 
 
13. I believe I can contract my pelvic floor muscles  
     before physical exertion eg coughing, laughing,     1     2      3      4     5 
lifting, standing up                                                               
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Pt code:     week:                                          
 
 
                                             1= not very confident,  5= extremely confident        
 
 
 
14. I believe that pelvic floor muscle exercise              1     2      3      4     5 
can help reduce urinary leakage                                          
 
 
                                                                                      
15. I believe that pelvic floor muscle exercise 
     can help avoid (or delay) the need for                     1     2      3      4      5 
     continence surgery                                                               
 
 
 
16. I believe I can contract my pelvic floor muscles    1      2     3      4      5 
     to increase pleasure during sexual intercourse                    
 
 
 
17. I believe I can do pelvic floor muscle exercises      
even without additional guidance or intervention  
from a therapist 
                                                                                1     2     3      4      5                      
                                                                                            
 
 
 
 
 
 
 
 
 
 
                            
 
 
 
 
 
Appendix 11   
   
Change in wording to item 17 of the Chen PFME SE questionnaire 
 
 
 
Original wording: 
 
I believe I can do pelvic floor muscle exercise even without the assistance of 
biofeedback and/or electrical stimulation 
 
 
 
Changed to  
 
I believe I can do pelvic floor muscle exercises even without additional 
guidance or intervention from a therapist 
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Appendix 12     
 
                                 Adherence Questionnaire   
 
 
1. Did you do the pelvic floor muscle exercises yesterday?  
( Please circle a letter) 
 
A.   No, because I don’t remember exactly how to do them  
 
B.   No, because I forgot to do them   
 
C.   No, because I didn’t feel like doing them   
 
D.   No, because my urinary leakage wasn’t bothering me enough  
to do them   
 
E.   No, because I was busy doing other things   
 
F.   No, because I was too tired to exercise  
 
G.   No, because the exercises give me an uncomfortable feeling   
 
H.   Yes  
 
 
 
 
2. How often did you do the exercises yesterday? 
 
A.   I did not exercise yesterday  
 
B.   I exercised a little,  ….times   
  
C.   I exercised now and then,  ….times  
 
D.   I exercised regularly,   ….times  
 
 
 
Version 1,  27.08.07  
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3. Did you do the exercises in the last 7 days? 
 
A. No, because I don’t remember exactly how to do them 
 
B. No, because I forgot to do them  
 
C. No, because I didn’t feel like doing them  
 
D. No, because my leakage wasn’t bothering me enough to do 
them  
 
E. No, because I was too busy doing other things  
 
F. No, because I was too tired  
 
G. No, because the exercises give me an uncomfortable feeling  
 
H. Yes  
 
 
 
4. In the last 7 days, on how many days did you do the exercises? 
Please circle. 
 
0 days  1day   2 days   3 days   4 days    5 days    6 days    7 days    
 
 
 
 
5. Give yourself a ‘score out of ten’ for how well you have exercised 
in this last week 
 
1        2        3        4        5        6        7        8        9        10 
 
 
 
 
 
 Version 1,  27.08.07 
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6. Can you write down a description of the exercises that have been 
suggested by the physiotherapist? 
 
      
 
             (Version 1)     
 
 
 
 
Version 1,  27.08.07 
 
 Appendix 13               Hospital Anxiety and Depression Scale 
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Appendix 14 
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Appendix 15         Frequency/volume chart 
 
Day:         Date: 
 
Time Amount 
of 
urine 
(mls) 
Tick 
leaks
Type 
of 
drink
Amount 
of 
drink 
(mls) 
Tick 
bowel 
movement 
Comments
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
Total 
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Appendix 16   Study flowchart 
 
  Excluded  (n= 100 ) 
 
  Not meeting inclusion criteria 
(n= 85 ) 
  Refused to participate 
(n= 5) 
  Other reasons  
(n=10) 
Randomized 
Enrollment 
Assessed for eligibility 
(n=160 ) 
       
 
 
 
 
 
 
 
 
DNA follow up at week 12 
(n=1) 
Allocated to Group A (n= 29 ) 
 
Received 1St allocated 
intervention (n= 29 ) 
  
Discontinued intervention before 
week 6 (n= 2)    
Reasons: referred to consultant, 
other personal commitments. 
 
 
DNA intervention at week 6 (n=1) 
Analysed  (n=  25) 
 
Analysis of completed cases 
plus 
Sensitivity analysis for main 
outcomes for n=29 
 
 DNA follow-up at week 12 
(n=2)  
Allocated to Group B (n= 31 ) 
 
Received 1st allocated 
intervention (n= 31 ) 
 
Discontinued intervention before 
week 6 (n= 2)  
Reasons: referred to consultant, 
family member ill. 
 
 
DNA intervention at week 6 (n=2) 
 
 
Follow-Up 
Allocation 
Analysed  (n= 25 ) 
 
Analysis of completed cases 
plus 
Sensitivity analysis for main 
outcomes for n=31
Analysis 
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